laware |
6770 |
|||
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(IRS Employer Identification Number) |
James R. Griffin, Esq. Weil, Gotshal & Manges LLP 200 Crescent Court, Suite 300 Dallas, TX 75201 (214) 746-7779 |
Kyle C. Krpata, Esq. Weil, Gotshal & Manges LLP 201 Redwood Shores Parkway Redwood Shores, CA 94065 (650) 802-3093 |
Daniel S. Kim, Esq. Mitchell Zuklie, Esq. Hari Raman, Esq. Albert Vanderlaan, Esq. Orrick, Herrington & Sutcliffe LLP 631 Wilshire Boulevard Santa Monica, CA 90401 (301) 633-2800 |
Austin Russell President and Chief Executive Officer Luminar Technologies, Inc. 2603 Discovery Drive, Suite 100 Orlando, FL 32826 (407) 900-5259 |
Large accelerated filer | ☐ | ☒ | ||||
Non-accelerated filer |
☐ | Smaller reporting company | ☒ | |||
Emerging Growth Company | ☒ |
Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) |
☐ | |
Exchange Act Rule 14d-1(d) (Cross Border Third-Party Tender Offer) |
☐ |
| ||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered |
Proposed Maximum Offering Price Per Public Unit |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee | ||||
Class A common stock to be issued in the Business Combination |
220,234,292 (1)(2) |
N/A | $2,647,216,190 (3) |
$343,609 (4) (5) | ||||
| ||||||||
|
(1) | Represents the estimated maximum number of shares of Class A common stock, par value $0.0001 per share (“ Class A Stock Post-Combination Company Luminar Class A Stock A-1 Preferred Stock, par value $0.00001 per share, (E) 1,322,780 issued and outstanding shares of Luminar Series A-2 Preferred Stock, par value $0.00001 per share, (F) 223,548 issued and outstanding shares of Luminar Series A-3 Preferred Stock, par value $0.00001 per share, (G) 49,827 issued and outstanding shares of Luminar Series A-4 Preferred Stock, par value $0.00001 per share, (H) 137,715 issued and outstanding shares of Luminar Series A-5 Preferred Stock, par value $0.00001 per share, (I) 247,420 issued and outstanding shares of Luminar Series A-6 Preferred Stock, par value $0.00001 per share, (J) 1,459,656 issued and outstanding shares of Luminar Series A-7 Preferred Stock, par value $0.00001 per share, (K) 385,777 issued and outstanding shares of Luminar Series A-8 Preferred Stock, par value $0.00001 per share, (L) 748,674 issued and outstanding shares of Luminar Series A-9 Preferred Stock, par value $0.00001 per share, (M) 252,801 issued and outstanding shares of Luminar Series A-10 Preferred Stock, par value $0.00001 per share, (N) 317,404 issued and outstanding shares of Luminar Series A-11 Preferred Stock, par value $0.00001 per share, and (O) 1,251,971 issued and outstanding shares of Luminar Series X Preferred Stock, par value $0.00001 per share (the “Luminar Series X Preferred Stock multiplied by (ii) 13.5787, the estimated Per Share Company Stock Consideration (as defined herein) under the Merger Agreement, equal to (A) (I) (x) $2,928,828,692 plus (y) $30,000,000, the maximum Subsequent Series X Financing Amount, divided by (II) $10.00, divided by (B) the sum of (without duplication) (x) 20,265,546, the maximum aggregate number of shares of Luminar Stock that will be outstanding as of immediately prior to the effective time of the First Merger (as defined herein) and (y) 1,524,704, the aggregate number of shares of Luminar Stock issuable upon exercise of all (I) Luminar Stock Options (as defined herein) and (II) Luminar Warrants (as defined herein), in each case, that will be outstanding as of immediately prior to the effective time of the First Merger; (b) 15,308,450 shares of Class A Stock that may be issued as contingent consideration in the Business Combination pursuant to the Merger Agreement; and (c) 35,000,000 shares representing the estimated maximum amount to be held in reserve for future issuance. |
(2) | Pursuant to Rule 416(a) promulgated under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions. |
(3) | Pursuant to Rules 457(c), 457(f)(1) and 457(f)(3) promulgated under the Securities Act and solely for the purpose of calculating the registration fee, the proposed aggregate maximum offering price is (i) $12.02 (the average of the high and low prices of Public Shares as reported on Nasdaq on September 8, 2020) multiplied by (ii) 220,234,292 shares of Class A Stock to be registered. |
(4) | Computed in accordance with Rule 457(f) under the Securities Act to be $343,608.66, which is equal to 0.0001298 multiplied by the proposed maximum aggregate offering price of shares of Class A Stock of $2,647,216,190. |
(5) |
Previously paid on September 14, 2020. |
• | at the closing of the Business Combination, First Merger Sub will merge with and into Luminar, with Luminar continuing as the Surviving Corporation (the “ First Merger |
• | immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation will merge with and into Second Merger Sub, with Second Merger Sub continuing as the Surviving Entity (the “ Second Merger Business Combination |
• | prior to the consummation of the Business Combination (and subject to approval by our stockholders), we will adopt the proposed Second Amended and Restated Certificate of Incorporation (the “ Second Amended and Restated Certificate of Incorporation Annex B , to provide for, among other things, the authorization of the Class B Stock to be issued in connection with the Business Combination; |
• | in connection with the Business Combination, the Luminar Equityholders will receive, in exchange for their Luminar equity, approximately 188,167,552 shares of Class A common stock, par value $0.0001 per share (“ Class A Stock Class B Stock Aggregate Company Stock Consideration Luminar Class A Stock Luminar Preferred Stock Luminar Founders Preferred Stock Luminar Restricted Stock Luminar Stock Plan Luminar Stock Options Luminar Warrants Company Stock Adjusted Fully Diluted Shares Per Share Company Stock Consideration Luminar Class B Stock |
together with the Luminar Class A Stock, the Luminar Preferred Stock and the Luminar Founders Preferred Stock, the “ Luminar Stock earn-out shares of Class A Stock or Class B Stock, as applicable (the “Earn-Out Shares |
• | at the closing of the Business Combination, the Company, our Sponsor, Randall Bort, Michael Cramer, Joseph Gatto, Austin Russell, GVA Auto, LLC, a Delaware limited liability company (“ GVA G2VP Luminar Holders Registration Rights Holders Registration Rights Agreement Earn-Out Shares or issuable upon the conversion of any Earn-Out Shares, in each case, held by the Luminar Holders, and (b) any other equity security of the Company issued or issuable with respect to any such share of Class A Stock by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise, will be entitled to registration rights; and |
• | our Initial Stockholders have agreed, and their permitted transferees will agree, to vote their Founder Shares, as well as any Public Shares purchased during or after the Company IPO, in favor of the Business Combination. |
• | a proxy statement for the special meeting of the Company in lieu of the 2020 annual meeting of the Company being held on [●], 2020, (the “ Special Meeting |
• | a consent solicitation statement for Luminar, where Luminar will solicit the written consent of the Luminar Stockholders with respect to the adoption of the Merger Agreement; and |
• | a prospectus for the Class A Stock that Luminar Stockholders will receive in the Business Combination. |
Sincerely, |
Dean Metropoulos |
Chairman of the Board of Directors |
1. | Transaction Proposal Merger Agreement First Merger Sub Second Merger Sub Luminar Annex A , and approve the transactions contemplated thereby, including, among other things, the merger of First Merger Sub with and into Luminar, with Luminar continuing as the Surviving Corporation (the “First Merger Second Merger Business Combination |
2. | Issuance Proposal Class A Stock Class F Stock Common Stock |
3. | Amendment Proposal Annex B (Proposal No. 3); |
4. | Governance Proposal non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with the United States Securities and Exchange Commission (“SEC |
5. | Management Longer Term Equity Incentive Plan Proposal Management Longer Term Equity Incentive Plan |
6. | Omnibus Incentive Plan Proposal Omnibus Incentive Plan |
7. | Employee Stock Purchase Plan Proposal Employee Stock Purchase Plan |
8. | Director Election Proposal |
9. | Adjournment Proposal |
By Order of the Board of Directors |
Dean Metropoulos |
Chairman of the Board of Directors |
Beverly Hills, California |
[●], 2020 |
1 | ||||
10 | ||||
11 | ||||
33 | ||||
65 | ||||
118 | ||||
121 | ||||
124 | ||||
133 | ||||
168 | ||||
177 | ||||
200 | ||||
201 | ||||
203 | ||||
204 | ||||
218 | ||||
219 | ||||
222 | ||||
232 | ||||
238 | ||||
267 | ||||
269 | ||||
286 | ||||
298 | ||||
314 | ||||
329 | ||||
336 | ||||
339 | ||||
340 | ||||
341 | ||||
343 | ||||
348 | ||||
354 | ||||
359 | ||||
368 | ||||
375 | ||||
378 | ||||
379 | ||||
379 | ||||
379 | ||||
379 | ||||
380 | ||||
380 | ||||
380 | ||||
380 | ||||
F-1 |
A-1 | ||||
B-1 | ||||
C-1 | ||||
D-1 | ||||
E-1 | ||||
F-1 | ||||
G-1 | ||||
H-1 | ||||
I-1 | ||||
J-1 | ||||
K-1 |
• | Level 1 (Driver Assistance): Vehicle is controlled by the driver, but some driving assistance features may be included. |
• | Level 2 (Partial Automation): Vehicle has combined automated functions like acceleration and steering, but the driver must remain fully engaged and monitor the driving environment at all times. |
• | Level 3 (Conditional Automation): Driver is necessary, but is not required to monitor the environment. The driver must be ready to take control of the vehicle at all times with notice. |
• | Level 4 (High Automation): The vehicle is capable of performing all driving functions under certain conditions. The driver may have the option to control the vehicle. |
• | Level 5 (Full Automation): The vehicle is capable of performing all driving functions under all conditions. The driver may have the option to control the vehicle. |
Q: |
Why am I receiving this proxy statement/consent solicitation statement/prospectus? |
A: | Our stockholders are being asked to consider and vote upon a proposal to approve the Merger Agreement and the transactions contemplated thereby, including the Business Combination, among other proposals. We have entered into the Merger Agreement, providing for, among other things, the merger of First Merger Sub with and into Luminar, with Luminar continuing as the Surviving Corporation (the “ First Merger Second Merger Business Combination Annex A . |
Q: |
When and where is the Special Meeting? |
A: | In light of public health concerns regarding the coronavirus (COVID-19) pandemic, the Special Meeting will be held via live webcast at https://www.cstproxy.com/goresmetropoulos/sm2020, on [●], 2020, at [●]. The Special Meeting can be accessed by visiting https://www.cstproxy.com/goresmetropoulos/sm2020, where you will be able to listen to the meeting live and vote during the meeting. Additionally, you have the |
option to listen only to the Special Meeting by dialing +1 877-770-3647 (toll-free within the U.S. and Canada) or +1 312-780-0854 (outside of the U.S. and Canada, standard rates apply). The passcode for telephone access is 11499520#, but please note that you cannot vote or ask questions if you choose to participate telephonically. Please note that you will only be able to access the Special Meeting by means of remote communication. |
Q: |
What are the specific proposals on which I am being asked to vote at the Special Meeting? |
A: | Our stockholders are being asked to approve the following proposals: |
1. | Transaction Proposal Annex A , and the transactions contemplated thereby, including, among other things, the Business Combination (Proposal No. 1); |
2. | Issuance Proposal |
3. | Amendment Proposal Annex B (Proposal No. 3); |
4. | Governance Proposal non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with SEC requirements (Proposal No. 4); |
5. | Management Longer Term Equity Incentive Plan Proposal |
6. | Omnibus Incentive Plan Proposal |
7. | Employee Stock Purchase Plan Proposal |
8. | Director Election Proposal |
9. | Adjournment Proposal |
Q: |
Are the proposals conditioned on one another? |
A: | Yes. The Business Combination is conditioned on the approval of the Transaction Proposal, the Issuance Proposal, and the Amendment Proposal at the Special Meeting. If we fail to obtain sufficient votes for the |
Transaction Proposal, the Issuance Proposal or the Amendment Proposal, we will not satisfy the conditions to closing of the Merger Agreement and we may be prevented from closing the Business Combination. Each of the proposals other than the Transaction Proposal, the Issuance Proposal and the Amendment Proposal is conditioned on the approval of the Transaction Proposal, the Issuance Proposal and the Amendment Proposal, other than the Governance Proposal and the Adjournment Proposal, which are not conditioned on the approval of any other proposal set forth in this proxy statement/consent solicitation statement/prospectus. It is important for you to note that in the event that the Transaction Proposal, the Issuance Proposal, or the Amendment Proposal do not receive the requisite vote for approval, we will not consummate the Business Combination. If we do not consummate the Business Combination and fail to complete an initial business combination by February 5, 2021 we will be required to dissolve and liquidate our Trust Account by returning the then remaining funds in such account to the Public Stockholders. |
Q: |
Why is the Company proposing the Business Combination? |
A: | We are a blank check company incorporated as a Delaware corporation on August 28, 2018 and incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (an “initial business combination . |
Q: |
Why is the Company providing stockholders with the opportunity to vote on the Business Combination? |
A: | Under the Current Company Certificate, we must provide all holders of Public Shares with the opportunity to have their Public Shares redeemed upon the consummation of our initial business combination either in conjunction with a tender offer or in conjunction with a stockholder vote. For business and other reasons, we have elected to provide our stockholders with the opportunity to have their Public Shares redeemed in connection with a stockholder vote rather than a tender offer. Therefore, we are seeking to obtain the approval of our stockholders of the Transaction Proposal in order to allow our Public Stockholders to effectuate redemptions of their Public Shares in connection with the closing of the Business Combination. The approval of the Business Combination is required under the Current Company Certificate. In addition, such approval is also a condition to the closing of the Business Combination under the Merger Agreement. |
Q: |
What revenues and profits/losses has Luminar generated in the last two years? |
A: | Luminar’s gross loss was $4.1 million for the year ended December 31, 2019, and Luminar’s gross profit was $0.8 million for the year ended December 31, 2018. Luminar’s revenue was $12.6 million and $11.7 million for the years ended December 31, 2019 and 2018, respectively. |
Q: |
What will happen in the Business Combination? |
A: | Pursuant to the Merger Agreement, and upon the terms and subject to the conditions set forth therein, the Company will acquire Luminar in a series of transactions we collectively refer to as the Business Combination. At the closing of the Business Combination contemplated by the Merger Agreement, among other things, First Merger Sub will merge with and into Luminar, with Luminar continuing as the Surviving Corporation, and Second Merger Sub will merge with and into the Surviving Corporation, with Second Merger Sub continuing as the Surviving Entity. As a result of the Mergers, at the closing of the Business Combination, the Post-Combination Company will own 100% of the outstanding stock of Luminar, and each share of Luminar Stock will be cancelled and converted into the right to receive the Per Share Company Stock Consideration and their respective share of Earn-Out Shares that may become issuable. |
Q: |
How has the announcement of the Business Combination affected the trading price of the Public Shares? |
A: | On August 21, 2020, the last trading date before the public announcement of the Business Combination, the Public Shares, Public Warrants and Public Units closed at $10.51, $1.59 and $11.75, respectively. On [●], 2020, the trading date immediately prior to the date of this proxy statement/consent solicitation statement/prospectus, the Public Shares, Public Warrants and Public Units closed at $[●], $[●] and $[●], respectively. |
Q: |
Following the Business Combination, will the Company’s securities continue to trade on a stock exchange? |
A: | Yes. The Public Shares, Public Units and Public Warrants are currently listed on Nasdaq under the symbols “GMHI,” “GMHIU” and “GMHIW,” respectively. We intend to apply to continue the listing of the Post-Combination Company’s Class A Stock and Public Warrants on the Nasdaq Capital Market under the symbols “LAZR” and “LAZRW,” respectively, upon the closing of the Business Combination. |
Q: |
Is the Business Combination the first step in a “going private” transaction? |
A: | No. We do not intend for the Business Combination to be the first step in a “going private” transaction. One of the primary purposes of the Business Combination is to provide a platform for Luminar to access the U.S. public markets. |
Q: |
Will the management of the Company change in the Business Combination? |
A: | Following the closing of the Business Combination, it is expected that the current senior management of Luminar will comprise the senior management of the Post-Combination Company, and, assuming the election of the nominees at the Special Meeting as set forth in the Director Election Proposal, the Post-Combination Company’s board of directors will consist of Austin Russell, Alec E. Gores, Matthew J. Simoncini, Scott A. McGregor, and Benjamin J. Kortlang. |
Q: |
How will the Business Combination impact the shares of the Company outstanding following the closing of the Business Combination? |
A: | As a result of the Business Combination and the consummation of the transactions contemplated thereby, the amount of Common Stock outstanding will increase by approximately 585.77% to approximately 342,883,000 shares of Common Stock (assuming that no shares of Class A Stock are redeemed and that none of the additional $30,000,000 of Luminar Series X Preferred Stock that may be sold in the Series X Financing is sold, but inclusive of shares issuable under the Rollover Options and any Assumed Warrants). Additional shares of Common Stock may be issuable in the future as a result of the issuance of additional shares that are not currently outstanding, including issuance of shares of Class A Stock upon exercise of the Public Warrants and Private Placement Warrants following the closing of the Business Combination. The issuance and sale of such shares in the public market could adversely impact the market price of our Common Stock, even if our business is doing well. |
Q: |
What will Luminar Stockholders receive in the Business Combination? |
A: | Subject to the terms of the Merger Agreement and customary adjustments set forth therein, the aggregate merger consideration to be paid in connection with the Business Combination is expected to be approximately 292,882,785 shares of Company common stock (deemed to have a value of $10.00 per share) with an implied value equal to the Aggregate Company Stock Consideration. Holders of shares of (a) Luminar Class A Stock, Luminar Preferred Stock and Luminar Founders Preferred Stock will be entitled to receive a number of shares of newly-issued Class A Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Stock, and (b) Luminar Class B Stock will be entitled to receive a number of shares of newly-issued Class B Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Class B Stock. The foregoing consideration to be paid to the Luminar Stockholders may be further increased by Earn-Out Shares of up to 7.5% of the sum of (x) the total outstanding capital stock of the Company and (y) the total shares subject to outstanding Rollover Options and Assumed Warrants, in each case as of the closing of the Business Combination. |
Q. |
What will holders of Luminar equity awards receive in the Business Combination? |
A: | Effective as of the effective time of the First Merger, each outstanding unexercised Luminar Stock Option and each outstanding unvested award of Luminar Restricted Stock will automatically be converted into, respectively, an option to acquire a number of shares of our Class A Stock or a number of shares of our Class A Stock, in each case, determined by multiplying the number of shares of Luminar Stock subject to such award as of immediately prior thereto by the Per Share Company Stock Consideration (determined in accordance with the Merger Agreement), rounded down to the nearest whole number of shares, subject to the same terms as were applicable thereto immediately prior thereto (including applicable vesting conditions), except to the extent such terms are rendered inoperative by the transactions contemplated by the Merger Agreement. Each such converted stock option will be exercisable solely for shares of our Class A Stock, and the per share exercise price for the stock issuable upon exercise thereof will be determined by dividing the per share exercise price for the shares of Luminar Class A Stock subject to the Luminar Stock Option immediately prior thereto by the Per Share Company Stock Consideration, rounded up to the nearest whole cent. |
Q: |
What equity stake will the current stockholders of the Company and the Luminar Equityholders hold in the Post-Combination Company after the consummation of the Business Combination? |
A: | It is anticipated that, upon completion of the Business Combination: (i) our Public Stockholders will retain an ownership interest of approximately 11.7% in the Post-Combination Company; (ii) our Initial Stockholders (including our Sponsor) will own approximately 4.2% of the Post-Combination Company (inclusive of merger consideration received in respect of our Initial Stockholders’ Series X investment); and (iii) the Luminar Equityholders (including the Series X Investors but excluding our Initial Stockholders) will own approximately 84.1% of the Post-Combination Company, which includes approximately 35% of the |
Post-Combination Company to be held by Austin Russell, with such amounts held by Mr. Russell expected to constitute approximately 83% of the voting power of the outstanding capital stock of the Post-Combination Company as of the closing of the Business Combination. |
Q: |
Will the Company obtain new financing in connection with the Business Combination? |
A: | No. We will not obtain new financing in connection with the Business Combination. However, concurrently with the execution of the Merger Agreement, Luminar entered into the Series X Agreements with the Series X Investors. Pursuant to the Series X Agreements, the Series X Investors agreed to purchase and Luminar agreed to issue and sell to such Series X Investors approximately 1,250,000 shares of Luminar Series X Preferred Stock for a purchase price of $135.7860 per share, or an aggregate of approximately $170,000,000 (collectively, the “ Series X Financing |
Q: |
Are there any arrangements to help ensure that the Company will have sufficient funds, together with the proceeds in its Trust Account, to fund the aggregate purchase price? |
A: | No. However, concurrently with the execution of the Merger Agreement, Luminar completed the Initial Closing of the Series X Financing. Additionally, pursuant the Series X Agreements, Luminar has the right to sell up to an additional approximately 221,000 shares of the Luminar Series X Preferred Stock until the close of business on October 31, 2020. The Company did not consider financing arrangements other than the Series X Financing, as the Company believes that cash generated from the additional equity invested in connection with the Series X financing is preferable to other financing arrangements. |
Q: |
Why is the Company proposing the Issuance Proposal? |
A: | We are proposing the Issuance Proposal in order to comply with Nasdaq Listing Rules 5635(a) and (d), which require stockholder approval of certain transactions that result in the issuance of 20% or more of the outstanding voting power or shares of Common Stock outstanding before the issuance of stock or securities. |
Q: |
Why is the Company proposing the Amendment Proposal? |
A: | The Second Amended and Restated Certificate of Incorporation that we are asking our stockholders to adopt in connection with the Business Combination (the “ Amendment Proposal Proposal No. 3 |
Agreement, we are required to submit the Amendment Proposal to our stockholders for adoption. For additional information please see the section entitled “ Proposal No. 3—The Amendment Proposal |
Q: |
Why is the Company proposing the Governance Proposal? |
A: | As required by applicable SEC guidance, we are requesting that our stockholders vote upon, on a non-binding advisory basis, a proposal to approve certain governance provisions contained in the Second Amended and Restated Certificate of Incorporation that materially affect stockholder rights. This separate vote is not otherwise required by Delaware law separate and apart from Proposal No. 3, but pursuant to SEC guidance, we are required to submit these provisions to our stockholders separately for approval. However, the stockholder vote regarding this proposal is an advisory vote, and is not binding on us or our Board (separate and apart from the approval of the Amendment Proposal). Furthermore, the Business Combination is not conditioned on the separate approval of the Governance Proposal (separate and apart from approval of the Amendment Proposal). For additional information, please see the section entitled “Proposal No. 4—The Governance Proposal. |
Q: |
Why is the Company proposing the Management Longer Term Equity Incentive Plan Proposal? |
A: | Our Board believes that it would be in the best interests of the Post-Combination Company to adopt the Management Longer Term Equity Incentive Plan to assist us in promoting our interests by (a) aligning the interests of eligible participants with those of our stockholders by providing long-term incentive compensation opportunities tied to our performance and the Class A Stock, and (b) attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of our business is largely dependent. The Management Longer Term Equity Incentive Plan will be adopted following the consummation of the Business Combination. For additional information, please see the section entitled “ Proposal No. The Management Longer Term Equity Incentive Plan Proposal |
Q: |
Why is the Company proposing the Omnibus Incentive Plan Proposal? |
A: | Our Board believes that it would be in the best interests of the Post-Combination Company to adopt the Omnibus Incentive Plan to assist us in promoting our interests by (a) aligning the interests of eligible participants with those of our stockholders by providing long-term incentive compensation opportunities tied to our performance and the Class A Stock, and (b) attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of our business is largely dependent. The Omnibus Incentive Plan will be adopted following the consummation of the Business Combination. For additional information, please see the section entitled “ Proposal No. The Omnibus Incentive Plan Proposal |
Q: |
Why is the Company proposing the Employee Stock Purchase Plan Proposal? |
A: | Our Board believes that it would be in the best interests of the Post-Combination Company to adopt the Employee Stock Purchase Plan to assist us in promoting our interests by (a) enabling eligible employees of the Post-Combination Company and certain of our subsidiaries to use payroll deductions to purchase shares of Class A Stock and thereby acquire an ownership interest in the Post-Combination Company, and (b) attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of our business is largely dependent. The Employee Stock Purchase Plan will be adopted following the consummation of the Business Combination. For additional information, please see the section entitled “ Proposal No. 7—The Employee Stock Purchase Plan Proposal |
Q: |
Why is the Company proposing the Adjournment Proposal? |
A: | We are proposing the Adjournment Proposal to allow the chairman of the Special Meeting to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Transaction |
Proposal, the Issuance Proposal, the Charter Approval Proposal, the Management Longer Term Equity Incentive Plan Proposal or the Omnibus Incentive Plan Proposal, but no other proposal if the Transaction Proposal, the Issuance Proposal, the Charter Approval Proposal, the Management Longer Term Equity Incentive Plan Proposal and the Omnibus Incentive Plan Proposal are approved. For additional information, please see the section entitled “ Proposal No. 9—The Adjournment Proposal |
Q: |
What happens if I sell my shares of Class A Stock before the Special Meeting? |
A: | The record date for the Special Meeting is earlier than the date that the Business Combination is expected to be completed. If you transfer your shares of Class A Stock after the record date, but before the Special Meeting, unless the transferee obtains from you a proxy to vote those shares, you will retain your right to vote at the Special Meeting. However, you will not be able to seek redemption of your shares of Class A Stock because you will no longer be able to deliver them for cancellation upon consummation of the Business Combination. If you transfer your shares of Class A Stock prior to the record date, you will have no right to vote those shares at the Special Meeting or redeem those shares for a pro rata portion of the proceeds held in our Trust Account. |
Q: |
What vote is required to approve the proposals presented at the Special Meeting? |
A: | The approval of the Transaction Proposal requires the affirmative vote of at least a majority of the votes cast by holders of outstanding shares of our Common Stock represented in person via the virtual meeting platform or by proxy and entitled to vote thereon at the Special Meeting. Failure to vote by proxy or to vote in person via the virtual meeting platform at the Special Meeting and broker non-votes will have no effect on the Transaction Proposal. Abstentions will be counted in connection with the determination of whether a valid quorum is established but will have no effect on the Transaction Proposal. Our Initial Stockholders have agreed to vote their shares of Common Stock in favor of the Transaction Proposal. |
Q: |
What happens if the Transaction Proposal is not approved? |
A: | If the Transaction Proposal is not approved and we do not consummate an initial business combination by February 5, 2021, we will be required to dissolve and liquidate the Trust Account. |
Q: |
How many votes do I have at the Special Meeting? |
A: | Our stockholders are entitled to one vote on each proposal presented at the Special Meeting for each share of Common Stock held of record as of [●], 2020, the record date for the Special Meeting. As of the close of business on the record date, there were [●] outstanding shares of Common Stock. |
Q: |
What constitutes a quorum at the Special Meeting? |
A: | A majority of the issued and outstanding shares of Common Stock entitled to vote as of the record date at the Special Meeting must be present, in person via the virtual meeting platform or represented by proxy, at |
the Special Meeting to constitute a quorum and in order to conduct business at the Special Meeting. Abstentions will be counted as present for the purpose of determining a quorum. Our Initial Stockholders, who currently own 20% of our issued and outstanding shares of Common Stock, will count towards this quorum. In the absence of a quorum, the chairman of the Special Meeting has power to adjourn the Special Meeting. As of the record date for the Special Meeting, 25,000,001 shares of Common Stock would be required to achieve a quorum. |
Q: |
How will the Company’s Sponsor, directors and officers vote? |
A: | Prior to the Company IPO, we entered into agreements with our Sponsor and each of our directors and officers, pursuant to which each agreed to vote any shares of Common Stock owned by them in favor of the Transaction Proposal. None of our Sponsor, directors or officers has purchased any shares of our Common Stock during or after the Company IPO and, as of the date of this proxy statement/consent solicitation statement/prospectus, neither we nor our Sponsor, directors or officers have entered into agreements, and are not currently in negotiations, to purchase shares prior to the consummation of the Business Combination. Currently, our Initial Stockholders own 20% of our issued and outstanding shares of Common Stock, including all of the Founder Shares, and will be able to vote all such shares at the Special Meeting. |
Q: |
What interests does the Sponsor and the Company’s current officers and directors have in the Business Combination? |
A: | The Sponsor, certain members of our Board and our officers may have interests in the Business Combination that are different from or in addition to (and which may conflict with) your interests. You should take these interests into account in deciding whether to approve the Business Combination. These interests include: |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective target |
businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 |
(1) | Assumes a value of $10.00 per share. |
(2) | Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to the Registration Rights Holders and their permitted transferees. |
Q: |
Did our Board obtain a third-party valuation or fairness opinion in determining whether or not to proceed with the Business Combination? |
A: | Yes. Although the Current Company Certificate does not require our Board to seek a third-party valuation or fairness opinion in connection with a business combination unless the target business is affiliated with our Sponsor, directors or officers, our Board received a fairness opinion from Moelis as to the fairness, from a financial point of view and as of the date of such opinion, of the consideration to be paid by the Company to the Luminar Stockholders in the Business Combination. Please see the section entitled “ Opinion of the Company’s Financial Advisor Annex H for additional information. |
Q: |
What happens if I vote against the Transaction Proposal? |
A: | If you vote against the Transaction Proposal but the Transaction Proposal still obtains the affirmative vote of a majority of the votes cast by holders of our outstanding shares of Common Stock represented in person via |
Q: |
Do I have redemption rights? |
A: | If you are a Public Stockholder, you may redeem your Public Shares for cash at the applicable redemption price per share equal to the quotient obtained by dividing (i) the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest not previously released to us to fund Regulatory Withdrawals and/or to pay its franchise and income taxes, by (ii) the total number of then-outstanding Public Shares; provided that we may not redeem any shares of Class A Stock issued in the Company IPO to the extent that such redemption would result in our failure to have net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) in excess of $5,000,000. A Public Stockholder, together with any of his, her or its affiliates or any other person with whom it is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming in the aggregate his, her or its shares or, if part of such a group, the group’s shares, in excess of 20% of the shares of Class A Stock included in the Public Units sold in the Company IPO. Holders of our outstanding Public Warrants do not have redemption rights in connection with the Business Combination. Our Sponsor, directors and officers have agreed to waive their redemption rights with respect to their shares of Common Stock in connection with the consummation of the Business Combination, and the Founder Shares will be excluded from the pro rata calculation used to determine the per-share redemption price. Our Initial Stockholders have also agreed to waive their right to a conversion price adjustment with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination. For illustrative purposes, based on the balance of our Trust Account of $406,397,612 as of June 30, 2020, the estimated per share redemption price would have been approximately $10.16. Additionally, shares properly tendered for redemption will only be redeemed if the Business Combination is consummated; otherwise holders of such shares will only be entitled to a pro rata portion of the Trust Account (including interest not previously released to the Company to fund Regulatory Withdrawals and/or to pay its franchise and income taxes) in connection with the liquidation of the Trust Account, unless we complete an alternative initial business combination prior to February 5, 2021. |
Q: |
Can our Initial Stockholders redeem their Founder Shares in connection with consummation of the Business Combination? |
A: | No. Our Initial Stockholders, officers and other current directors have agreed to waive their redemption rights, with respect to their Founder Shares and any Public Shares they may hold, in connection with the consummation of the Business Combination. |
Q: |
Is there a limit on the number of shares I may redeem? |
A: | Yes. A Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), is |
Q: |
Is there a limit on the total number of Public Shares that may be redeemed? |
A: | Yes. The Current Company Certificate provides that we may not redeem our Public Shares in an amount that would result in our failure to have net tangible assets in excess of $5,000,000 (such that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the Merger Agreement. Other than this limitation, the Current Company Certificate does not provide a specified maximum redemption threshold. In the event the aggregate cash consideration we would be required to pay for all shares of Class A Stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the Merger Agreement exceeds the aggregate amount of cash available to us, we may not complete the Business Combination or redeem any shares, all shares of Class A Stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate initial business combination. |
Q: |
Will how I vote affect my ability to exercise redemption rights? |
A: | No. You may exercise your redemption rights whether you vote your Public Shares for or against, or whether you abstain from voting on, the Transaction Proposal, the Issuance Proposal, the Amendment Proposal or any of the Governance Proposal or any other proposal described by this proxy statement/consent solicitation statement/prospectus. As a result, the Merger Agreement can be approved by stockholders who will redeem their shares and no longer remain stockholders, leaving stockholders who choose not to redeem their shares holding shares in a company with a potentially less-liquid trading market, fewer stockholders, potentially less cash and the potential inability to meet the listing standards of Nasdaq. |
Q: |
How do I exercise my redemption rights? |
A: | In order to exercise your redemption rights, you must (i) if you hold Public Units, separate the underlying Public Shares and Public Warrants, and (ii) prior to 5:00 P.M., Eastern Time on [●], 2020 (two business days before the Special Meeting), tender your shares physically or electronically and submit a request in writing that the Company redeem your Public Shares for cash to Continental Stock Transfer & Trust Company, the Transfer Agent, at the following address: |
Q: |
What are the U.S. federal income tax consequences of exercising my redemption rights? |
A: | The U.S. federal income tax consequences of the redemption depends on particular facts and circumstances. Please see the section entitled “ Material Tax Considerations—Material U.S. Federal Income Tax Considerations for Holders of Class A Stock |
Q: |
If I am a Public Warrant holder, can I exercise redemption rights with respect to my Public Warrants? |
A: | No. The holders of Public Warrants have no redemption rights with respect to such Public Warrants. |
Q: |
Do I have appraisal rights or dissenters’ rights if I object to the proposed Business Combination? |
A: | No. Appraisal rights or dissenters’ rights are not available to holders of shares of Common Stock in connection with the Business Combination. |
Q: |
What happens to the funds held in the Trust Account upon consummation of the Business Combination? |
A: | If the Business Combination is consummated, the funds held in the Trust Account will be used to: (i) pay our Public Stockholders who properly exercise their redemption rights; (ii) pay the $14,000,000 Deferred Discount to the underwriters of the Company IPO, in connection with the Business Combination; (iii) pay certain other fees, costs and expenses (including regulatory fees, legal fees, accounting fees, printer fees and other professional fees) that were incurred by the Company and other parties to the Merger Agreement in connection with the transactions contemplated by the Merger Agreement, including the Business Combination, and pursuant to the terms of the Merger Agreement; and (iv) assuming a minimum level of cash available at the Company and Luminar as of the effective time of the First Merger, repay all Luminar’s outstanding indebtedness. Any remaining funds will be used by the Post-Combination Company for general corporate purposes. |
Q: |
What conditions must be satisfied to complete the Business Combination? |
A: | There are a number of closing conditions in the Merger Agreement, including the expiration of the applicable waiting period under the HSR Act, the approval and adoption by the Luminar Stockholders of the Merger Agreement and the transactions contemplated thereby and the approval by the stockholders of the Company of the Transaction Proposal, the Issuance Proposal and the Amendment Proposal. For a summary of the conditions that must be satisfied or waived prior to completion of the Business Combination, please see the section entitled “ The Merger Agreement and Related Agreements |
Q: |
What happens if the Business Combination is not consummated? |
A: | There are certain circumstances under which the Merger Agreement may be terminated. Please see the section entitled “ The Merger Agreement and Related Agreements |
Q: |
When is the Business Combination expected to be completed? |
A: | The closing of the Business Combination is expected to take place on or prior to the third business day following the satisfaction or waiver of the conditions described below in the subsection entitled “ The Merger Agreement and Related Agreements The Merger Agreement—Conditions to Closing of the Business Combination Termination Date |
Q: |
What do I need to do now? |
A: | You are urged to read carefully and consider the information contained in this proxy statement/consent solicitation statement/prospectus, including the Annexes, and to consider how the Business Combination will affect you as a stockholder. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement/consent solicitation statement/prospectus and on the enclosed proxy card or, if you hold your shares through a brokerage firm, bank or other nominee, on the voting instruction form provided by the broker, bank or nominee. |
Q: |
How do I vote? |
A: | If you were a holder of record of shares of our Common Stock on [●], 2020, the record date for the Special Meeting, you may vote with respect to the proposals in person via the virtual meeting platform at the Special Meeting, or by completing, signing, dating and returning the enclosed proxy card in the postage-paid envelope provided. |
Q: |
What will happen if I abstain from voting or fail to vote at the Special Meeting? |
A: | At the Special Meeting, we will count a properly executed proxy marked “ ABSTAIN AGAINST |
Q: |
What will happen if I sign and return my proxy card without indicating how I wish to vote? |
A: | Signed and dated proxies we receive without an indication of how the stockholder intends to vote on a proposal will be voted “ FOR |
Q: |
If I am not going to attend the Special Meeting via the virtual meeting platform, should I return my proxy card instead? |
A: | Yes. Whether you plan to attend the Special Meeting or not, please read the enclosed proxy statement/consent solicitation statement/prospectus carefully, and vote your shares by completing, signing, dating and returning the enclosed proxy card in the postage-paid envelope provided. |
Q: |
If my shares are held in “street name,” will my broker, bank or nominee automatically vote my shares for me? |
A: | No. Under the rules of various national and regional securities exchanges, your broker, bank, or nominee cannot vote your shares with respect to non-discretionary matters unless you provide instructions on how to vote in accordance with the information and procedures provided to you by your broker, bank, or nominee. We believe that all of the proposals presented to the stockholders at this Special Meeting will be considered non-discretionary and, therefore, your broker, bank, or nominee cannot vote your shares without your instruction non-vote.” Broker non-votes will not be counted for the purposes of determining the existence of a quorum or for purposes of determining the number of votes cast at the Special Meeting. Your bank, broker, or other nominee can vote your shares only if you provide instructions on how to vote. You should instruct your broker to vote your shares in accordance with directions you provide. |
Q: |
How will a broker non-vote impact the results of each proposal? |
A: | Broker non-votes will count as a vote “AGAINST |
Q: |
May I change my vote after I have mailed my signed proxy card? |
A: | Yes. You may change your vote by sending a later-dated, signed proxy card to our Secretary at the address listed below so that it is received by our Secretary prior to the Special Meeting or attend the Special Meeting in person via the virtual meeting platform and vote. You also may revoke your proxy by sending a notice of revocation to our Secretary, which must be received by our Secretary prior to the Special Meeting. |
Q: |
What should I do if I receive more than one set of voting materials? |
A: | You may receive more than one set of voting materials, including multiple copies of this proxy statement/consent solicitation statement/prospectus and multiple proxy cards or voting instruction cards. For example, |
if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast your vote with respect to all of your shares. |
Q: |
Who will solicit and pay the cost of soliciting proxies for the Special Meeting? |
A: | We will pay the cost of soliciting proxies for the Special Meeting. We have engaged Morrow Sodali LLC (“ Morrow out-of-pocket |
Q: |
Who can help answer my questions? |
A: | If you have questions about the proposals or if you need additional copies of this proxy statement/consent solicitation statement/prospectus or the enclosed proxy card you should contact: |
Q: |
Why am I receiving this proxy statement/consent solicitation statement/prospectus? |
A: |
Luminar Stockholders are being asked to adopt the Merger Agreement and approve the transactions contemplated thereby, including the Mergers (the “ Luminar Proposal The Business Combination Consideration in the Business Combination |
Q: |
What are the specific proposals on which I am being asked to approve in the written consent furnished with this proxy statement/consent solicitation statement/prospectus? |
A: |
Luminar Stockholders are being asked to approve the following proposals: |
1. | Luminar Proposal Annex A and approve the transactions contemplated thereby, including the Mergers. |
2. | Unbundled Governance Proposal Unbundled Governance Proposal |
Q: |
Who is entitled to act by written consent? |
A: |
Luminar Stockholders of record holding shares of Luminar Stock at the close of business on the record date of [●], 2020 (the “ Luminar Record Date |
Q: |
How can I give my consent? |
A: |
Luminar Stockholders may give their consent by completing, dating and signing the written consent enclosed with this proxy statement/consent solicitation statement/prospectus and returning it to Luminar by emailing a .pdf copy to Luminar’s consent solicitor, Morrow Sodali LLC, at luminar.info@investor.morrowsodali.com or by mailing your written consent to Morrow Sodali LLC at 470 West Avenue, Suite 3000, Stamford, CT 06902. |
Q: |
What approval is required to adopt the Merger Agreement? |
A: |
Written consents from the holders of at least a majority of the outstanding voting power of the issued and outstanding shares of Luminar Stock (voting as a single class and on an as-converted basis) are required to adopt the Luminar Proposal. |
Q: |
Do Luminar Stockholders have appraisal rights if they object to the Mergers? |
A: |
Yes. Pursuant to Section 262 of the DGCL, Luminar Stockholders who comply with the applicable requirements of Section 262 of the DGCL and do not otherwise fail to perfect, waive, withdraw or lose the right to appraisal under Delaware law have the right to seek appraisal of the fair value of their shares of Luminar Stock, as determined by the Court of Chancery, if the First Merger is completed. The “fair value” of your shares of Luminar Stock as determined by the Court of Chancery may be more or less than, or the same as, the value of the consideration that you are otherwise entitled to receive under the Merger Agreement. Luminar Stockholders who do not consent to the adoption of the Merger Agreement and who wish to preserve their appraisal rights must so advise Luminar by submitting a demand for appraisal within the period prescribed by Section 262 of the DGCL after receiving a notice from Luminar or the Post-Combination Company that appraisal rights are available to them, and must otherwise precisely follow the procedures prescribed by Section 262 of the DGCL. Failure to follow any of the statutory procedures set forth in Section 262 of the DGCL will result in the loss or waiver of appraisal rights under Delaware law. In view of the complexity of Section 262 of the DGCL, Luminar Stockholders who may wish to pursue appraisal rights should consult their legal and financial advisors. For additional information on appraisal rights available to Luminar Stockholders, see the section entitled “ Appraisal Rights |
Q: |
What are the material U.S. federal income tax consequences of the Mergers to Luminar Stockholders that are United States Persons? |
A: |
Luminar and the Company intend for the Mergers to qualify as a “reorganization” within the meaning of Section 368(a) of the U.S. Tax Code. Assuming that the Mergers qualify as a reorganization, a Luminar Stockholder that is a United States Person that receives Class A Stock in exchange for Luminar Class A Stock, Luminar Preferred Stock or Luminar Founders Preferred Stock, or receives Class B Stock in exchange for Luminar Class B Stock in the Mergers generally will not recognize gain or loss for U.S. federal income tax purposes (except with respect to any cash received in lieu of a fractional share of Class A Stock or Class B Stock or imputed interest). However, there are many requirements that must be satisfied in order for the Mergers to qualify as a reorganization, some of which are based upon factual determinations. Neither the Company nor Luminar has requested or received a ruling from the IRS or requested a closing tax opinion of counsel that the Mergers will qualify as a reorganization. If it is determined that the Mergers are not treated as a reorganization within the meaning of Section 368(a) of the U.S. Tax Code, unless the First Merger qualifies as a tax-free exchange of property for stock under Section 351 of the U.S. Tax Code, the exchange of Luminar Stock for Class A Stock or Class B Stock in the Mergers will be a fully taxable transaction. |
Q: |
What is the deadline for returning my written consent? |
A: |
Luminar’s board of directors has set 12:00 noon, New York City time, on [●], 2020, as the target date for the receipt of written consents, which is the date on which Luminar expects to receive the written consent of Austin Russell, Luminar’s Founder, President and Chief Executive Officer, in accordance with the Support Agreement. Luminar reserves the right to extend the final date for receipt of written consents beyond such date. Any such extension may be made without notice to Luminar Stockholders. Once a sufficient number of consents to adopt the Merger Agreement has been received, the consent solicitation will conclude. |
Q: |
Who can help answer my questions? |
A: |
If you have any questions about the Mergers or how to return your written consent, or if you need additional copies of this proxy statement/consent solicitation statement/prospectus or a replacement written consent, you should contact Luminar’s agent in connection with the consent solicitation, Morrow Sodali LLC, by phone at (800) 662-5200 or by email at luminar.info@investor.morrowsodali.com. |
• | at the closing of the Business Combination, First Merger Sub will merge with and into Luminar, with Luminar continuing as the Surviving Corporation of the First Merger; |
• | immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation will merge with and into Second Merger Sub, with Second Merger Sub continuing as the Surviving Entity of the Second Merger; |
• | prior to the consummation of the Business Combination (and subject to approval by our stockholders), we will adopt the proposed Second Amended and Restated Certificate of Incorporation, to provide for, among other things, the authorization of the Class B Stock to be issued in connection with the Business Combination; |
• | in connection with the Business Combination, the Luminar Stockholders will receive, in exchange for their Luminar Stock, the Aggregate Company Stock Consideration. Holders of shares of (a) Luminar Class A Stock, Luminar Preferred Stock and Luminar Founders Preferred Stock will be entitled to receive a number of shares of newly-issued Class A Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Class A Stock, Luminar Preferred Stock or Luminar Founders Preferred Stock, as applicable, and (b) Luminar Class B Stock will be entitled to receive a number of shares of newly-issued Class B Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Class B Stock. The foregoing consideration to be paid to the Luminar Stockholders may be further increased by amounts payable as Earn-Out Shares, of up to 7.5% of the sum of (x) the total outstanding capital stock of the Company and (y) the total shares subject to outstanding Rollover Stock Options and Assumed Warrants, in each case, as of the closing of the Business Combination; |
• | at the closing of the Business Combination, the Registration Rights Holders will enter into the Registration Rights Agreement, pursuant to which, (a) any (i) outstanding share of Class A Stock or any Private Placement Warrants, (ii) shares of Class A Stock issued or issuable upon the exercise of any other equity security of the Company (including shares of Class A Stock issued or issuable upon the conversion of the Class F Stock or the Class B Stock and upon exercise of the Private Placement Warrants), and (iii) shares of Class A Stock issued as Earn-Out Shares or issuable upon the conversion of any Earn-Out Shares, in each case, held by the Luminar Holders, and (b) any other equity security of the Company issued or issuable with respect to any such share of Class A Stock by way of a stock |
dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise, will be entitled to registration rights; |
• | our Initial Stockholders have agreed, and their permitted transferees will agree, to vote their Founder Shares, as well as any Public Shares purchased during or after the Company IPO, in favor of the Business Combination. |
(1) | For more information about the ownership interests of our Initial Stockholders, including our Sponsor, prior to the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(1) | Stockholders of Luminar include Austin Russell, Luminar’s Founder, President and Chief Executive Officer, holders of Luminar Preferred Stock, including investors affiliated with the Company, G2VP I, LLC and GVA Auto, LLC, certain current and former employees of Luminar and other holders. |
(1) | For more information about the ownership interests of our Initial Stockholders, including our Sponsor, following the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(2) | The ownership interests of Luminar Equityholders includes the (i) ownership interests of the Series X Investors (excluding our Initial Stockholders) acquired as a result of the Series X Financing, (ii) the Rollover Options and (iii) the Assumed Warrants. |
(3) | For more information about the ownership interests of the Luminar Stockholders, following the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(4) | The foregoing ownership percentages are calculated inclusive of the Rollover Options and Assumed Warrants and assume (i) no exercise of redemption rights by our Public Stockholders (ii) no inclusion of any Public Shares issuable upon the exercise of the Company Warrants and (iii) no shares of Class A Stock or Class B Stock are issued as Earn-Out Shares. |
• | the applicable waiting period(s) under the HSR Act in respect of the transactions contemplated by the Merger Agreement shall have expired or been terminated; |
• | there shall not have been enacted or promulgated any governmental order, statute, rule or regulation enjoining or prohibiting the consummation of the transactions contemplated by the Merger Agreement; |
• | the Company shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) remaining after the completion of the redemption offer and prior to the closing of the First Merger; |
• | the approval by the Company Stockholders of the Transaction Proposal, the Issuance Proposal and the Amendment Proposal shall have been obtained; |
• | the adoption by the Luminar Stockholders of the Merger Agreement and each other agreement contemplated thereby shall have been obtained; |
• | the Class A Stock to be issued in connection with the Business Combination (including the Class A Stock to be issued pursuant to the earn-out) shall have been approved for listing on Nasdaq, subject to the requirement to have a sufficient number of round lot holders and official notice of listing; and |
• | this proxy statement/consent solicitation statement/prospectus shall have become effective under the Securities Act and no stop order suspending the effectiveness of this proxy statement/consent solicitation statement/prospectus shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the SEC and not withdrawn. |
• | the accuracy of the representations and warranties of the Company, First Merger Sub and Second Merger Sub as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on the Company, First Merger Sub and Second Merger Sub, taken as a whole, or a material adverse effect on the Company’s, First Merger Sub’s and Second Merger Sub’s ability to consummate the transactions contemplated by the Merger Agreement, including the Mergers; |
• | each of the covenants of the Company to be performed or complied with as of or prior to the closing shall have been performed or complied with in all material respects; | ||
|
|
|
|
• | the receipt of a certificate signed by an executive officer of the Company certifying that the two preceding conditions have been satisfied; and |
• | the Current Company Certificate shall be amended and restated in the form of the Second Amended and Restated Certificate of Incorporation. |
• | the accuracy of the representations and warranties of Luminar as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on Luminar; |
• | each of the covenants of Luminar to be performed or complied with as of or prior to the closing of the First Merger shall have been performed or complied with in all material respects; and |
• | the receipt of a certificate signed by an officer of Luminar certifying that the two preceding conditions have been satisfied. |
• | Industry Leadership of Luminar lidar |
• | Commercial Viability |
• | Business and Financial Condition and Prospects |
prospects for growth in executing upon and achieving Luminar’s business plan, and noted its unique and innovative lidar technology, its unique market position, opportunities for sustained organic growth and the opportunity for mass commercialization of its technology. |
• | Visionary Management Team |
• | Opinion of our Financial Advisor Opinion of the Company’s Financial Advisor |
• | Other Alternatives |
• | Terms of the Merger Agreement |
• | Independent Director Role |
• | Benefits Not Achieved . |
• | Liquidation of the Company . |
• | Exclusivity . |
• | Stockholder Vote . |
• | Closing Conditions . |
• | Litigation . |
• | Fees and Expenses . |
• | Other Risks . Risk Factors |
• | Interests of Certain Persons . The Business Combination—Interests of Certain Persons in the Business Combination—Interests of the Company Initial Stockholders and the Company’s Other Current Officers and Directors |
• | Other Alternatives |
• | Terms of the Merger Agreement |
• | Consideration Received by Luminar Stockholders |
• | Size of Post-Combination Company |
• | Access to Capital |
• | Benefit from Being a Public Company |
• | Opportunity to Increase Earnings and Expand Prospects |
• | Insider Letters Insiders |
• | Support Agreement . Luminar’s board of directors considered that Austin Russell was expected to enter into a Support Agreement with the Company. Under the Support Agreement, Mr. Russell would agree, within three business days of the registration statement on Form S-4 of which this proxy statement/consent solicitation statement/prospectus is a part being declared effective by the SEC, to execute and deliver a written consent with respect to the outstanding shares of Luminar Class A Stock and Luminar Founders Preferred Stock held by him adopting the Merger Agreement and approving the other transactions contemplated thereby, including the Mergers, which, as of the close of business on the Luminar Record Date, represent approximately [ 62]% of the aggregate issued and outstanding shares of Luminar Class A Stock and [ 88]% of the shares of the aggregate issued and outstanding Luminar Founders Preferred Stock, or approximately [ 38]% of the total voting power of Luminar Stock. For a more detailed description of the Support Agreement, see the sections titled “The Business Combination—Support Agreement ” and “The Merger Agreement and Related Agreements—Support Agreement ” beginning on pages [●] and [●], respectively, of this proxy statement/consent solicitation statement/prospectus. |
• | Lock-up AgreementLock-Up Agreements. Under the Lock-Up Agreement, such stockholders will agree not to, without the prior written consent of the board of directors of the Company, (i) sell or otherwise dispose of, or agree to sell or dispose of, any shares of Class A Stock held by the stockholder immediately after the effective time of the Mergers or any shares of Class A issuable upon the exercise of options, warrants or other convertible securities to purchase shares of Class A Stock held by the stockholder immediately after the effective time of the Mergers (“Lock-Up SharesLock-Up Shares, or (iii) publicly announce any intention to effect any transaction specified in clause “(i)” or “(ii)” above for 180 days after the closing date of the Mergers. |
• | Registration Rights Agreement Earn-Out Shares or issuable upon the conversion of certain Earn-Out Shares (as defined in the Merger Agreement), and Private Placement Warrants, subject to certain requirements and customary conditions. The Registration Rights Agreement will also provide that the Post-Combination Company will pay certain expenses relating to such registrations and indemnify the Registration Rights Holders against (or make contributions in respect of) certain liabilities which may arise under the Securities Act. For a more detailed description of the Registration Rights Agreement, see the section titled “The Merger Agreement and Related Agreements—Registration Rights Agreement |
• | Risk that the Business Combination may not be completed. |
• | Effects on reputation, business and employees if the Business Combination is not completed. |
• | Expenses and challenges. |
• | Costs of being a public company. |
• | Restrictions on operation of Luminar’s business. |
business consistent with past practice and in accordance with specified restrictions, which might delay or prevent Luminar from undertaking certain business opportunities that might arise pending closing. |
• | Interests of Luminar executive officers and directors. |
• | Other risks. Risk Factors |
1. | Transaction Proposal Annex A , and the transactions contemplated thereby, including, among other things, the Business Combination (Proposal No. 1); |
2. | Issuance Proposal |
3. | Amendment Proposal Annex B (Proposal No. 3); |
4. | Governance Proposal non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with SEC requirements (Proposal No. 4); |
5. | Management Longer Term Equity Incentive Plan Proposal |
6. | Omnibus Incentive Plan Proposal |
7. | Employee Stock Purchase Plan Proposal |
8. | Director Election Proposal |
9. | Adjournment Proposal |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective target businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 |
(1) | Assumes a value of $10.00 per share. |
(2) | Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to Registration Rights Holders and their permitted transferees. |
• | Mr. Russell, Luminar’s Founder, President and Chief Executive Officer, will exchange certain Luminar Class A Stock owned by him for Luminar Class B Stock (prior to the consummation of the Business Combination); |
• | Luminar directors may serve as directors of the Post-Combination Company; |
• | Outstanding equity awards will convert into equity awards of the Post-Combination Company; and |
• | Luminar officers may participate in the Management Longer Term Equity Incentive Plan. |
Name |
Age |
Position | ||
Dean Metropoulos |
73 | Chairman and Director | ||
Alec E. Gores |
67 | Chief Executive Officer and Director | ||
Andrew McBride |
40 | Chief Financial Officer and Secretary | ||
Randall Bort |
55 | Director | ||
Michael Cramer |
67 | Director | ||
Joseph Gatto |
64 | Director |
Name |
Age |
Position | |||||
Executive Officers |
|||||||
Austin Russell |
25 | President and Chief Executive Officer, and Director | |||||
Thomas J. Fennimore |
44 | Chief Financial Officer | |||||
M. Scott Faris |
55 | Chief Business Officer | |||||
Jason Eichenholz |
48 | Chief Technology Officer | |||||
Non-Employee Directors |
|||||||
Matthew J. Simoncini |
59 | Director | |||||
Scott A. McGregor |
64 | Director | |||||
Benjamin J. Kortlang |
45 | Director |
Name |
Age |
Position | ||
Executive Officers |
||||
Austin Russell |
25 | Chairperson, President and Chief Executive Officer (Class III) | ||
Thomas J. Fennimore |
44 | Chief Financial Officer | ||
M. Scott Faris |
55 | Chief Business Officer | ||
Jason Eichenholz |
48 | Chief Technology Officer | ||
Non-Employee Directors |
||||
Alec E. Gores |
67 | Director (Class II) | ||
Matthew J. Simoncini |
59 | Director (Class II) | ||
Scott A. McGregor |
64 | Director (Class I) | ||
Benjamin J. Kortlang |
45 | Director (Class I) |
For the Six Months Ended June 30, 2020 (unaudited) |
For the Six Months Ended June 30, 2019 (unaudited) |
For the Year Ended December 31, 2019 (audited) |
For the Period from August 28, 2018 (inception) to December 31, 2018 (audited) |
|||||||||||||
Professional fees and other expenses |
(358,968 | ) | (309,984 | ) | (620,871 | ) | (20,554 | ) | ||||||||
State franchise taxes, other than income tax |
(100,000 | ) | (100,000 | ) | (200,000 | ) | (1,431 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(458,968 | ) | (409,984 | ) | (820,871 | ) | (21,985 | ) | ||||||||
Other income—interest income |
1,325,278 | 3,892,361 | 7,707,654 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) before income taxes |
$ | 866,310 | $ | 3,482,377 | $ | 6,886,783 | $ | (21,985 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Provision for income tax |
(218,352 | ) | (727,551 | ) | (1,441,607 | ) | — | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) attributable to common shares |
$ | 647,958 | $ | 2,754,826 | $ | 5,445,176 | $ | (21,985 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) per ordinary share: |
||||||||||||||||
Class A ordinary shares—basic and diluted |
$ | 0.02 | $ | 0.09 | $ | 0.16 | $ | — | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Class F ordinary shares—basic and diluted |
$ | (0.01 | ) | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.00 | ) | ||||
|
|
|
|
|
|
|
|
As of June 30, 2020 (unaudited) |
As of December 31, 2019 (audited) |
As of December 31, 2018 (audited) |
||||||||||
Assets |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 1,011,395 | $ | 1,365,240 | $ | 52,489 | ||||||
Deferred offering costs |
— | — | 437,375 | |||||||||
Prepaid assets |
107,501 | 136,399 | — | |||||||||
|
|
|
|
|
|
|||||||
Total current assets |
1,118,896 | 1,501,639 | 489,864 | |||||||||
Deferred income tax |
15,079 | 2,353 | — | |||||||||
Investments and cash held in Trust Account |
406,397,612 | 406,434,959 | — | |||||||||
|
|
|
|
|
|
|||||||
Total assets |
$ | 407,531,587 | $ | 407,938,951 | $ | 489,864 | ||||||
|
|
|
|
|
|
|||||||
Liabilities and Stockholders’ Equity |
||||||||||||
Current liabilities: |
||||||||||||
Accrued expenses, formation and offering costs |
$ | 85,889 | $ | 53,203 | $ | 335,418 | ||||||
State franchise tax accrual |
20,000 | 200,000 | 1,431 | |||||||||
Notes and advances payable—related party |
— | — | 150,000 | |||||||||
Current income tax and interest payable |
194,654 | 1,102,662 | — | |||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
300,543 | 1,355,865 | 486,849 | |||||||||
Deferred underwriting compensation |
14,000,000 | 14,000,000 | — | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
$ | 14,300,543 | $ | 15,355,865 | $ | 486,849 | ||||||
Commitments and contingencies: |
||||||||||||
Class A subject to possible redemption, 38,713,476, 38,713,476 and -0- |
387,134,760 | 387,134,760 | — |
As of June 30, 2020 (unaudited) |
As of December 31, 2019 (audited) |
As of December 31, 2018 (audited) |
||||||||||
Stockholders’ equity: |
||||||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding |
— | — | — | |||||||||
Common stock |
||||||||||||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized, 1,286,524, 1,286,524 and -0- -0- |
129 | 129 | — | |||||||||
Class F common stock, $0.0001 par value; 20,000,000 shares authorized, 10,000,000 shares issued and outstanding |
1,000 | 1,000 | 1,078 | |||||||||
Additional paid-in capital |
24,006 | 24,006 | 23,922 | |||||||||
Retained earnings/(accumulated deficit) |
6,071,149 | 5,423,191 | (21,985 | ) | ||||||||
|
|
|
|
|
|
|||||||
Total stockholders’ equity |
6,096,284 | 5,448,326 | 3,015 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities and stockholders’ equity |
$ | 407,531,587 | $ | 407,938,951 | $ | 489,864 | ||||||
|
|
|
|
|
|
(in thousands, except per share data) |
Six Months Ended June 30, 2020 |
Six Months Ended June 30, 2019 |
As of and for the year ended December 31, 2019 |
As of and for the year ended December 31, 2018 |
||||||||||||
Statement of Operations Data: |
||||||||||||||||
Net sales |
$ | 7,296 | $ | 3,719 | $ | 12,602 | $ | 11,692 | ||||||||
Total operating expenses |
30,696 | 28,630 | 58,562 | 64,982 | ||||||||||||
Net loss |
(41,016 | ) | (63,095 | ) | (94,718 | ) | (79,550 | ) | ||||||||
Net loss per share attributable to common stockholders—Basic and diluted |
(4.34 | ) | (8.43 | ) | (11.47 | ) | (12.00 | ) | ||||||||
Balance Sheet Data: |
||||||||||||||||
Total assets |
50,216 | N/A | 51,864 | 28,202 | ||||||||||||
Total liabilities |
54,778 | N/A | 18,851 | 152,869 | ||||||||||||
Total mezzanine equity |
244,743 | N/A | 244,743 | — | ||||||||||||
Total shareholders’ deficit |
(249,305 | ) | N/A | (211,730 | ) | (124,667 | ) |
• | Assuming No R edemptions |
• | Assuming Maxi m um R edemptions : |
Pro Forma Combined (Assuming No Redemptions) |
Pro Forma Combined (Assuming Maximum Redemptions) |
|||||||
Summary Unaudited Pro Forma Condensed Combined |
||||||||
Statement of Operations Data |
||||||||
Six Months Ended June 30, 2020 |
||||||||
Net sales |
$ | 7,296 | $ | 7,296 | ||||
Net loss per share of Class A Stock—basic and diluted |
$ | (0.11 | ) | $ | (0.13 | ) | ||
Weighted average shares outstanding of Class A Stock—basic and diluted |
216,948,840 | 177,440,969 | ||||||
Net loss per share of Class B Stock—basic and diluted |
$ | (0.11 | ) | $ | (0.13 | ) | ||
Weighted average shares outstanding of Class B Stock—basic and diluted |
104,715,233 | 104,715,233 |
Pro Forma Combined (Assuming No Redemptions) |
Pro Forma Combined (Assuming Maximum Redemptions) |
|||||||
Summary Unaudited Pro Forma Condensed Combined |
||||||||
Statement of Operations Data |
||||||||
Year Ended December 31, 2019 |
||||||||
Net sales |
$ | 12,602 | $ | 12,602 | ||||
Net loss per share of Class A Stock—basic and diluted |
$ | (0.30 | ) | $ | (0.34 | ) | ||
Weighted average shares outstanding of Class A Stock—basic and diluted |
216,948,840 | 177,440,969 | ||||||
Net loss per share of Class B Stock—basic and diluted |
$ | (0.30 | ) | $ | (0.34 | ) | ||
Weighted average shares outstanding of Class B Stock—basic and diluted |
104,715,233 | 104,715,233 | ||||||
Summary Unaudited Pro Forma Condensed Combined |
||||||||
Balance Sheet Data as of June 30, 2020 |
||||||||
Total assets |
$ | 537,762 | $ | 168,403 | ||||
Total liabilities |
$ | 10,998 | $ | 39,707 | ||||
Total stockholders’ equity |
$ | 526,764 | $ | 128,696 |
Trading Date |
Public Units (GMHIU) |
Public Shares (GMHI) |
Public Warrants (GMHIW) |
|||||||||
August 21, 2020 |
$ | 11.75 | $ | 10.51 | $ | 1.59 | ||||||
[●] |
$[●] | $[●] | $[●] |
Public Units (GMHIU) |
Public Shares (GMHI) |
Public Warrants (GMHIW) |
||||||||||||||||||||||
High |
Low |
High |
Low |
High |
Low |
|||||||||||||||||||
Fiscal Year 2020 |
||||||||||||||||||||||||
Quarter ended March 31, 2020 |
$ | 12.00 | $ | 9.69 | $ | 11.00 | $ | 9.45 | $ | 1.82 | $ | 0.65 | ||||||||||||
Quarter ended June 30, 2020 |
$ | 12.50 | $ | 10.18 | $ | 10.82 | $ | 9.87 | $ | 2.25 | $ | 1.00 | ||||||||||||
Fiscal Year 2019 |
||||||||||||||||||||||||
Quarter ended March 31, 2019 (1)(2) |
$ | 10.25 | $ | 10.12 | $ | 9.81 | $ | 9.75 | $ | 1.40 | $ | 1.30 | ||||||||||||
Quarter ended June 30, 2019 |
$ | 10.50 | $ | 10.19 | $ | 10.28 | $ | 9.79 | $ | 1.35 | $ | 1.15 | ||||||||||||
Quarter ended September 30, 2019 |
$ | 10.63 | $ | 10.47 | $ | 10.34 | $ | 10.02 | $ | 1.42 | $ | 1.28 | ||||||||||||
Quarter ended December 31, 2019 |
$ | 10.75 | $ | 10.58 | $ | 10.20 | $ | 10.05 | $ | 1.54 | $ | 1.25 |
(1) | Beginning on February 1, 2019 with respect to GMHIU. |
(2) | Beginning on March 25, 2019 with respect to GMHI and GMHIW. |
• | continues to utilize its third-party partners for design, testing and commercialization; |
• | expands its production capabilities to produce its lidar solutions, including costs associated with outsourcing the production of its lidar solutions; |
• | expands its design, development, installation and servicing capabilities; |
• | builds up inventories of parts and components for its lidar solutions; |
• | produces an inventory of its lidar solutions; and |
• | increases its sales and marketing activities and develops its distribution infrastructure. |
• | produce and deliver lidar and software products of acceptable performance; |
• | forecast its revenue and budget for and manage its expenses; |
• | attract new customers and retain existing customers; |
• | comply with existing and new or modified laws and regulations applicable to its business; |
• | plan for and manage capital expenditures for its current and future products, and manage its supply chain and supplier relationships related to its current and future products; |
• | anticipate and respond to macroeconomic changes and changes in the markets in which it operates; |
• | maintain and enhance the value of its reputation and brand; |
• | effectively manage its growth and business operations, including the impacts of the COVID-19 pandemic on its business; |
• | develop and protect intellectual property; |
• | hire, integrate and retain talented people at all levels of its organization; and |
• | successfully develop new solutions to enhance the experience of customers. |
• | investing in research and development (“R&D”); |
• | expanding its sales and marketing efforts to attract new customers; |
• | investing in new applications and markets for its products; |
• | further enhancing its manufacturing processes and partnerships; |
• | pursuing litigation to protect its intellectual property; and |
• | investing in legal, accounting, and other administrative functions necessary to support its operations as a public company. |
• | the timing and magnitude of orders and shipments of Luminar’s products in any quarter; |
• | pricing changes Luminar may adopt to drive market adoption or in response to competitive pressure; |
• | Luminar’s ability to retain its existing customers and attract new customers; |
• | Luminar’s ability to develop, introduce, manufacture and ship in a timely manner products that meet customer requirements; |
• | disruptions in Luminar’s sales channels or termination of its relationship with important channel partners; |
• | delays in customers’ purchasing cycles or deferments of customers’ purchases in anticipation of new products or updates from Luminar or its competitors; |
• | fluctuations in demand pressures for Luminar’s products; |
• | the mix of products sold in any quarter; |
• | the duration of the global COVID-19 pandemic and the time it takes for economic recovery; |
• | the timing and rate of broader market adoption of autonomous systems utilizing Luminar’s solutions across the automotive and other market sectors; |
• | market acceptance of lidar and further technological advancements by Luminar’s competitors and other market participants; |
• | the ability of Luminar’s customers to commercialize systems that incorporate its products; |
• | any change in the competitive dynamics of Luminar’s markets, including consolidation of competitors, regulatory developments and new market entrants; |
• | Luminar’s ability to effectively manage its inventory; |
• | changes in the source, cost, availability of and regulations pertaining to materials Luminar uses; |
• | adverse litigation, judgments, settlements or other litigation-related costs, or claims that may give rise to such costs; and |
• | general economic, industry and market conditions, including trade disputes. |
• | foreign currency fluctuations; |
• | local economic conditions; |
• | political instability; |
• | import or export requirements; |
• | foreign government regulatory requirements; |
• | reduced protection for intellectual property rights in some countries; |
• | tariffs and other trade barriers and restrictions; and |
• | potentially adverse tax consequences. |
• | exchange rate fluctuations; |
• | political and economic instability, international terrorism and anti-American sentiment, particularly in emerging markets; |
• | global or regional health crises, such as the COVID-19 pandemic or other health epidemics and outbreaks; |
• | potential for violations of anti-corruption laws and regulations, such as those related to bribery and fraud; |
• | preference for locally branded products, and laws and business practices favoring local competition; |
• | potential consequences of, and uncertainty related to, the “Brexit” process in the United Kingdom, which could lead to additional expense and complexity in doing business there; |
• | increased difficulty in managing inventory; |
• | delayed revenue recognition; |
• | less effective protection of intellectual property; |
• | stringent regulation of the autonomous or other systems or products using Luminar’s products and stringent consumer protection and product compliance regulations, including but not limited to General Data Protection Regulation in the European Union, European competition law, the Restriction of Hazardous Substances Directive, the Waste Electrical and Electronic Equipment Directive and the European Ecodesign Directive that are costly to comply with and may vary from country to country; |
• | difficulties and costs of staffing and managing foreign operations; |
• | import and export laws and the impact of tariffs; |
• | changes in local tax and customs duty laws or changes in the enforcement, application or interpretation of such laws; and |
• | U.S. government’s restrictions on certain technology transfer to certain countries of concern. |
• | identify, select and apply GAAP sufficiently to provide reasonable assurance that transactions were being appropriately recorded; and |
• | assess risk and design appropriate control activities over information technology systems and financial and reporting processes necessary to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements. |
• | changes in tax laws or the regulatory environment; |
• | changes in accounting and tax standards or practices; |
• | changes in the composition of operating income by tax jurisdiction; and |
• | Luminar’s operating results before taxes. |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective target businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 | |||||
(1) Assumes a value of $10.00 per share. (2) Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to Registration Rights Holders and their permitted transferees. |
• | changes in the valuation of our deferred tax assets and liabilities; |
• | expected timing and amount of the release of any tax valuation allowances; |
• | tax effects of stock-based compensation; |
• | costs related to intercompany restructurings; |
• | changes in tax laws, regulations or interpretations thereof; or |
• | lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates. |
• | actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us; |
• | changes in the market’s expectations about our operating results; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | speculation in the press or investment community; |
• | success of competitors; |
• | our operating results failing to meet the expectation of securities analysts or investors in a particular period; |
• | changes in financial estimates and recommendations by securities analysts concerning the Post-Combination Company or the market in general; |
• | operating and stock price performance of other companies that investors deem comparable to the Post-Combination Company; |
• | our ability to market new and enhanced products on a timely basis; |
• | changes in laws and regulations affecting our business; |
• | commencement of, or involvement in, litigation involving the Post-Combination Company; |
• | changes in the Post-Combination Company’s capital structure, such as future issuances of securities or the incurrence of additional debt; |
• | the volume of shares of our Class A Stock available for public sale; |
• | any major change in the Post-Combination Company’s Board or management; |
• | sales of substantial amounts of Common Stock by our directors, officers or significant stockholders or the perception that such sales could occur; |
• | the realization of any of the risk factors presented in this proxy statement/consent solicitation statement/prospectus; |
• | additions or departures of key personnel; |
• | failure to comply with the requirements of Nasdaq; |
• | failure to comply with the Sarbanes-Oxley Act or other laws or regulations; |
• | actual, potential or perceived control, accounting or reporting problems; |
• | changes in accounting principles, policies and guidelines; and |
• | general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and health epidemics and pandemics (including the ongoing COVID-19 public health emergency), acts of war or terrorism. |
• | providing for a classified board of directors with staggered, three-year terms; |
• | authorizing its board of directors to issue Preferred Stock with voting or other rights or preferences that could discourage a takeover attempt or delay changes in control; |
• | prohibiting cumulative voting in the election of directors; |
• | providing that vacancies on its board of directors may be filled only by a majority of directors then in office, even though less than a quorum; |
• | prohibiting the adoption, amendment or repeal of the Amended and Restated Bylaws or the repeal of the provisions of its Second Amended and Restated Certificate of Incorporation to be in effect upon the closing of the Business Combination regarding the election and removal of directors without the required approval of at least two-thirds of the shares entitled to vote at an election of directors; |
• | prohibiting stockholder action by written consent; |
• | limiting the persons who may call special meetings of stockholders; and |
• | requiring advance notification of stockholder nominations and proposals. |
• | the Post-Combination Company will indemnify its directors and officers for serving the Post-Combination Company in those capacities or for serving other business enterprises at its request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful; |
• | the Post-Combination Company may, in its discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law; |
• | the Post-Combination Company will be required to advance expenses, as incurred, to its directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification; |
• | the Post-Combination Company will not be obligated pursuant to its Amended and Restated Bylaws to indemnify a person with respect to proceedings initiated by that person against the Post-Combination Company or its other indemnitees, except with respect to proceedings authorized by its board of directors or brought to enforce a right to indemnification; |
• | the rights conferred in the Amended and Restated Bylaws are not exclusive, and the Post-Combination Company is authorized to enter into indemnification agreements with its directors, officers, employees and agents and to obtain insurance to indemnify such persons; and |
• | the Post-Combination Company may not retroactively amend its Amended and Restated Bylaw provisions to reduce its indemnification obligations to directors, officers, employees and agents. |
• | the realization of any of the risk factors presented in this proxy statement/consent solicitation statement/prospectus; |
• | actual or anticipated differences in our estimates, or in the estimates of analysts, for our revenues, Adjusted EBITDA, results of operations, level of indebtedness, liquidity or financial condition; |
• | additions and departures of key personnel; |
• | failure to comply with the requirements of Nasdaq; |
• | failure to comply with the Sarbanes-Oxley Act or other laws or regulations; |
• | future issuances, sales, resales or repurchases or anticipated issuances, sales, resales or repurchases, of our securities; |
• | publication of research reports about the Company; |
• | the performance and market valuations of other similar companies; |
• | commencement of, or involvement in, litigation involving Luminar or us; |
• | broad disruptions in the financial markets, including sudden disruptions in the credit markets; |
• | speculation in the press or investment community; |
• | actual, potential or perceived control, accounting or reporting problems; |
• | changes in accounting principles, policies and guidelines; and |
• | other events or factors, including those resulting from infectious diseases, health epidemics and pandemics (including the ongoing COVID-19 public health emergency), natural disasters, war, acts of terrorism or responses to these events. |
• | labor availability and costs for hourly and management personnel; |
• | profitability of our products, especially in new markets and due to seasonal fluctuations; |
• | changes in interest rates; |
• | impairment of long-lived assets; |
• | macroeconomic conditions, both nationally and locally; |
• | negative publicity relating to products we serve; |
• | changes in consumer preferences and competitive conditions; |
• | expansion to new markets; and |
• | fluctuations in commodity prices. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A Stock is a “penny stock” which will require brokers trading in our Class A Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; or |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | the audited financial statements of the Company as of and for the fiscal year ended December 31, 2019 and the period from August 28, 2018 (inception) to December 31, 2018, prepared in accordance with GAAP; |
• | the unaudited financial statements of the Company as of and for the six months ended June 30, 2020 and for the six months ended June 30, 2019, prepared in accordance with GAAP; |
• | the audited consolidated financial statements of Luminar as of and for the fiscal years ended December 31, 2019 and December 31, 2018, prepared in accordance with GAAP; |
• | the unaudited condensed consolidated financial statements of Luminar as of and for the six months ended June 30, 2020 and June 30, 2019, prepared in accordance with GAAP; and |
• | the unaudited pro forma condensed combined financial statements of the Post-Combination Company for the year ended December 31, 2019 and as of and for the six months ended June 30, 2020, prepared in accordance with GAAP. |
• | general economic uncertainty and the effect of general economic conditions on Luminar’s industry in particular, including the level of demand and financial performance of the autonomous vehicle industry and market adoption of lidar; |
• | Luminar’s history of losses and whether it will continue to incur significant expenses and continuing losses for the foreseeable future; |
• | the effect of continued pricing pressures, automotive OEM cost reduction initiatives and the ability of automotive OEMs to re-source or cancel vehicle or technology programs which may result in lower than anticipated margins, or losses, which may adversely affect Luminar’s business; |
• | the ability of Luminar to protect and enforce its intellectual property rights; |
• | whether Luminar’s lidar products are selected for inclusion in autonomous driving or ADAS systems by automotive OEMs or their suppliers; |
• | Luminar’s inability to reduce and control the cost of the inputs on which Luminar relies, which could negatively impact the adoption of its products and its profitability; |
• | changes in personnel and availability of qualified personnel; |
• | the effects of the ongoing coronavirus (COVID-19) pandemic or other infectious diseases, health epidemics, pandemics and natural disasters on Luminar’s business; |
• | Luminar’s ability to remediate the material weakness in its internal controls over financial reporting; |
• | Luminar’s ability to transition to an outsourced manufacturing business model; |
• | Luminar’s anticipated investments in and results from sales and marketing and R&D; |
• | the success of Luminar’s customers in developing and commercializing products using Luminar’s solutions; |
• | Luminar’s estimated total addressable market; |
• | the amount and timing of future sales; |
• | whether the complexity of Luminar’s products results in undetected defects and reliability issues which could reduce market adoption of its new products, damage its reputation and expose Luminar to product liability and other claims; |
• | strict government regulation that is subject to amendment, repeal or new interpretation and the Post-Combination Company’s ability to comply with modified or new laws and regulations applying to its business; |
• | possible delays in closing the Business Combination, whether due to the inability to obtain Company stockholder or regulatory approval, litigation relating to the Business Combination or the failure to satisfy any of the conditions to closing the Business Combination, as set forth in the Merger Agreement; |
• | any waivers of the conditions to closing the Business Combination as may be permitted in the Merger Agreement; |
• | the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, and the ability of the Post-Combination Company to manage its growth and expand its business operations effectively following the consummation of the Business Combination; |
• | whether the concentration of the Post-Combination Company’s stock ownership and voting power limits the stockholders of the Post-Combination Company’s ability to influence corporate matters; |
• | the ability to obtain or maintain the listing of Class A Stock on Nasdaq following the Business Combination; and |
• | the increasingly competitive environment in which the Post-Combination Company will operate. |
1. | Transaction Proposal Annex A , and the transactions contemplated thereby, including, among other things, the Business Combination (Proposal No. 1); |
2. | Issuance Proposal |
3. | Amendment Proposal Annex B (Proposal No. 3); |
4. | Governance Proposal non-binding advisory basis, a separate proposal with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with SEC requirements (Proposal No. 4); |
5. | Management Longer Term Equity Incentive Plan Proposal |
6. | Omnibus Incentive Plan Proposal |
7. | Employee Stock Purchase Plan Proposal |
8. | Director Election Proposal |
9. | Adjournment Proposal |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 |
Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective target businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 | |||||
(1) Assumes a value of $10.00 per share. (2) Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
|
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to Registration Rights Holders and their permitted transferees. |
• | you may send another proxy card with a later date; |
• | you may notify our Secretary in writing to Gores Metropoulos, Inc., 9800 Wilshire Blvd., Beverly Hills, CA 90212, before the Special Meeting that you have revoked your proxy; or |
• | you may attend the Special Meeting, revoke your proxy, and vote in person via the virtual meeting platform, as indicated above. |
• | if you hold Public Units, separate the underlying Public Shares and Public Warrants; |
• | check the box on the enclosed proxy card marked “Stockholder Certification” if you are not acting in concert or as a “group” (as defined in Section 13d-3 of the Exchange Act) with any other stockholder with respect to Public Shares; |
• | prior to 5:00 P.M., Eastern Time on [●], 2020 (two business days before the Special Meeting), tender your shares physically or electronically and submit a request in writing that we redeem your Public Shares for cash to Continental Stock Transfer & Trust Company, the Transfer Agent, at the following address: |
• | deliver your Public Shares either physically or electronically through DTC’s DWAC system to the Transfer Agent at least two business days before the Special Meeting. Stockholders seeking to exercise their redemption rights and opting to deliver physical certificates should allot sufficient time to obtain physical certificates from the Transfer Agent and time to effect delivery. Stockholders should generally allot at least two weeks to obtain physical certificates from the Transfer Agent. However, it may take longer than two weeks. Stockholders who hold their shares in street name will have to coordinate with their bank, broker or other nominee to have the shares certificated or delivered electronically. If you do not submit a written request and deliver your Public Shares as described above, your shares will not be redeemed. |
• | at the closing of the Business Combination, First Merger Sub will merge with and into Luminar, with Luminar continuing as the Surviving Corporation of the First Merger; |
• | immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation will merge with and into Second Merger Sub, with Second Merger Sub continuing as the Surviving Entity of the Second Merger; |
• | prior to the consummation of the Business Combination (and subject to approval by our stockholders), we will adopt the proposed Second Amended and Restated Certificate of Incorporation, to provide for, among other things the authorization of the Class B Stock to be issued in connection with the Business Combination; |
• | in connection with the Business Combination, the Luminar Stockholders will receive in exchange for their Luminar Stock, the Aggregate Company Stock Consideration. Holders of shares of (a) Luminar Class A Stock, Luminar Preferred Stock and Luminar Founders Preferred Stock, will be entitled to receive a number of shares of newly-issued Class A Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Class A Stock, Luminar Preferred Stock or Luminar Founders Preferred Stock, as applicable, and (b) Luminar Class B Stock will be entitled to receive a number of shares of newly-issued Class B Stock equal to the Per Share Company Stock Consideration for each such share of Luminar Class B Stock. The foregoing consideration to be paid to the Luminar Stockholders may be further increased by amounts payable as Earn-Out Shares, of up to 7.5% of the sum of (x) the total outstanding capital stock of the Company and (y) the total shares subject to the Rollover Options and Assumed Warrants, in each case, as of the closing of the Business Combination; |
• | at the closing of the Business Combination, the Registration Rights Holders will enter into the Registration Rights Agreement, pursuant to which, (a) any (i) outstanding share of Class A Stock or any Private Placement Warrants, (ii) shares of Class A Stock issued or issuable upon the exercise of any other equity security of the Company (including shares of Class A Stock issued or issuable upon the conversion of the Class F Stock or the Class B Stock and upon exercise of the Private Placement Warrants), and (iii) shares of Class A Stock issued as Earn-Out Shares or issuable upon the conversion of any Earn-Out Shares, in each case, held by the Luminar Holders, and (b) any other equity security of the Company issued or issuable with respect to any such share of Class A Stock by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise, will be entitled to registration rights; and |
• | our Initial Stockholders have agreed, and their permitted transferees will agree, to vote their Founder Shares, as well as any Public Shares purchased during or after the Company IPO, in favor of the Business Combination. |
(1) | For more information about the ownership interests of our Initial Stockholders, including our Sponsor, prior to the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(1) | Stockholders of Luminar include Austin Russell, Luminar’s Founder, President and Chief Executive Officer, holders of Luminar Preferred Stock, including investors affiliated with the Company, G2VP I, LLC and GVA Auto, LLC, certain current and former employees of Luminar and other holders. |
(1) | For more information about the ownership interests of our Initial Stockholders, including our Sponsor, following the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(2) | The ownership interests of Luminar Equityholders includes (i) the ownership interests of the Series X Investors (excluding our Initial Stockholders) acquired as a result of the Series X Financing, (ii) the Rollover Options and (iii) the Assumed Warrants. |
(3) | For more information about the ownership interests of the Luminar Stockholders, following the Business Combination, please see the section entitled “ Beneficial Ownership of Securities |
(4) | The foregoing ownership percentages are calculated inclusive of the Rollover Options and Assumed Warrants and assume (i) no exercise of redemption rights by our Public Stockholders (ii) no inclusion of any Public Shares issuable upon the exercise of the Company Warrants and (iii) no shares of Class A Stock or Class B Stock are issued as Earn-Out Shares. |
($ and shares in thousands) |
Assume No Earn Out Target |
Triggering Event I (3) Achieved |
Triggering Event II (4) Achieved |
Triggering Event III (5) Achieved |
Triggering Event IV (6) Achieved |
Triggering Event V (7) Achieved |
Triggering Event VI (8) Achieved |
|||||||||||||||||||||
Aggregate Company Stock Consideration |
$ | 2,928,829 | $ | 2,928,829 | $ | 2,928,829 | $ | 2,928,829 | $ | 2,928,829 | $ | 2,928,829 | $ | 2,928,829 | ||||||||||||||
Minus: Series X Financing Amount (1) |
170,000 | 170,000 | 170,000 | 170,000 | 170,000 | 170,000 | 170,000 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Consideration to Luminar Equityholders (9) |
$ | 2,758,829 | $ | 2,758,829 | $ | 2,758,829 | $ | 2,758,829 | $ | 2,758,829 | $ | 2,758,829 | $ | 2,758,829 | ||||||||||||||
$ Value of Earn Out Shares (2) |
$ | 0 | $ | 55,718 | $ | 124,295 | $ | 205,730 | $ | 300,022 | $ | 407,173 | $ | 527,182 | ||||||||||||||
Earn Out Shares (M) |
0 | 4,286 | 8,572 | 12,858 | 17,144 | 21,430 | 25,716 | |||||||||||||||||||||
Aggregate Consideration (inclusive of $ Value of Earn Out Shares) |
$ | 2,758,829 | $ | 2,814,547 | $ | 2,883,124 | $ | 2,964,558 | $ | 3,058,851 | $ | 3,166,002 | $ | 3,286,011 | ||||||||||||||
Total Shares |
275,883 | 280,169 | 284,455 | 288,741 | 293,027 | 297,313 | 301,599 |
(1) | Represents approximately $170 million paid by the Series X Investors to Luminar in exchange for the Series X Preferred Stock sold in the Series X Financing. |
(2) | Value of Earn-Out Shares based on Class A Stock or Class B Stock, as applicable, awarded at each Triggering Event multiplied by the applicable Common Share Price (as defined in the Merger Agreement) required to be achieved at such Triggering Event. For example, Triggering Event IV will be met when the Common Share Price reaches $22.00, at which time approximately 4.286 million Earn-Out Shares will be issued with an implied value of approximately $94.29 million (based on $22.00 stock price). The total Value of Earn-Out Shares in Triggering Event IV would also include three tranches of approximately 4.286 million Earn-Out shares per tranche with implied values, respectively, of approximately of $81.44 million (based on $19.00 stock price from Triggering Event III), $68.58 million (based on $16.00 stock price from Triggering Event II) and $55.72 million (based on $13.00 stock price from Triggering Event I). |
(3) | “Triggering Event I” means the date on which the Common Share Price is greater than $13.00 after the closing date of the Business Combination, but within the time period between the date that is 180 days following the closing of the Business Combination (the “ Lockup Expiration Date Earn Out Period |
(4) | “Triggering Event II” means the date on which the Common Share Price is greater than $16.00 after the closing date of the Business Combination, but within the Earn Out Period. |
(5) | “Triggering Event III” means the date on which the Common Share Price is greater than $19.00 after the closing date of the Business Combination, but within the Earn Out Period. |
(6) | “Triggering Event IV” means the date on which the Common Share Price is greater than $22.00 after the closing date of the Business Combination, but within the Earn Out Period. |
(7) | “Triggering Event V” means the date on which the Common Share Price is greater than $25.00 after the closing date of the Business Combination, but within the Earn Out Period. |
(8) | “Triggering Event VI” means the date on which the Common Share Price is greater than $28.00 after the closing date of the Business Combination, but within the Earn Out Period. |
(9) | Excludes consideration payable in respect of Series X Preferred Stock. |
• | the applicable waiting period(s) under the HSR Act in respect of the transactions contemplated by the Merger Agreement shall have expired or been terminated; |
• | there shall not have been enacted or promulgated any governmental order, statute, rule or regulation enjoining or prohibiting the consummation of the transactions contemplated by the Merger Agreement; |
• | the Company shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) remaining after the completion of the redemption offer and prior to the closing of the First Merger; |
• | the approval by the Company Stockholders of the Transaction Proposal, the Issuance Proposal and the Amendment Proposal shall have been obtained; |
• | the adoption by the Luminar Stockholders of the Merger Agreement and each other agreement contemplated thereby shall have been obtained; |
• | the Class A Stock to be issued in connection with the Business Combination (including the Class A Stock to be issued pursuant to the earn-out) shall have been approved for listing on Nasdaq, subject to the requirement to have a sufficient number of round lot holders and official notice of listing; and |
• | this proxy statement/consent solicitation statement/prospectus shall have become effective under the Securities Act and no stop order suspending the effectiveness of this proxy statement/consent solicitation statement/prospectus shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the SEC and not withdrawn. |
• | the accuracy of the representations and warranties of the Company, First Merger Sub and Second Merger Sub as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on the Company, First Merger Sub and Second Merger Sub, taken as a whole, or a material adverse effect on the Company’s, First Merger Sub’s and Second Merger Sub’s ability to consummate the transactions contemplated by the Merger Agreement, including the Mergers; |
• | each of the covenants of the Company to be performed or complied with as of or prior to the closing shall have been performed or complied with in all material respects; |
• | the receipt of a certificate signed by an executive officer of the Company certifying that the two preceding conditions have been satisfied; and |
• | the Current Company Certificate shall be amended and restated in the form of the Second Amended and Restated Certificate of Incorporation. |
• | the accuracy of the representations and warranties of Luminar as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on Luminar; |
• | each of the covenants of Luminar to be performed or complied with as of or prior to the closing of the First Merger shall have been performed or complied with in all material respects; and |
• | the receipt of a certificate signed by an officer of Luminar certifying that the two preceding conditions have been satisfied. |
• | considered and conducted an analysis of over 27 potential acquisition targets (other than Luminar) (the “ Other Potential Targets non-disclosure agreements with 17 of the Other Potential Targets; and |
• | ultimately engaged in detailed discussions, due diligence and negotiations with 5 Other Potential Target businesses or their representatives. |
• | Industry Leadership of Luminar . lidar |
• | Commercial Viability . |
• | Business and Financial Condition and Prospects . |
• | Visionary Management Team . |
• | Opinion of our Financial Advisor . —Opinion of the Company’s Financial Advisor |
• | Other Alternatives . |
• | Terms of the Merger Agreement . |
• | Independent Director Role . |
• | Benefits Not Achieved . |
• | Liquidation of the Company . |
• | Exclusivity . |
• | Stockholder Vote . |
• | Closing Conditions . |
• | Litigation . |
• | Fees and Expenses . |
• | Other Risks . Risk Factors |
• | Interests of Certain Persons . The Business Combination—Interests of Certain Persons in the Business Combination—Interests of the Company Initial Stockholders and the Company’s Other Current Officers and Directors |
• | Other Alternatives. |
Luminar to create greater value for Luminar Stockholders, while also providing greater liquidity for its stockholders by owning stock in a public company. |
• | Terms of the Merger Agreement. |
• | Consideration Received by Luminar Stockholders. |
• | Size of Post-Combination Company. |
• | Access to Capital. |
• | Benefit from Being a Public Company. |
• | Opportunity to Increase Earnings and Expand Prospects. |
• | Insider Letters. |
• | Support Agreement. S-4 of which this proxy statement/consent solicitation statement/prospectus is a part being declared effective by the SEC, to execute and deliver a written consent with respect to the outstanding shares of Luminar Class A Stock and Luminar Founders Preferred Stock held by him adopting the Merger Agreement and approving the other transactions contemplated thereby, including the Mergers, which, as of the close of business on the Luminar Record Date, represent approximately [62]% of the aggregate issued and outstanding shares of Luminar Class A Stock and [88]% of the shares of the issued and outstanding Luminar Founders Preferred Stock, or approximately [38]% of the total voting power of Luminar capital stock. For a more detailed description of the Support Agreement, see the sections titled “The Business Combination Support Agreement The Merger Agreement and Related Agreements—Support Agreement |
• | Lock-up Agreement.Lock-Up SharesLock-Up Shares, or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) for 180 days after the closing date of the Mergers. |
• | Registration Rights Agreement. The Merger Agreement and Related Agreements—Registration Rights Agreement |
• | Risk that the Business Combination may not be completed. |
• | Effects on reputation, business and employees if the Business Combination is not completed. |
• | Expenses and challenges. |
• | Costs of being a public company. |
• | Restrictions on operation of Luminar’s business. |
• | Interests of Luminar executive officers and directors. |
may be different from, or in addition to, the interests of Luminar Stockholders generally, including the manner in which they would be affected by the Business Combination. |
• | Other risks. Risk Factors |
• | reviewed certain internal information relating to the business, earnings, cash flow, assets, liabilities and prospects of Luminar furnished to Moelis by the Company, including financial and other forecasts provided to, or discussed with, Moelis by the management of the Company. For additional information, please see the section entitled “ The Business Combination—Certain Financial Projections Provided to Our Board |
• | reviewed certain internal information relating to expenses expected to result from the Business Combination; |
• | conducted discussions with members of management of the Company concerning the information described in the foregoing, as well as the business and prospects of Luminar and the Company generally; |
• | reviewed publicly available financial and stock market data of certain other companies in lines of business that Moelis deemed relevant; |
• | reviewed a draft, dated August 21, 2020, of the Merger Agreement; |
• | reviewed the Company’s and Luminar’s capital structure both pre-Business Combination and post-Business Combination; |
• | conducted such other financial studies and analyses and took into account such other information as Moelis deemed appropriate; and |
• | reviewed, but did not rely on for purposes of its opinion, the financial terms of certain other transactions that it deemed relevant. |
Company |
Enterprise Value ($MM) |
Enterprise Value/ Revenue | |||||||||||||
CY2024 |
CY2025 | ||||||||||||||
NVIDIA Corporation |
$ | 317,269 | 10.1 | x | 8.6 | x | |||||||||
Ballard Power Systems Inc. |
$ | 3,906 | 8.5 | x | 6.2 | x | |||||||||
Tesla, Inc. |
$ | 474,311 | 6.5 | x | 6.0 | x | |||||||||
Virgin Galactic Holdings, Inc. |
$ | 3,284 | 6.5 | x | n/a | ||||||||||
Plug Power Inc. |
$ | 6,670 | 6.2 | x | 4.6 | x | |||||||||
Nikola Corporation |
$ | 16,627 | 5.8 | x | 3.5 | x | |||||||||
Workhorse Group Inc. |
$ | 1,905 | 1.4 | x | 0.8 | x | |||||||||
Median |
6.5 |
x |
5.3 |
x |
Reference Range |
Implied Total Enterprise Value Range ($MM) |
Consideration ($MM) |
||||
CY2024 Pro Forma Revenue |
$2,092—$3,347 | $ | 2,900 | |||
CY2025 Pro Forma Revenue |
$2,927—$5,018 | $ | 2,900 |
Implied Total Enterprise Value Range ($MM) |
Consideration ($MM) | |
$3,083 - $9,649 |
$2,900 |
Fiscal Year Ending December 31, |
||||||||||||||||||||||||||||||||||||||||||||
($ in millions) |
2020E |
2021E |
2022E |
2023E |
2024E |
2025E |
2026E |
2027E |
2028E |
2029E |
2030E |
|||||||||||||||||||||||||||||||||
Total Revenue |
$15 | $26 | $35 | $124 | $418 | $836 | $1,399 | $2,077 | $2,894 | $3,879 | $5,056 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total Cost of Goods Sold |
$22 | $20 | $23 | $60 | $164 | $305 | $488 | $684 | $945 | $1,246 | $1,587 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Gross Profit |
($7 | ) | $6 | $12 | $63 | $254 | $531 | $911 | $1,394 | $1,948 | $2,633 | $3,469 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Operating Income |
($72 | ) | ($95 | ) | ($100 | ) | ($71 | ) | $102 | $337 | $678 | $1,061 | $1,490 | $2,019 | $2,673 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Adjusted EBITDA |
($61 | ) | ($90 | ) | ($88 | ) | ($51 | ) | $126 | $365 | $707 | $1,091 | $1,520 | $2,056 | $2,717 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total Capital Expenditures |
($4 | ) | ($26 | ) | ($33 | ) | ($39 | ) | ($18 | ) | ($21 | ) | ($31 | ) | ($32 | ) | ($38 | ) | ($46 | ) | ($58 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
EBITDA less Capital Expenditures |
($66 | ) | ($116 | ) | ($121 | ) | ($90 | ) | $108 | $344 | $676 | $1,059 | $1,483 | $2,010 | $2,658 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Change in Net Working Capital |
($9 | ) | ($26 | ) | ($6 | ) | $7 | ($24 | ) | ($55 | ) | ($76 | ) | ($92 | ) | ($109 | ) | ($136 | ) | ($165 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Luminar’s projections are unaudited, based upon estimated results and do not include the impact of purchase accounting or other impacts from the consummation of the Business Combination. Some figures may not add up exactly due to rounding. |
H2’20 |
Fiscal Year Ending December 31, |
Terminal |
||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) (1)(2) |
2020E |
2021E |
2022E |
2023E |
2024E |
2025E |
2026E |
2027E |
2028E |
2029E |
2030E |
Year |
||||||||||||||||||||||||||||||||||||
Revenue |
$8 | $26 | $35 | $124 | $418 | $836 | $1,399 | $2,077 | $2,894 | $3,879 | $5.056 | $5056 | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
% Growth |
(12 | %) | 68 | % | 38 | % | 250 | % | 238 | % | 100 | % | 67 | % | 48 | % | 39 | % | 34 | % | 30 | % | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Adjusted EBITDA |
($31 | ) | ($90 | ) | ($88 | ) | ($51 | ) | $126 | $365 | $707 | $1,091 | $1,520 | $2,056 | $2,717 | $2,717 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Less: Depreciation and Amortization |
(2 | ) | (6 | ) | (12 | ) | (20 | ) | (24 | ) | (28 | ) | (29 | ) | (30 | ) | (30 | ) | (37 | ) | (44 | ) | (58 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Adjusted EBIT |
($32 | ) | ($95 | ) | ($100 | ) | ($71 | ) | $102 | $337 | $678 | $1,061 | $1,490 | $2,019 | $2,673 | $2,658 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Less: Taxes @ 25% |
— | — | — | — | (25 | ) | (84 | ) | (170 | ) | (265 | ) | (373 | ) | (505 | ) | (668 | ) | (665 | ) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Plus: Depreciation and Amortization |
2 | 6 | 12 | 20 | 24 | 28 | 29 | 30 | 30 | 37 | 44 | 58 | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Less: Change in Net Working Capital |
(13 | ) | (26 | ) | (6 | ) | 7 | (24 | ) | (55 | ) | (76 | ) | (92 | ) | (109 | ) | (136 | ) | (165 | ) | (165 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Less: Capital Expenditures |
(3 | ) | (26 | ) | (33 | ) | (39 | ) | (18 | ) | (21 | ) | (31 | ) | (32 | ) | (38 | ) | (46 | ) | (58 | ) | (58 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Unlevered Free Cash Flow |
($46 | ) | ($142 | ) | ($127 | ) | ($83 | ) | $58 | $206 | $431 | $702 | $1,002 | $1,370 | $1,826 | $1,829 | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Some figures may not add up due to rounding. |
(2) | Depreciation and amortization assumed to equal capital expenditures in terminal year. |
(3) | Terminal year Change in Net Working Capital and Capital Expenditures assumed to equal 2030E projections. |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public |
share amount as is in the Trust Account on the liquidation date, by the claims of prospective target businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 |
(1) | Assumes a value of $10.00 per share. |
(2) | Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to Registration Rights Holders and their permitted transferees. |
• | Mr. Russell, Luminar’s Founder, President and Chief Executive Officer, will exchange certain Luminar Class A Stock owned by him for Luminar Class B Stock (prior to the consummation of the Business Combination), |
• | Luminar directors may serve as directors of the Post-Combination Company, |
• | Outstanding equity awards will convert into equity awards of the Post-Combination Company, and |
• | Luminar officers may participate in the Management Longer Term Equity Incentive Plan. |
Sources |
Uses |
|||||||||
Company Cash in Trust Account (2) |
$ | 406,397,612 | Seller Rollover (3) |
$ | 2,758,827,200 | |||||
Series X Investors |
170,000,135 | Proceeds to Luminar (4) (5) |
526,397,747 | |||||||
Seller Rollover (3) |
2,758,827,200 | Company Estimated Transaction Expenses | 25,000,000 | |||||||
Luminar Estimated Transaction Expenses | 25,000,000 | |||||||||
|
|
|
|
|||||||
Total Sources (6) |
$ |
3,335,224,947 |
Total Uses (6) |
$ |
3,335,224,947 |
(1) | Under the Series X Agreements, Luminar is permitted to sell up to another $30,000,000 of Series X Preferred Stock. Assumes no such additional amounts are sold. |
(2) | Assumes no Company stockholder has exercised its redemption rights to receive cash from the Trust Account. This amount will be reduced by the amount of cash used to satisfy any redemptions. |
(3) | Amount represents $2,928,828,692 of stock consideration less approximately $170.0 million raised from the Series X investment. Dollar amount represents the number of shares existing Luminar Equityholders (excluding the Series X Investors) will receive valued at a share price of $10.00. This amount is not impacted by the number of redemptions. |
(4) | Proceeds to Luminar is calculated based on the assumed $406.4 million of Company cash and $170.0 million raised from the Series X Financing less $25 million for estimated Company transaction expenses and less $25 million for estimated Luminar transaction expenses. |
(5) | Does not reflect the repayment of any indebtedness, which repayment is required to be made at the closing of the Business Combination if the amount of the Company’s cash at the closing of the Business Combination (which, for the avoidance of doubt, would be reduced by any amounts required to be paid to satisfy any redemptions of shares of Class A Stock by our Public Stockholders, but would include the amount of Luminar’s cash at the closing of the Business Combination) exceeds $300,000,000. |
(6) | Totals may be different due to rounding. |
Sources & Uses (1) |
||||||||||
Sources |
Uses |
|||||||||
Company Cash in Trust Account (2) |
$ | 5,000,001 | Seller Rollover (3) |
$ | 2,758,827,200 | |||||
Series X Investors |
170,000,135 | Proceeds to Luminar (4) (5) |
125,000,136 | |||||||
Seller Rollover (3) |
2,758,827,200 | Company Estimated Transaction Expenses | 25,000,000 | |||||||
Luminar Estimated Transaction Expenses | 25,000,000 | |||||||||
|
|
|
|
|||||||
Total Sources (6) |
$ |
2,933,827,336 |
Total Uses (6) |
$ |
2,933,827,336 |
(1) | Under the Series X Agreements, Luminar is permitted to sell up to another $30,000,000 of Series X Preferred Stock. Assumes no such additional amounts are sold. |
(2) | Assumes 98.8% of the outstanding shares of Class A Stock have been redeemed by the Company’s stockholders to receive cash from the Trust Account, reducing the amount of Company cash by $401.4 million. |
(3) | Amount represents $2,928,828,692 of stock consideration less approximately $170.0 million raised from the Series X investment. Dollar amount represents the number of shares existing Luminar Equityholders (excluding the Series X Investors) will receive valued at a share price of $10.00. This amount is not impacted by the number of redemptions. |
(4) | Proceeds to Luminar is calculated based on the assumed $5.0 million of Company cash and $170.0 million raised from Series X investment less $25 million for estimated Company transaction expenses and less $25 million for estimated Luminar transaction expenses. |
(5) | Does not reflect the repayment of any indebtedness, which repayment is required to be made at the closing of the Business Combination if the amount of the Company’s cash at the closing of the Business Combination (which, for the avoidance of doubt, would be reduced by any amounts required to be paid to satisfy any redemptions of shares of Class A Stock by our Public Stockholders, but would include the amount of Luminar’s cash at the closing of the Business Combination) exceeds $300,000,000. |
(6) | Totals may be different due to rounding. |
Name |
Age |
Position | ||
Dean Metropoulos |
73 | Chairman and Director | ||
Alec E. Gores |
67 | Chief Executive Officer and Director | ||
Andrew McBride |
40 | Chief Financial Officer and Secretary | ||
Randall Bort |
55 | Director | ||
Michael Cramer |
67 | Director | ||
Joseph Gatto |
64 | Director |
Name |
Age |
Position | ||||
Executive Officers |
||||||
Austin Russell |
25 | President and Chief Executive Officer, and Director | ||||
Thomas J. Fennimore |
44 | Chief Financial Officer | ||||
M. Scott Faris |
55 | Chief Business Officer | ||||
Jason Eichenholz |
48 | Chief Technology Officer | ||||
Non-Employee Directors |
||||||
Matthew J. Simoncini |
59 | Director | ||||
Scott A. McGregor |
64 | Director | ||||
Benjamin J. Kortlang |
45 | Director |
Name |
Age |
Position | |||||
Executive Officers |
|||||||
Austin Russell |
25 | Chairperson, Director (Class III), President and Chief Executive Officer | |||||
Thomas J. Fennimore |
44 | Chief Financial Officer | |||||
M. Scott Faris |
55 | Chief Business Officer | |||||
Jason Eichenholz |
48 | Chief Technology Officer | |||||
Non-Employee Directors |
|||||||
Alec E. Gores |
67 | Director (Class II) | |||||
Benjamin J. Kortlang |
45 | Director (Class I) | |||||
Scott A. McGregor |
64 | Director (Class I) | |||||
Matthew J. Simoncini |
59 | Director (Class II) |
• | banks and financial institutions; |
• | insurance companies; |
• | brokers and dealers in securities, currencies or commodities; |
• | dealers or traders in securities subject to a mark-to-market |
• | regulated investment companies and real estate investment trusts; |
• | governmental organizations and qualified foreign pension funds; |
• | persons holding Class A Stock as part of a “straddle,” hedge, integrated transaction or similar transaction; |
• | U.S. holders (as defined below) whose functional currency is not the U.S. dollar; |
• | partnerships or other pass-through entities for U.S. federal income tax purposes (and investors in such entities); |
• | certain former citizens or long-term residents of the United States; |
• | controlled foreign corporations and passive foreign investment companies; |
• | any holder of Founder Shares; and |
• | tax-exempt entities. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the United States, any state thereof or the District of Columbia; |
• | an estate the income of which is subject to U.S. federal income tax purposes regardless of its source; or |
• | a trust, if (i) a court within the United States is able to exercise primary supervision over the administration of such trust and one or more “United States persons” (within the meaning of the U.S. Tax Code) have the authority to control all substantial decisions of the trust or (ii) the trust validly elected to be treated as a United States person for U.S. federal income tax purposes. |
• | a non-resident alien individual, other than certain former citizens and residents of the United States subject to U.S. tax as expatriates; |
• | a foreign corporation; or |
• | an estate or trust that is not a U.S. holder; |
• | the gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United States (and, under certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the Non-U.S. holder); or |
• | we are or have been a “United States real property holding corporation” for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of the redemption or the period that the Non-U.S. holder held our Class A Stock, and, in the case where shares of our Class A Stock are regularly traded on an established securities market, the Non-U.S. holder has owned, directly or constructively, more than 5% of our Class A Stock at any time within the shorter of the five-year period preceding the redemption or such Non-U.S. holder’s holding period for the shares of our Class A Stock. |
• | An individual who is a citizen or resident of the United States, as determined for U.S. federal income tax purposes; |
• | A corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States or any state thereof or the District of Columbia; |
• | A trust, the substantial decisions of which are controlled by one or more United States Persons and which is subject to the primary supervision of a United States court, or a trust that has validly elected under applicable Treasury regulations to be treated as a United States person for U.S. federal income tax purposes; or |
• | An estate that is subject to U.S. federal income tax on its income regardless of source. |
• | No gain or loss will be recognized by a holder of Luminar Stock for U.S. federal income tax purposes on the exchange of its shares of Luminar Class A Stock, Luminar Preferred Stock or Luminar Founders Preferred Stock for Class A Stock (including any Earn-Out Shares), or on the exchange of its Luminar Class B Stock for Class B Stock (including any Earn-Out Shares) in the First Merger, except, in each case, with respect to cash received in lieu of fractional shares and imputed interest. |
• | Other than with respect to Earn-Out Shares treated as imputed interests (as described below), the aggregate tax basis of the Class A Stock or Class B Stock, including any Earn-Out Shares, received in the First Merger by a holder of Luminar Stock will be equal to the aggregate tax basis of the Luminar Stock it exchanged in the First Merger, except that such holder’s aggregate tax basis in the Class A Stock or Class B Stock will be reduced by the tax basis allocable to any fractional share interest in the Class A Stock or Class B Stock for which cash was received. |
• | Other than with respect to Earn-Out Shares treated as imputed interests (as described below), the tax holding period of the Class A Stock or Class B Stock, including any Earn-Out Shares, received in the First Merger by a holder of Luminar Stock, including any fractional interest for which such holder receives cash, will include the holding period of the Luminar Stock that it surrendered in exchange therefor in the First Merger. |
• | the applicable waiting period(s) under the HSR Act in respect of the transactions contemplated by the Merger Agreement shall have expired or been terminated; |
• | there shall not have been enacted or promulgated any governmental order, statute, rule or regulation enjoining or prohibiting the consummation of the transactions contemplated by the Merger Agreement; |
• | the Company shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) remaining after the completion of the redemption offer and prior to the closing of the First Merger; |
• | the approval by the Company Stockholders of the Transaction Proposal, the Issuance Proposal and the Amendment Proposal shall have been obtained; |
• | the approval by the Luminar Stockholders of the Merger Agreement and each other agreement contemplated thereby shall have been obtained; |
• | the Class A Stock to be issued in connection with the Business Combination (including the Class A Stock to be issued pursuant to the earn-out) shall have been approved for listing on Nasdaq, subject to the requirement to have a sufficient number of round lot holders and official notice of listing; and |
• | this proxy statement/consent solicitation statement/prospectus shall have become effective under the Securities Act and no stop order suspending the effectiveness of this proxy statement/consent solicitation statement/prospectus shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the SEC and not withdrawn. |
• | the accuracy of the representations and warranties of the Company, First Merger Sub and Second Merger Sub as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on the Company, First Merger Sub and Second Merger Sub, taken as a whole, or a material adverse effect on the Company’s, First Merger Sub’s and Second Merger Sub’s ability to consummate the transactions contemplated by the Merger Agreement, including the Mergers; |
• | each of the covenants of the Company to be performed or complied with as of or prior to the closing shall have been performed or complied with in all material respects; |
• | the receipt of a certificate signed by an executive officer of the Company certifying that the two preceding conditions have been satisfied; and |
• | the Current Company Certificate shall be amended and restated in the form of the Second Amended and Restated Certificate of Incorporation. |
• | the accuracy of the representations and warranties of Luminar as of the date of the Merger Agreement and as of the closing date of the Business Combination, other than, in most cases, where the failure to be true and correct has not and would not reasonably be expected to have a material adverse effect on Luminar; |
• | each of the covenants of Luminar to be performed or complied with as of or prior to the closing of the First Merger shall have been performed or complied with in all material respects; and |
• | the receipt of a certificate signed by an officer of Luminar certifying that the two preceding conditions have been satisfied. |
• | other than as contemplated by the Merger Agreement, change or amend the certificate of incorporation, bylaws or other organizational documents of Luminar or any of its subsidiaries; |
• | (a) make, declare or pay any dividend or distribution (whether in cash, stock or property) to the stockholders of Luminar in their capacities as stockholders; (b) effect any recapitalization, reclassification, split or other change in its capitalization; (c) except in connection with the exercise of any Luminar Stock Option or Luminar Warrant outstanding as of the date of the Merger Agreement in accordance with its terms, authorize for issuance, issue, sell, transfer, pledge, encumber, dispose of or deliver any additional shares of its capital stock or securities convertible into or exchangeable for shares of its capital stock, or issue, sell, transfer, pledge, encumber or grant any right, option, restricted stock unit, stock appreciation right or other commitment for the issuance of shares of its capital stock, or split, combine or reclassify any shares of its capital stock; or (d) repurchase, redeem or otherwise acquire, or offer to repurchase, redeem or otherwise acquire, any shares of its capital stock or other equity interests, except for: (i) the acquisition by Luminar or any of its subsidiaries of any shares of capital stock, membership interests or other equity interests of Luminar or its subsidiaries in connection with the forfeiture or cancellation of such equity interests; (ii) transactions between Luminar and any of its wholly-owned subsidiaries or between wholly-owned subsidiaries of Luminar; and (iii) purchases or redemptions pursuant to exercises of Luminar Stock Options issued and outstanding as of the date hereof or the withholding of shares to satisfy net settlement or tax obligations with respect to equity awards in accordance with the terms of such equity awards; |
• | enter into, or amend or modify any material term of, terminate (excluding any expiration in accordance with its terms), renew or fail to exercise any renewal rights, or waive or release any material rights, claims or benefits under, any material contract of Luminar (or any contract, that if existing on the date hereof, would have been deemed to be a material contract of Luminar) (in each case other than |
pursuant to (a) offers, bids or proposals made by Luminar or its subsidiaries on or prior to the date hereof that, if accepted, would result in a contract with a governmental authority or (b) requirements from any governmental authority to modify the scope of work under any contract to which it and Luminar or its subsidiaries are parties), any lease related to the leased real property of Luminar or any collective bargaining or similar agreement (including agreements with works councils and trade unions and side letters) to which Luminar or its subsidiaries is a party or by which it is bound, other than entry into, amendments of, modifications of, terminations of, or waivers or releases under, such agreements in the ordinary course of business consistent with past practice; |
• | sell, transfer, lease, pledge or otherwise encumber or subject to any lien (other than certain permitted liens), abandon, cancel, let lapse or convey or dispose of any material assets, properties or business of Luminar and its subsidiaries, taken as a whole (including certain specified intellectual property or software of Luminar), except for dispositions of obsolete or worthless assets and other than in the ordinary course of business consistent with past practice; |
• | other than in the ordinary course of business consistent with past practice and except as otherwise required pursuant to the employee benefit plans of Luminar in effect on the date of the Merger Agreement or applicable law: (a) increase any compensation, benefits or severance of, or grant or provide any change in control, retention, sale bonus or similar payments or benefits to any current or former director, employee or independent contractor of Luminar or its subsidiaries; (b) adopt, enter into, materially amend or terminate any employee benefit plan of Luminar or agreement, arrangement or plan which would be an employee benefit plan of Luminar if in effect on the date of the Merger Agreement, or any collective bargaining or similar agreement (including agreements with works councils and trade unions and side letters) to which Luminar or its subsidiaries is a party or by which it is bound (except for routine renewals of collective bargaining or similar agreements); (c) grant or provide any severance or termination payments or benefits to any current or former director, employee or independent contractor of Luminar or its subsidiaries; (d) hire, terminate (other than for cause) or place on unpaid leave or furlough any director or employee of Luminar or its subsidiaries, or give notice of any such actions; (e) take any action that will result in the acceleration, vesting or creation of any right of any current or former director or employee of Luminar or its subsidiaries under any employee benefit plan of Luminar; and (f) grant any equity or equity-based compensation awards; provided, that, with respect to employees and independent contractors, clauses “(a)” and “(c)” (and, with respect to newly hired employees, clause “(d)”) shall apply only to those with an annual base salary in excess of $150,000, whether or not such actions were taken in the ordinary course of business consistent with past practice; |
• | (a) fail to maintain its existence or acquire by merger or consolidation with, or merge or consolidate with, or purchase a material portion of the assets or equity of, any corporation, partnership, limited liability company, association, joint venture or other business organization or division thereof or (b) adopt or enter into a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization of Luminar or its subsidiaries (other than the transactions contemplated by the Merger Agreement); |
• | make any capital expenditures (or commitment to make any capital expenditures) that in the aggregate exceed $5,000,000, other than any capital expenditure (or series of related capital expenditures) consistent in all material respects with Luminar’s annual capital expenditure budget for periods following the date of the Merger Agreement, made available to the Company; |
• | make any loans, advances or capital contributions to, or investments in, any other person or entity (including to any of its officers, directors, agents or consultants, but excluding any of Luminar’s subsidiaries) except for loans, advances or capital contributions pursuant to and in accordance with the terms of agreements or legal obligations existing as of the date of the Merger Agreement as set forth on the Schedules, make any material change in its existing borrowing or lending arrangements relating to such loans, advances, capital contributions or investments for or on behalf of such persons or entities, |
or enter into any “keep well” or similar agreement to maintain the financial condition of any other person or entity, other than advances to employees or officers of Luminar or its subsidiaries in the ordinary course of business consistent with past practice; |
• | make or change any material tax election, adopt, change or make a request to change any tax accounting method or period, file any amendment to a tax return, enter into any closing agreement with a governmental authority with respect to a material amount of taxes, surrender any right to claim a material refund of taxes, settle or compromise any examination, audit or other action with a governmental authority relating to any material taxes or consent to any extension or waiver of the statutory period of limitations applicable to any claim or assessment in respect of taxes; |
• | enter into any agreement that restricts the ability of Luminar or its subsidiaries to engage or compete in any line of business, or enter into any agreement that restricts the ability of Luminar or its subsidiaries to enter a new line of business; |
• | acquire any fee interest in real property; |
• | enter into, renew or amend in any material respect any affiliate agreement of Luminar; |
• | waive, release, compromise, settle or satisfy any pending or threatened action or compromise or settle any liability, other than in the ordinary course of business consistent with past practice or that otherwise does not exceed $500,000 in the aggregate; |
• | (a) issue or sell any debt securities or rights to acquire any debt securities of Luminar or any of its subsidiaries or guarantee any debt securities of another person or entity, or (b) incur, create, assume, refinance, guarantee or otherwise become liable for (whether directly, contingently or otherwise) any indebtedness; |
• | (a) accelerate or delay collection of notes or accounts receivable in advance of or beyond their regular due dates or the dates when the same would have been collected in the ordinary course of business or (b) delay or accelerate payment of any account payable in advance of or beyond its due date or the date such liability would have been paid in the ordinary course of business; |
• | enter into any material new line of business outside of the business currently conducted by Luminar and its subsidiaries as of the date of the Merger Agreement; |
• | make any material change in financial accounting methods, principles or practices, except insofar as may have been required by a change in GAAP (including pursuant to standards, guidelines and interpretations of the Financial Accounting Standards Board or any similar organization) or applicable law; |
• | voluntarily fail to maintain, cancel or materially change coverage under any insurance policy in form and amount equivalent in all material respects to the insurance coverage currently maintained with respect to Luminar and its subsidiaries and their assets and properties; |
• | implement any employee layoffs, plant closings, or similar events that individually or in the aggregate would give rise to any obligations or liabilities on the part of Luminar or its subsidiaries under WARN or any similar state or local “mass layoff” or “plant closing” law, including any temporary layoffs or furloughs that would trigger obligations or liabilities under WARN should they last for longer than 6 months, other than in the ordinary course of business consistent with past practice as a result of the expiration or termination of a Contract with a governmental authority without renewal, a government shutdown or the reduction in the scope of work of a such a Contract; or |
• | enter into any agreement to do any action prohibited under the foregoing. |
• | change, modify or amend the trust agreement (or any other agreement related to the Trust Account), the Company’s organizational documents or the organizational documents of First Merger Sub or Second Merger Sub, or form or establish any other subsidiary; |
• | (a) make, declare, set aside or pay any dividends on, or make any other distribution (whether in cash, stock or property) in respect of any of its outstanding capital stock or other equity interests, (b) split, combine, reclassify or otherwise change any of its capital stock or other equity interests; (c), other than the redemption of any shares of Class A Stock or as otherwise required by the Company’s organizational documents in order to consummate the transactions contemplated by the Merger Agreement, repurchase, redeem or otherwise acquire, or offer to repurchase, redeem or otherwise acquire, any capital stock of, or other equity interests in, the Company; or (d) effect a recapitalization or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any capital stock or warrant, or effect any like change in capitalization; |
• | enter into, renew or amend any Company affiliate agreement (or any contract, that if existing on the date of the Merger Agreement, would have constituted a Company affiliate agreement); |
• | enter into, or amend or modify any term of (in a manner adverse to the Company or any of its subsidiaries (including, following the effective time of the First Merger, Luminar and its subsidiaries)), terminate (excluding any expiration in accordance with its terms), or waive or release any material rights, claims or benefits under, any Company material contract (or any contract, that if existing on the date hereof, would have been deemed a Company material contract required), or any employee benefit plan of the Company (or plan that would be an employee benefit plan of the Company if in effect on the date hereof) or collective bargaining or similar agreement (including agreements with works councils and trade unions and side letters) to which the Company or its subsidiaries is a party or by which it is bound; |
• | waive, release, compromise, settle or satisfy any pending or threatened claim (including any pending or threatened action) or compromise or settle any liability; |
• | incur, guarantee or otherwise become liable for (whether directly, contingently or otherwise) any indebtedness, issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities of the Company, as applicable, or enter into any arrangement having the economic effect of any of the foregoing; |
• | (a) offer, issue, deliver, grant or sell, or authorize or propose to offer, issue, deliver, grant or sell, any capital stock of, or other equity interests in, the Company or any of its subsidiaries or any securities convertible into, or any rights, warrants or options to acquire, any such capital stock or equity interests, other than (i) in connection with the exercise of any Company Warrants outstanding on the date hereof in accordance with the terms thereof or (ii) the transactions contemplated by the Merger Agreement or (b) amend, modify or waive any of the terms or rights set forth in, any the Company Warrant or the Warrant Agreement, including any amendment, modification or reduction of the warrant price set forth therein; |
• | fail to maintain its existence or acquire by merger or consolidation with, or merge or consolidate with, or purchase a material portion of the assets or equity of, any corporation, partnership, limited liability company, association, joint venture or other business organization or division thereof; or adopt or enter into a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization (other than the transactions contemplated by the Merger Agreement); |
• | other than in the ordinary course of business consistent with past practice, make any loans, advances or capital contributions to, or investments in, any other person or entity, make any change in its existing |
borrowing or lending arrangements relating to such loans, advances, capital contributions or investments for or on behalf of such persons or entities, or enter into any “keep well” or similar agreement to maintain the financial condition of any other person or entity; |
• | make any change in its financial accounting methods, principles or practices, except insofar as may have been required by a change in GAAP (including pursuant to standards, guidelines and interpretations of the Financial Accounting Standards Board or any similar organization) or applicable law; |
• | voluntarily fail to maintain, cancel or materially change coverage under any insurance policy in form and amount equivalent to the insurance coverage currently maintained with respect to the Company and its subsidiaries and their assets and properties; |
• | (a) make or rescind any material tax election; (b) settle or compromise any material tax claim; (c) change (or request to change) any method of accounting for tax purposes; (d) file any material amended tax return; (e) waive or extend any statute of limitations in respect of a period within which an assessment or reassessment of material taxes may be issued (other than any extension pursuant to an extension to file any tax return); (f) knowingly surrender any claim for a refund of taxes; or (g) enter into any “closing agreement” as described in Section 7121 of the U.S. Tax Code (or any similar provision of tax law), with any governmental authority; |
• | create any material liens (other than permitted liens) on any material property or assets of the Company, First Merger Sub or Second Merger Sub; |
• | engage in any material new line of business; or |
• | enter into any agreement to do any action prohibited under the foregoing. |
• | initiate, solicit or knowingly encourage or knowingly facilitate any inquiries or requests for information with respect to, or the making of, any inquiry regarding, or any proposal or offer that constitutes, or could reasonably be expected to result in or lead to, any acquisition proposal (as defined below); |
• | engage in, continue or otherwise participate in any negotiations or discussions concerning, or provide access to its properties, books and records or any confidential information or data to, any person or entity relating to any proposal, offer, inquiry or request for information that constitutes, or could reasonably be expected to result in or lead to, any acquisition proposal; |
• | furnish any non-public information regarding Luminar or its subsidiaries or access to the properties, assets or employee of Luminar or its subsidiaries to any person or entity with respect to, or the making of, any inquiry regarding, or any proposal or offer that constitutes, or could reasonably be expected to result in or lead to, any acquisition proposal or request for information; |
• | approve, endorse or recommend, or propose publicly to approve, endorse or recommend, any acquisition proposal; |
• | execute or enter into, any letter of intent, memorandum of understanding, agreement in principle, confidentiality agreement (other than an acceptable confidentiality agreement executed in accordance with the no solicitation provisions), Merger Agreement, acquisition agreement, exchange agreement, joint venture agreement, partnership agreement, option agreement or other similar agreement for or relating to any acquisition proposal; |
• | submit any acquisition proposal to the Luminar Stockholders; or |
• | resolve or agree to do any of the foregoing; |
• | prior to obtaining the Luminar Approval, (a) contacting and engaging in any negotiations or discussions with any person or entity and its representatives who has made a bona fide written acquisition proposal after the date hereof that did not result from a material breach of the no solicitation provisions and (b) providing access to Luminar’s or any of its subsidiaries’ properties, books and records and providing information or data in response to a request therefor by a person or entity who has made a bona fide written acquisition proposal that did not result from a material breach of the no solicitation provisions, in each case, if Luminar board of directors (i) shall have determined in good faith, after consultation with its outside legal counsel and financial advisor(s), that such acquisition proposal constitutes or would reasonably be expected to constitute, result in or lead to a superior proposal; (ii) shall have determined in good faith, after consultation with its outside legal counsel, that the failure to do so would be inconsistent with its fiduciary duties under applicable law; and (iii) has received from the person or entity so requesting such information an executed acceptable confidentiality agreement; provided that Luminar shall provide to the Company, First Merger Sub and Second Merger Sub any material non-public information or data that is provided to any person or entity that was not previously made available to the Company, First Merger Sub or Second Merger Sub prior to or substantially concurrently with the time it is provided to such person or entity (and in any event within 24 hours thereof); |
• | prior to obtaining the Luminar Approval, making a Luminar Change in Recommendation (only to the extent permitted by the no solicitation provisions); or |
• | resolving, authorizing, committing or agreeing to take any of the foregoing actions, only to the extent such actions would be permitted by the foregoing bullet points. |
• | “acquisition proposal” means any proposal or offer from any person, entity or “group” (as defined in the Exchange Act) (other than the Company, First Merger Sub, Second Merger Sub or their respective affiliates or with respect to the transactions contemplated by the Merger Agreement) relating to, in a single transaction or series of related transactions: (a) any direct or indirect acquisition or purchase of a business that constitutes 15% or more of the revenues, income or assets of Luminar and its subsidiaries, taken as a whole; (b) any direct or indirect acquisition of 15% or more of the consolidated assets of Luminar and its subsidiaries, taken as a whole (based on the fair market value thereof, as determined in good faith by the Luminar board of directors), including through the acquisition of one or more subsidiaries of Luminar owning such assets; (c) the acquisition of beneficial ownership, or the right to acquire beneficial ownership, of 15% or more of the total voting power of the equity securities of Luminar, any tender offer or exchange offer that if consummated would result in any person or entity beneficially owning 15% or more of the total voting power of the equity securities of Luminar, or any merger, reorganization, consolidation, share exchange, business combination, recapitalization, liquidation, dissolution or similar transaction involving Luminar (or any subsidiary of Luminar) that constitutes 15% or more of the revenues, income or assets of Luminar and its subsidiaries, taken as a whole; or (d) any issuance or sale or other disposition (including by way of merger, reorganization, division, consolidation, share exchange, business combination, recapitalization or other similar transaction) of 15% or more of the total voting power of the equity securities of Luminar. |
• | “superior proposal” means an unsolicited bona fide and written acquisition proposal made after the date of the Merger Agreement, that did not result from a material breach of the no solicitation provisions, that the Luminar board of directors in good faith determines (after consultation with its outside legal counsel and financial advisor(s)) is reasonably likely to be consummated in accordance with its terms and would, if consummated, result in a transaction that is more favorable from a financial point of view to the stockholders of Luminar (solely in their capacity as such) than the transactions contemplated hereby after taking into account all such factors and matters deemed relevant in good faith by the Luminar board of directors, including legal, financial (including the financing terms of any such proposal), regulatory, timing or other aspects of such proposal and the Merger Agreement and the transactions contemplated hereby (including any offer by the Company to amend the terms of the Merger Agreement, termination or break-up fee and conditions to consummation); provided that for |
purposes of the definition of “superior proposal”, the term “acquisition proposal” shall have the meaning assigned to such term summarized above, except that the references to “15%” in such definition shall be deemed to be references to “80%”. |
• | “Luminar intervening event” means an event, fact, development, circumstance or occurrence (but specifically excluding any acquisition proposal, superior proposal, any changes in capital markets or any declines or improvements in financial markets) that materially affects the business, assets, operations or prospects of Luminar and its subsidiaries, taken as a whole, and that was not known and was not reasonably foreseeable to the Luminar board of directors as of the date of the Merger Agreement (or the consequences of which were not reasonably foreseeable to the Luminar board of directors as of the date of the Merger Agreement), and that becomes known to Luminar or the Luminar board of directors after the date of the Merger Agreement. |
• | Luminar and the Company providing, subject to certain specified restrictions and conditions, to the other party and its respective representatives reasonable access to Luminar’s and the Company’s (as applicable) and its subsidiary’s properties, records, systems, contracts and commitments; |
• | Luminar, its subsidiaries and controlled affiliates agreeing not to engage in transactions involving securities of the Company without the Company’s prior consent; |
• | Luminar waiving claims to the Trust Account in the event that the Business Combination does not consummate; |
• | Luminar and the Company cooperating on the preparation and efforts to make effective this proxy statement/consent solicitation statement/prospectus; |
• | Luminar agreeing to perform any and all obligations under each of the Luminar Warrant Amendments and using commercially reasonable efforts to cause the other parties to the Luminar Warrant Amendments to consummate the transactions contemplated by the Luminar Warrant Amendments; |
• | the Company making certain disbursements from the Trust Account; |
• | the Company keeping current and timely filing all reports required to be filed or furnished with the SEC and otherwise complying in all material respects with its reporting obligations under applicable securities laws; |
• | Luminar taking all actions necessary to cause certain agreements to be terminated; |
• | the Company agreeing to take all actions necessary or appropriate to cause certain appointments to the board of the Company; |
• | the Company taking steps to exempt the acquisition of the Class A Stock and Class B Stock from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder; |
• | the Company adopting the Amended and Restated Bylaws prior to the consummation of the transactions contemplated by the Merger Agreement; |
• | the Company agreeing to enforce the terms and conditions of the letter agreements with our Sponsor and our directors and officers; |
• | cooperation between Luminar and the Company in obtaining any necessary third-party consents required to consummate the Business Combination; |
• | agreement relating to the intended tax treatment of the transactions contemplated by the Merger Agreement; |
• | the Parties agreeing to terms relating to confidentiality and publicity relating to the Merger Agreement and the transactions contemplated thereby; |
• | Luminar delivering to the Company a valid certification from the Company pursuant to Treasury Regulations Section 1.1445-2(c); and |
• | Luminar agreeing to consummate the transactions contemplated by the Share Exchange Agreement with Austin Russell and each of the Company and Luminar agreeing to deliver to one another executed copies of the Registration Rights Agreement and the Lock-Up Agreements. |
• | by written consent of Luminar and the Company; or |
• | by written notice from either Luminar or the Company to the other if the approval of the Company stockholders to the Transaction Proposal, the Issuance Proposal and the Amendment Proposal are not obtained at the Special Meeting (subject to any adjournment or recess of the Special Meeting). |
• | prior to the closing of the First Merger, by written notice to the Company from Luminar if (i) there is any breach of any representation, warranty, covenant or agreement on the part of the Company set forth in the Merger Agreement, such that the conditions described in the first two bullet points under the heading “— Conditions to Closing of the Business Combination; Conditions to Luminar’s Obligations Terminating Company Breach Company Cure Period Termination Date Lapse non-appealable governmental order or a statute, rule or regulation; provided, that the right to terminate the Merger Agreement under this paragraph shall not be available if Luminar’s failure to fulfill any obligation under the Merger Agreement has been the primary cause of, or primarily resulted in, the failure of the closing to occur on or before such date; or |
• | by written notice to the Company from Luminar prior to obtaining the approval of the Company Stockholders of each of the proposals contained in this proxy statement/consent solicitation statement/prospectus (the “ Required Company Stockholder Approval |
• | prior to the closing of the First Merger, by written notice to Luminar from the Company if (i) there is any breach of any representation, warranty, covenant or agreement on the part of Luminar set forth in the Merger Agreement such that the conditions described in the first two bullet points under the heading “— Conditions to Closing of the Business Combination; Conditions to the Company’s Obligations Terminating Luminar Breach Luminar Cure Period non-appealable governmental order or a statute, rule or regulation; provided, that the right to terminate the Merger Agreement under this paragraph shall not be available if the Company’s failure to fulfill any obligation under the Merger Agreement has been the primary cause of, or primarily resulted in, the failure of the closing to occur on or before such date; |
• | by written notice to Luminar from the Company if the Luminar board of directors (i) shall have made, prior to obtaining the Luminar Approval, a Luminar Change in Recommendation or (ii) shall have failed to include the Luminar Board Recommendation in this proxy statement/consent solicitation statement/prospectus (collectively, a “ Luminar Board Recommendation Change or Omission |
• | by written notice to Luminar from the Company if the Luminar Approval has not been obtained within three business days following the date that this proxy statement/consent solicitation statement/prospectus is disseminated by Luminar to the Luminar Stockholders pursuant to the terms of the Merger Agreement. |
For the Six Months Ended June 30, 2020 (unaudited) |
For the Six Months Ended June 30, 2019 (unaudited) |
For the Year Ended December 31, 2019 (audited) |
For the Period from August 28, 2018 (inception) to December 31, 2018 (audited) |
|||||||||||||
Professional fees and other expenses |
(358,968 | ) | (309,984 | ) | (620,871 | ) | (20,554 | ) | ||||||||
State franchise taxes, other than income tax |
(100,000 | ) | (100,000 | ) | (200,000 | ) | (1,431 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(458,968 | ) | (409,984 | ) | (820,871 | ) | (21,985 | ) | ||||||||
Other income—interest income |
1,325,278 | 3,892,361 | 7,707,654 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) before income taxes |
$ | 866,310 | $ | 3,482,377 | $ | 6,886,783 | $ | (21,985 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Provision for income tax |
(218,352 | ) | (727,551 | ) | (1,441,607 | ) | — | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) attributable to common shares |
$ | 647,958 | $ | 2,754,826 | $ | 5,445,176 | $ | (21,985 | ) | |||||||
|
|
|
|
|
|
|
|
|||||||||
Net income/(loss) per ordinary share: |
||||||||||||||||
Class A ordinary shares—basic and diluted |
$ | 0.02 | $ | 0.09 | $ | 0.16 | $ | — | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Class F ordinary shares—basic and diluted |
$ | (0.01 | ) | $ | (0.03 | ) | $ | (0.05 | ) | $ | (0.00 | ) | ||||
|
|
|
|
|
|
|
|
As of June 30, 2020 (unaudited) |
As of December 31, 2019 (audited) |
As of December 31, 2018 (audited) |
||||||||||
Assets |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 1,011,395 | $ | 1,365,240 | $ | 52,489 | ||||||
Deferred offering costs |
— | — | 437,375 | |||||||||
Prepaid assets |
107,501 | 136,399 | — | |||||||||
|
|
|
|
|
|
|||||||
Total current assets |
1,118,896 | 1,501,639 | 489,864 | |||||||||
Deferred income tax |
15,079 | 2,353 | — | |||||||||
Investments and cash held in Trust Account |
406,397,612 | 406,434,959 | — | |||||||||
|
|
|
|
|
|
|||||||
Total assets |
$ | 407,531,587 | $ | 407,938,951 | $ | 489,864 | ||||||
|
|
|
|
|
|
|||||||
Liabilities and Stockholders’ Equity |
||||||||||||
Current liabilities: |
||||||||||||
Accrued expenses, formation and offering costs |
$ | 85,889 | $ | 53,203 | $ | 335,418 | ||||||
State franchise tax accrual |
20,000 | 200,000 | 1,431 | |||||||||
Notes and advances payable—related party |
— | — | 150,000 | |||||||||
Current income tax and interest payable |
194,654 | 1,102,662 | — | |||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
300,543 | 1,355,865 | 486,849 | |||||||||
Deferred underwriting compensation |
14,000,000 | 14,000,000 | — | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
$ | 14,300,543 | $ | 15,355,865 | $ | 486,849 | ||||||
Commitments and contingencies: |
||||||||||||
Class A subject to possible redemption, 38,713,476, 38,713,476 and -0- shares |
387,134,760 | 387,134,760 | — | |||||||||
Stockholders’ equity: |
||||||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding |
— | — | — | |||||||||
Common stock |
||||||||||||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized, 1,286,524, 1,286,524 and -0- shares -0- |
129 | 129 | — | |||||||||
Class F common stock, $0.0001 par value; 20,000,000 shares authorized, 10,000,000 shares issued and outstanding |
1,000 | 1,000 | 1,078 | |||||||||
Additional paid-in capital |
24,006 | 24,006 | 23,922 | |||||||||
Retained earnings/(accumulated deficit) |
6,071,149 | 5,423,191 | (21,985 | ) | ||||||||
|
|
|
|
|
|
|||||||
Total stockholders’ equity |
6,096,284 | 5,448,326 | 3,015 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities and stockholders’ equity |
$ | 407,531,587 | $ | 407,938,951 | $ | 489,864 | ||||||
|
|
|
|
|
|
(in thousands, except per share data) |
As of and for the Six Months Ended June 30, 2020 |
As of and for the Six Months Ended June 30, 2019 |
As of and for the year ended December 31, 2019 |
As of and for the year ended December 31, 2018 |
||||||||||||
Statement of Income Data: |
||||||||||||||||
Net sales |
$ | 7,296 | $ | 3,719 | $ | 12,602 | $ | 11,692 | ||||||||
Total operating expenses |
30,696 | 28,630 | 58,562 | 64,982 | ||||||||||||
Net loss |
(41,016 | ) | (63,095 | ) | (94,718 | ) | (79,550 | ) | ||||||||
Net loss per share attributable to common stockholders—Basic and diluted |
(4.34 | ) | (8.43 | ) | (11.47 | ) | (12.00 | ) | ||||||||
Balance Sheet Data: |
||||||||||||||||
Total assets |
50,216 | N/A | 51,864 | 28,202 | ||||||||||||
Total liabilities |
54,778 | N/A | 18,851 | 152,869 | ||||||||||||
Total mezzanine equity |
244,743 | N/A | 244,743 | — | ||||||||||||
Total deficit |
(249,305 | ) | N/A | (211,730 | ) | (124,667 | ) |
(in thousands, except for share amounts) |
||||
Shares transferred at Closing (1) |
292,882,785 | |||
Value per share (2) |
$ | 10.00 | ||
|
|
|||
Total Share Consideration |
$ | 2,928,828 | ||
|
|
(1) | The number of outstanding shares in the table above assumes the issuance of approximately 21,218,712 shares of Class A Stock underlying Rollover Options and Assumed Warrants that do not represent legally outstanding shares of Class A Stock at closing. |
(2) | Share Consideration is calculated using a $10.00 reference price. Actual total Share Consideration will be dependent on the value of common stock at closing. |
• | Assuming No Redemptions |
• | Assuming Maximum Redemptions: |
Assuming No Redemptions (Shares) |
% |
Assuming Maximum Redemptions (Shares) |
% |
|||||||||||||
Class A Stock issued to Luminar Equityholders (1), (2), (3) |
188,167,552 | 54.9 | % | 188,167,552 | 62.0 | % | ||||||||||
Class B Stock issued to Luminar Equityholders (1), (4) |
104,715,233 | 30.5 | % | 104,715,233 | 34.5 | % | ||||||||||
Public Shares (Class A Stock) |
40,000,000 | 11.7 | % | 492,129 | 0.2 | % | ||||||||||
Founder Shares (Class A Stock) |
10,000,000 | 2.9 | % | 10,000,000 | 3.3 | % | ||||||||||
|
|
|
|
|||||||||||||
Pro Forma common stock at June 30, 2020 |
342,882,785 |
303,374,914 |
||||||||||||||
|
|
|
|
|||||||||||||
Rollover Options and Assumed Warrants (3) |
(21,218,712 | ) | (21,218,712 | ) | ||||||||||||
|
|
|
|
|||||||||||||
Pro Forma common stock Outstanding at June 30, 2020 |
321,664,073 |
282,156,202 |
||||||||||||||
|
|
|
|
(1) | Excludes approximately 15,308,450 of Class A Stock and 10,407,758 of Class B Stock in estimated potential earn out shares as the price threshold for each tranche have not yet been triggered. |
(2) | Includes the issuance of 1,251,971 shares of Luminar Series X Preferred Stock in August 2020 and September 2020 that will be converted into approximately 17,000,065 shares of Class A Stock upon the close of the Business Combination. |
(3) | The number of outstanding shares in the table above assumes the issuance of approximately 21,218,712 shares of Class A Stock underlying Rollover Options and Assumed Warrants that do not represent legally outstanding shares of Class A Stock at closing. |
(4) | Class B common stock carry ten votes per share whereas Class A common stock will have one vote per share. |
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||||||||||||||||||||
As of June 30, 2020 |
As of June 30, 2020 |
Pro Forma Adjustments |
As of June 30, 2020 |
|||||||||||||||||||||||||||||||||||
Luminar (Historical) |
Luminar Pro Forma Adjustments |
Luminar As Adjusted |
Gores (Historical) |
Pro Forma Adjustments |
Pro Forma Combined |
Pro Forma Combined |
||||||||||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||||||||||||||||
Cash and cash equivalents |
$ | 20,643 | $ | 164,337 | (A) | $ | 177,139 | $ | 1,011 | $ | 406,398 | (D) | $ | 508,066 | 32,039 | (L) | $ | 138,707 | ||||||||||||||||||||
(7,841 | ) | (B) | (106 | ) | (E) | (401,398 | ) | (M) | ||||||||||||||||||||||||||||||
(44,337 | ) | (F) | ||||||||||||||||||||||||||||||||||||
(32,039 | ) | (L) | ||||||||||||||||||||||||||||||||||||
Restricted cash and cash equivalents |
225 | — | 225 | — | — | 225 | — | 225 | ||||||||||||||||||||||||||||||
Marketable securities |
6,374 | — | 6,374 | — | — | 6,374 | — | 6,374 | ||||||||||||||||||||||||||||||
Accounts receivable, net |
5,618 | — | 5,618 | — | — | 5,618 | — | 5,618 | ||||||||||||||||||||||||||||||
Inventories, net |
4,961 | — | 4,961 | — | — | 4,961 | — | 4,961 | ||||||||||||||||||||||||||||||
Prepaids and other current assets |
2,873 | — | 2,873 | 108 | — | 2,981 | — | 2,981 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total current assets |
40,694 | 156,496 | 197,190 | 1,119 | 329,916 | 528,225 | (369,359 | ) | 158,866 | |||||||||||||||||||||||||||||
Non-current assets: |
||||||||||||||||||||||||||||||||||||||
Investments and cash held in Trust Account |
— | — | — | 406,398 | (406,398 | ) | (D) | — | — | — | ||||||||||||||||||||||||||||
Property and equipment, net |
7,630 | — | 7,630 | — | — | 7,630 | — | 7,630 | ||||||||||||||||||||||||||||||
Goodwill |
701 | — | 701 | — | — | 701 | — | 701 | ||||||||||||||||||||||||||||||
Deferred income tax |
— | — | — | 15 | — | 15 | — | 15 | ||||||||||||||||||||||||||||||
Other long-term assets |
1,191 | — | 1,191 | — | — | 1,191 | — | 1,191 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total non-current assets |
9,522 | — | 9,522 | 406,413 | (406,398 | ) | 9,537 | — | 9,537 | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
TOTAL ASSETS |
$ |
50,216 |
$ |
156,496 |
$ |
206,712 |
$ |
407,532 |
$ |
(76,482 |
) |
$ |
537,762 |
(369,359 |
) |
$ |
168,403 |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||||||||||||||||||||||||||||||||
Accounts payable |
3,553 | — | 3,553 | — | — | 3,553 | — | 3,553 | ||||||||||||||||||||||||||||||
Accrued expenses and other current liabilities |
5,544 | — | 5,544 | 86 | (86 | ) | (E) | 5,544 | — | 5,544 | ||||||||||||||||||||||||||||
State franchise tax accrual |
— | — | — | 20 | (20 | ) | (E) | — | — | — | ||||||||||||||||||||||||||||
Current portion of long-term debt |
3,948 | (3,456 | ) | (B) | 492 | — | (492 | ) | (L) | — | 492 | (L) | 492 | |||||||||||||||||||||||||
Other current liabilities |
593 | — | 593 | 195 | — | 788 | — | 788 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total current liabilities |
13,638 | (3,456 | ) | 10,182 | 301 | (598 | ) | 9,885 | 492 | 10,377 | ||||||||||||||||||||||||||||
Non-current liabilities: |
||||||||||||||||||||||||||||||||||||||
Deferred underwriting compensation |
— | — | — | 14,000 | (14,000 | ) | (F) | — | — | — | ||||||||||||||||||||||||||||
Long-term debt |
32,602 | (4,385 | ) | (B) | 28,217 | — | (28,217 | ) | (L) | — | 28,217 | (L) | 28,217 | |||||||||||||||||||||||||
Warrant liabilities |
7,425 | — | 7,425 | — | (7,425 | ) | (G) | — | — | — | ||||||||||||||||||||||||||||
Other long-term liabilities |
1,113 | — | 1,113 | — | — | 1,113 | — | 1,113 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total non-current liabilities |
41,140 | (4,385 | ) | 36,755 | 14,000 | (49,642 | ) | 1,113 | 28,217 | 29,330 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total liabilities |
54,778 | (7,841 | ) | 46,937 | 14,301 | (50,240 | ) | 10,998 | 28,709 | 39,707 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Common stock subject to possible redemption |
— | — | — | 387,135 | (387,135 | ) | (H) | — | — | — | ||||||||||||||||||||||||||||
Series A Preferred Stock |
244,743 | — | 244,743 | — | (244,743 | ) | (I) | — | — | — | ||||||||||||||||||||||||||||
Series X Preferred Stock |
— | 164,337 | (A) | 164,337 | — | (164,337 | ) | (A) | — | — | — |
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||||||||||||||||||||
As of June 30, 2020 |
As of June 30, 2020 |
Pro Forma Adjustments |
As of June 30, 2020 |
|||||||||||||||||||||||||||||||||||
Luminar (Historical) |
Luminar Pro Forma Adjustments |
Luminar As Adjusted |
Gores (Historical) |
Pro Forma Adjustments |
Pro Forma Combined |
Pro Forma Combined |
||||||||||||||||||||||||||||||||
Stockholders' equity (deficit): |
||||||||||||||||||||||||||||||||||||||
Preferred stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Founders' preferred stock |
— | — | (C) | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Common stock |
— | — | (C) | — | — | — | — | |||||||||||||||||||||||||||||||
Class A Stock |
— | — | (C) | — | — | 2 | (A) | 22 | (4 | ) | (M) | 18 | ||||||||||||||||||||||||||
4 | (H) | |||||||||||||||||||||||||||||||||||||
15 | (I) | |||||||||||||||||||||||||||||||||||||
1 | (J) | |||||||||||||||||||||||||||||||||||||
Class B Stock |
— | — | (C) | — | — | 10 | (I) | 10 | 10 | |||||||||||||||||||||||||||||
Class F Stock |
— | — | — | 1 | (1 | ) | (J) | — | — | |||||||||||||||||||||||||||||
Additional paid-in capital |
13,906 | 3,000 | (C) | 16,906 | 24 | 164,335 | (A) | 798,873 | (401,394 | ) | (M) | 397,479 | ||||||||||||||||||||||||||
(27,737 | ) | (F) | ||||||||||||||||||||||||||||||||||||
7,425 | (G) | |||||||||||||||||||||||||||||||||||||
387,131 | (H) | |||||||||||||||||||||||||||||||||||||
244,718 | (I) | |||||||||||||||||||||||||||||||||||||
6,071 | (K) | |||||||||||||||||||||||||||||||||||||
Treasury stock |
— | — | — | — | — | (I) | — | — | — | |||||||||||||||||||||||||||||
Accumulated other comprehensive income |
8 | — | 8 | — | — | 8 | — | 8 | ||||||||||||||||||||||||||||||
Retained earnings/(accumulated deficit) |
(263,219 | ) | (3,000 | ) | (C) | (266,219 | ) | 6,071 | (2,600 | ) | (F) | (272,149 | ) | 3,330 | (L) | (268,819 | ) | |||||||||||||||||||||
(6,071 | ) | (K) | — | |||||||||||||||||||||||||||||||||||
(3,330 | ) | (L) | ||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total stockholders’ equity (deficit) |
(249,305 | ) | — | (249,305 | ) | 6,096 | 769,973 | 526,764 | (398,068 | ) | 128,696 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
50,216 |
$ |
156,496 |
$ |
206,712 |
$ |
407,532 |
$ |
(76,482 |
) |
$ |
537,762 |
$ |
(369,359 |
) |
$ |
168,403 |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assuming No Redemptions and Maximum Redemptions |
||||||||||||||||||||
For the Six Months Ended June 30, 2020 |
For the Six Months Ended June 30, 2020 |
|||||||||||||||||||
Luminar (Historical) |
Gores (Historical) |
Pro Forma Adjustments |
Pro Forma Combined |
|||||||||||||||||
Net sales |
$ | 7,296 | $ | — | $ | — | $ | 7,296 | ||||||||||||
Cost of sales |
11,285 | — | — | 11,285 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Gross loss |
(3,989 | ) | — | — | (3,989 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||
Selling and marketing expenses |
3,075 | — | — | 3,075 | ||||||||||||||||
General and administrative expenses |
9,505 | — | — | 9,505 | ||||||||||||||||
Research and development expenses |
18,116 | — | — | 18,116 | ||||||||||||||||
State franchise taxes, other than income tax |
— | 100 | — | 100 | ||||||||||||||||
Other operating expenses |
— | 359 | — | 359 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
30,696 | 459 | — | 31,155 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating loss |
(34,685 | ) | (459 | ) | — | (35,144 | ) | |||||||||||||
Interest income |
121 | 1,325 | (1,325 | ) | (AA) | 121 | ||||||||||||||
Interest expense |
(1,021 | ) | — | — | (1,021 | ) | ||||||||||||||
Changes in fair values of warrant liabilities |
(4,574 | ) | — | 4,574 | (BB) | — | ||||||||||||||
Loss on extinguishment of debt |
(866 | ) | — | — | (866 | ) | ||||||||||||||
Other income |
10 | — | — | 10 | ||||||||||||||||
Other expense |
(1 | ) | — | — | (1 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Income (loss) before income taxes |
(41,016 | ) | 866 | 3,249 | (36,901 | ) | ||||||||||||||
Provision for (benefit from) income taxes |
— | 218 | (218 | ) | (CC) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net income (loss) attributable to common stockholders |
$ | (41,016 | ) | $ | 648 | $ | 3,467 | $ | (36,901 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||
Weighted average shares outstanding - Common stock |
9,447,670 | |||||||||||||||||||
Common stock - basic and diluted |
$ | (4.34 | ) | |||||||||||||||||
Weighted average shares outstanding - Class A Stock |
40,000,000 | 216,948,840 | 177,440,969 | |||||||||||||||||
Class A Stock - basic and diluted |
$ | 0.02 | $ | (0.11 | ) | $ | (0.13 | ) | ||||||||||||
Weighted average shares outstanding - Class F Stock |
10,000,000 | |||||||||||||||||||
Class F Stock - basic and diluted |
$ | (0.01 | ) | |||||||||||||||||
Weighted average shares outstanding - Class B Stock |
104,715,233 | 104,715,233 | ||||||||||||||||||
Class B Stock - basic and diluted |
$ | (0.11 | ) | $ | (0.13 | ) |
Assuming No Redemptions & Maximum Redemptions |
||||||||||||||||||||
For the Year ended December 31, 2019 |
For the Year ended December 31, 2019 |
|||||||||||||||||||
Luminar (Historical) |
Gores (Historical) |
Pro Forma Adjustments |
Pro Forma Combined |
|||||||||||||||||
Net sales |
$ | 12,602 | $ | — | $ | — | $ | 12,602 | ||||||||||||
Cost of sales |
16,655 | — | — | 16,655 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Gross loss |
(4,053 | ) | — | — | (4,053 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||
Selling and marketing expenses |
4,730 | — | — | 4,730 | ||||||||||||||||
General and administrative expenses |
16,861 | — | — | 16,861 | ||||||||||||||||
Research and development expenses |
36,971 | — | — | 36,971 | ||||||||||||||||
State franchise taxes, other than income tax |
— | 200 | — | 200 | ||||||||||||||||
Other operating expenses |
— | 621 | — | 621 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
58,562 | 821 | — | 59,383 | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Operating loss |
(62,615 | ) | (821 | ) | — | (63,436 | ) | |||||||||||||
Interest income |
509 | 7,708 | (7,708 | ) | (AA | ) | 509 | |||||||||||||
Interest expense |
(2,239 | ) | — | — | (2,239 | ) | ||||||||||||||
Change in fair value of SAFE notes |
(24,215 | ) | — | — | (24,215 | ) | ||||||||||||||
Changes in fair values of warrant liabilities |
(256 | ) | — | 256 | (BB | ) | — | |||||||||||||
Loss on extinguishment of debt |
(6,124 | ) | — | — | (6,124 | ) | ||||||||||||||
Other income |
262 | — | — | 262 | ||||||||||||||||
Other expense |
(40 | ) | — | — | (40 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Income (loss) before income taxes |
(94,718 | ) | 6,887 | (7,452 | ) | (95,283 | ) | |||||||||||||
Provision for (benefit from) income taxes |
— | 1,442 | (1,442 | ) | (CC | ) | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Net income (loss) attributable to common stockholders |
$ | (94,718 | ) | $ | 5,445 | $ | (6,010 | ) | $ | (95,283 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||
Weighted average shares outstanding - Common stock |
8,718,104 | |||||||||||||||||||
Common stock - basic and diluted |
$ | (11.47 | ) | |||||||||||||||||
Weighted average shares outstanding - Class A Stock |
36,164,000 | 216,948,840 | 177,440,969 | |||||||||||||||||
Class A Stock - basic and diluted |
$ | 0.16 | $ | (0.30 | ) | $ | (0.34 | ) | ||||||||||||
Weighted average shares outstanding - Class F Stock |
10,162,656 | |||||||||||||||||||
Class F Stock - basic and diluted |
$ | (0.05 | ) | |||||||||||||||||
Weighted average shares outstanding - Class B Stock |
104,715,233 | 104,715,233 | ||||||||||||||||||
Class B Stock - basic and diluted |
$ | (0.30 | ) | $ | (0.34 | ) |
1. |
Basis of Presentation |
• | The Company’s unaudited balance sheet as of June 30, 2020 and the related notes as of June 30, 2020, included elsewhere in this proxy statement/consent solicitation statement/prospectus; |
• | Luminar’s unaudited consolidated balance sheet as of June 30, 2020 and the related notes as of June 30, 2020, included elsewhere in this proxy statement/consent solicitation statement/prospectus. |
• | The Company’s unaudited statement of operations for the six months ended June 30, 2020 and the related notes, included elsewhere in this proxy statement/consent solicitation statement/prospectus; and |
• | Luminar’s unaudited statement of income for the six months ended June 30, 2020 and the related notes, included elsewhere in this proxy statement/consent solicitation statement/prospectus. |
• | The Company’s audited statement of operations for the twelve months ended December 31, 2019 and the related notes, included elsewhere in this proxy statement/consent solicitation statement/prospectus; and |
• | Luminar’s audited statement of income for the twelve months ended December 31, 2019 and the related notes, included elsewhere in this proxy statement/consent solicitation statement/prospectus. |
2. |
Accounting Policies |
3. |
Adjustments to Unaudited Pro Forma Condensed Combined Financial Information |
(A) | Reflects the issuance of 1,251,971 shares of Luminar Series X Preferred Stock in August 2020 and September 2020 at a price of $135.786 per share, and proceeds of $164.3 million, net of equity issuance costs of $5.7 million. Upon the close of the Business Combination, Luminar Series X Preferred Stock will be converted into Class A Stock at an estimated exchange ratio of approximately 13.5787. |
(B) | Reflects the settlement of certain of Luminar’s outstanding loan balances on August 21, 2020. |
(C) | Reflects the reclassification of Luminar common stock into Luminar Class A Stock and the exchange of certain shares of Luminar Class A Stock and certain shares of Luminar Founders Preferred Stock for shares of Luminar Class B Stock. On August 21, 2020, Luminar filed an amended and restated charter which, among other things, reclassified all Luminar common stock as Luminar Class A Stock and authorized Luminar Series X Preferred Stock and Luminar Class B Stock. Additionally, on August 24, 2020, Luminar entered into a share exchange agreement, pursuant to which Mr. Russell’s shares of Luminar Class A Stock and Luminar Founders Preferred Stock will be exchanged prior to the closing of the Business Combination for Luminar Class B Stock. The Luminar Class B Stock has the same economic rights as the Luminar Class A Stock; however, Luminar Class B Stock carry 10 votes per share whereas Luminar Class A Stock carry one vote per share. Therefore, the incremental fair value of the Luminar Class B Stock results in an estimated compensation charge of approximately $3.0 million that is recognized at the time of the exchange. |
(D) | Reflects the reclassification of $406.4 million of cash and cash equivalents held in the Trust Account at the balance sheet date that becomes available to fund the Business Combination. |
(E) | Reflects the settlement of the Company’s historical liabilities that will be settled upon the close of the Business Combination. |
(F) | Represents the settlement of estimated remaining transaction costs totaling $44.3 million, consisting in part of $14.0 million of deferred underwriting fees, approximately $27.7 million of equity issuance costs, and $2.6 million of transaction costs to be expensed as incurred. |
(G) | Represents the reclassification of Luminar warrants from liability to equity classification as a result of the Business Combination. |
(H) | Reflects the reclassification of approximately $387.1 million of Class A Stock subject to possible redemption to permanent equity. |
(I) | Represents recapitalization of Luminar equity and issuance of 171,167,847 of the Post-Combination Company’s Class A Stock (exclusive of the Series X Preferred Stock conversion noted in Adjustment A) and 104,715,233 of the Post-Combination Company’s Class B Stock to holders of Luminar Class A Stock and Luminar Class B Stock, respectively, as consideration for the Business Combination. |
(J) | Reflects the conversion of Class F Stock to Class A Stock. In connection with the closing of the Business Combination, all shares of Class F Stock will convert into shares of Class A Stock. |
(K) | Reflects the reclassification of the Company’s historical retained earnings. |
(L) | Reflects the repayment of Luminar outstanding indebtedness, including settlement of unamortized discounts, in accordance with the Merger Agreement, as cash and cash equivalents exceed $300.0 million under the no redemption scenario. Additionally, this adjustment reflects an estimated prepayment penalty of $1.9 million. |
(M) | Reflects the maximum redemption of 39,507,871 Public Shares for aggregate redemption payments of $401.4 million allocated to Class A Stock and additional paid-in capital using par value $0.0001 per share and at a redemption price of $10.16 per share. |
(AA) | Reflects the elimination of interest income on the Trust Account. |
(BB) | Reflects the elimination of the impact of change in fair value of warrant liabilities as the warrants are expected to become equity-classified as a result of the recapitalization, and therefore will not be marked to market at each reporting period. |
(CC) | Reflects elimination of income tax expense as a result of elimination of the Trust Account income (noted in footnote AA). |
5. |
Loss per Share |
For the Six Months Ended June 30, 2020 |
For the Year ended December 31, 2019 |
|||||||||||||||
(in thousands, except share and per share data) |
Assuming No Redemptions |
Assuming Maximum Redemptions |
Assuming No Redemptions |
Assuming Maximum Redemptions |
||||||||||||
Net loss attributable to common stockholders |
(36,901 | ) | (36,901 | ) | (95,283 | ) | (95,283 | ) | ||||||||
Weighted average shares outstanding of Class A Stock—basic and diluted |
216,948,840 | 177,440,969 | 216,948,840 | 177,440,969 | ||||||||||||
Net loss per share of Class A Stock—basic and diluted (1), (2), (3) |
$ | (0.11 | ) | $ | (0.13 | ) | $ | (0.30 | ) | $ | (0.34 | ) | ||||
Weighted average shares outstanding of Class B Stock—basic and diluted |
104,715,233 | 104,715,233 | 104,715,233 | 104,715,233 | ||||||||||||
Net loss per share of Class B Stock—basic and diluted (2), (3) |
$ | (0.11 | ) | $ | (0.13 | ) | $ | (0.30 | ) | $ | (0.34 | ) |
(1) | Excludes approximately 21,218,712 shares of Class A Stock underlying Rollover Options and Assumed Warrants that do not represent legally outstanding shares of Class A Stock at closing. |
(2) | For the purposes of applying the if converted method for calculating diluted earnings per share, it was assumed that all outstanding warrants sold in the Company IPO and the private placement are exchanged to common stock. However, since this results in anti-dilution, the effect of such exchange was not included in calculation of diluted loss per share. |
(3) | Net loss is allocated proportionally to each class of share based on the total shares outstanding per class divided by the total shares outstanding for all classes. |
• | Assuming No Redemptions |
• | Assuming Maximum Redemptions: |
Combined Pro Forma |
Luminar Equivalent Per Share Pro Forma (2) |
|||||||||||||||||||||||
Luminar (Historical) |
Gores (Historical) |
Assuming No Redemptions |
Assuming Maximum Redemptions |
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||
As of and for the six months ended June 30, 2020 (3) |
||||||||||||||||||||||||
Book Value per share (1) |
$ | (26.39 | ) | $ | 0.12 | $ | 1.64 | $ | 0.46 | $ | 22.27 | $ | 6.25 | |||||||||||
Weighted averages shares outstanding - basic and diluted |
9,447,670 | |||||||||||||||||||||||
Net loss per share - basic and diluted |
$ | (4.34 | ) | |||||||||||||||||||||
Weighted average shares outstanding of Class A Stock - basic and diluted |
40,000,000 | 216,948,840 | 177,440,969 | 166,948,840 | 166,948,840 | |||||||||||||||||||
Net income (loss) per share of Class A Stock - basic and diluted |
$ | 0.02 | $ | (0.11 | ) | $ | (0.13 | ) | $ | (1.49 | ) | $ | (1.77 | ) | ||||||||||
Weighted average shares outstanding of Class F Stock - basic and diluted |
10,000,000 | |||||||||||||||||||||||
Net loss per share of Class F Stock - basic and diluted |
$ | (0.01 | ) | |||||||||||||||||||||
Weighted average shares outstanding of Class B Stock - basic and diluted |
104,715,233 | 104,715,233 | 104,715,233 | 104,715,233 | ||||||||||||||||||||
Net loss per share of Class B Stock - basic and diluted |
$ | (0.11 | ) | $ | (0.13 | ) | $ | (1.49 | ) | $ | (1.77 | ) |
Combined Pro Forma |
Luminar Equivalent Per Share Pro Forma (2) |
|||||||||||||||||||||||
Luminar (Historical) |
Gores (Historical) |
Assuming No Redemptions |
Assuming Maximum Redemptions |
Assuming No Redemptions |
Assuming Maximum Redemptions |
|||||||||||||||||||
For the Year ended December 31, 2019 (3) |
||||||||||||||||||||||||
Weighted averages shares outstanding - basic and diluted |
8,718,104 | |||||||||||||||||||||||
Net loss per share - basic and diluted |
$ | (11.47 | ) | |||||||||||||||||||||
Weighted average shares outstanding of Class A Stock - basic and diluted |
36,164,000 | 216,948,840 | 177,440,969 | 166,948,840 | 166,948,840 | |||||||||||||||||||
Net income (loss) per share of Class A Stock - basic and diluted |
$ | 0.16 | $ | (0.30 | ) | $ | (0.34 | ) | $ | (4.07 | ) | $ | (4.62 | ) | ||||||||||
Weighted average shares outstanding of Class F Stock - basic and diluted |
10,162,656 | |||||||||||||||||||||||
Net loss per share of Class F Stock - basic and diluted |
$ | (0.05 | ) | |||||||||||||||||||||
Weighted average shares outstanding of Class B Stock - basic and diluted |
104,715,233 | 104,715,233 | 104,715,233 | 104,715,233 | ||||||||||||||||||||
Net loss per share of Class B Stock - basic and diluted |
$ | (0.30 | ) | $ | (0.34 | ) | $ | (4.07 | ) | $ | (4.62 | ) |
(1) | Book value per share = Total equity excluding preferred shares/shares outstanding |
(2) | The equivalent pro forma basic and diluted per share data for Luminar is calculated by multiplying the combined pro forma per share data by 13.5787, an estimate of the Per Share Company Stock Consideration. |
(3) | No cash dividends were declared during the periods presented. |
Trading Date |
Public Units (GMHIU) |
Public Shares (GMHI) |
Public Warrants (GMHIW) |
|||||||||
August 21, 2020 |
$ | 11.75 | $ | 10.51 | $ | 1.59 | ||||||
[●] |
$ | [●] | $ | [●] | $ | [●] |
Name |
Age |
Title | ||
Dean Metropoulos |
73 | Chairman and Director | ||
Alec E. Gores |
67 | Chief Executive Officer and Director | ||
Andrew McBride |
40 | Chief Financial Officer and Secretary | ||
Randall Bort |
55 | Director | ||
Michael Cramer |
67 | Director | ||
Joseph Gatto |
64 | Director |
• | the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and permitted non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
• | reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear hiring policies for employees or former employees of the independent auditors; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; |
• | obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor’s internal quality-control procedures and (ii) any material issues raised by the most |
recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
• | reviewing and approving on an annual basis the compensation of all of our other officers; |
• | reviewing on an annual basis our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; and |
• | if required, producing a report on executive compensation to be included in our annual proxy statement; and reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | the fact that our Initial Stockholders have agreed not to redeem any of the Founder Shares in connection with a stockholder vote to approve a proposed initial business combination; |
• | the fact that our Initial Stockholders have agreed to waive their rights to conversion price adjustments with respect to any shares of our Common Stock they may hold in connection with the consummation of the Business Combination; |
• | the fact that our Sponsor paid an aggregate of $25,000 for 10,781,250 Founder Shares and after giving effect to the cancellation of 781,250 Founder Shares on March 18, 2019, the remaining 10,000,000 Founder Shares will have a significantly higher value at the time of the Business Combination, which if unrestricted and freely tradable would be valued at approximately $100,000,000 but, given the restrictions on such shares, we believe such shares have less value; |
• | the fact that our Initial Stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if we fail to complete an initial business combination by February 5, 2021; |
• | the fact that our Sponsor paid an aggregate of approximately $10,000,000 for its 6,666,666 Private Placement Warrants to purchase shares of Class A Stock and that such Private Placement Warrants will expire worthless if a business combination is not consummated by February 5, 2021; |
• | the continued right of our Sponsor to hold our Class A Stock and the shares of Class A Stock to be issued to our Sponsor upon exercise of its Private Placement Warrants following the Business Combination, subject to certain lock-up periods; |
• | if the Trust Account is liquidated, including in the event we are unable to complete an initial business combination within the required time period, our Sponsor has agreed to indemnify us to ensure that the proceeds in the Trust Account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the Trust Account on the liquidation date, by the claims of prospective target businesses with which we have entered into an acquisition agreement or claims of any third party (other than our independent public accountants) for services rendered or products sold to us, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the Trust Account; |
• | the continued indemnification of our existing directors and officers and the continuation of our directors’ and officers’ liability insurance following the closing of the Business Combination; |
• | the fact that our Sponsor, officers and directors will lose their entire investment in us and will not be reimbursed for any out-of-pocket |
• | that affiliates of our Sponsor, Mr. Alec E. Gores and Mr. Dean Metropoulos participated in the Series X Financing and, thereafter, will receive the Per Share Company Stock Consideration for each share of Luminar Series X Preferred Stock that they hold in connection with the closing of the Business Combination; |
• | the fact that our Sponsor and members of our current Board and management would hold the following number of shares in the Post-Combination Company at the closing of the Business Combination: |
Name of Person/Entity |
Shares of Class A Stock |
Value of Class A Stock (1) |
||||||
Sponsor |
9,925,000 | $ | 99,250,000 | |||||
Alec E. Gores |
11,928,290 | $ | 119,282,900 | |||||
Dean Metropoulos |
99,993 | $ | 999,930 | |||||
Andrew McBride |
4,127 | $ | 41,270 | |||||
Randall Bort |
25,000 | $ | 250,000 | |||||
Michael Cramer |
25,000 | $ | 250,000 | |||||
Joseph Gatto (2) |
124,993 | $ | 1,249,930 |
(1) | Assumes a value of $10.00 per share. |
(2) | Assumes an additional investment of approximately $1,000,000 for Luminar Series X Preferred Stock. |
• | that, at the closing of the Business Combination, we will enter into the Registration Rights Agreement with the Registration Rights Holders (in which certain members of our Board and affiliates are included), which provides for registration rights to Registration Rights Holders and their permitted transferees. |
• | the corporation could financially undertake the opportunity; |
• | the opportunity is within the corporation’s line of business; and |
• | it would not be fair to the corporation and its stockholders for the opportunity not to be brought to the attention of the corporation. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Dean Metropoulos |
Metropoulos & Co. |
Private equity and SPAC investments |
Director and Officer | |||
Alec E. Gores |
The Gores Group, LLC (1) |
Private equity and SPAC investments |
Director and Officer | |||
Andy McBride |
The Gores Group, LLC (1) |
Private equity and SPAC investments |
Director and Officer | |||
Randall Bort |
None |
|||||
Michael Cramer |
None |
|||||
Joseph Gatto |
None |
(1) | Includes all portfolio companies and certain other affiliates of The Gores Group. |
Year Ended December 31, 2019 |
For the Period from August 28, 2018 (inception) to December 31, 2018 |
|||||||
Audit Fees |
184,500 | 23,500 | ||||||
Audit Related Fees |
— | — | ||||||
|
|
|
|
|||||
Tax Fees |
— | — | ||||||
All Other Fees |
— | — | ||||||
|
|
|
|
|||||
Total |
$ | 184,500 | $ | 23,500 |
• | Level 0 – Active Safety: AEB LKA |
• | Luminar value-add: |
inclement weather. We expect this to greatly improve upon today’s systems, and to be much more effective at taking proactive measures to avoid accidents and extending the AEB capability to higher speed driving scenarios. Additionally, the ability to detect lanes out to 150 meters and do so in these same adverse environmental conditions adds to the robustness of LKA systems and helps prevent temporary loss of lanes or lack of detection altogether as often seen in today’s systems. |
• | Levels 1 and 2 – Driver Assist: LCS ACC head-on collision assistance which will require simultaneous braking and steering control. |
• | Luminar value-add: |
• | Levels 3 and 4 – Highway Autonomy: |
• | Luminar value-add: hands-off and eyes-off operation. This allows the driver to utilize their time for something other than supervising the driving function, which is the ultimate product purpose of autonomy. |
• | Levels 4 and 5 - Urban/Full Autonomy: |
everywhere and in all conditions without human intervention or even occupants. We group this L4/L5 functionality due to the current focus on urban and suburban driving in the form of robo-taxis. Commercial trucking also aspires to L5 capability but is focusing its L4 efforts on highways as this yields the highest benefit. An urban L4 is extremely complicated compared with highway L4. We do expect that robo-taxis and automated people movers will be a strong growth market, but the timeline is more uncertain and we expect this market growth to be limited while technology for both vehicles and infrastructure matures. |
• | Luminar value-add: |
• | Smart Cities. |
• | Aerospace and Defense. |
• | Smart Cities. |
• | Aerospace & Defense. off-road. While our products are used in many different applications, most involve enabling some form of autonomous drive capability. We anticipate entering into multi-year supply agreements with our defense contractor partners in this market to generate a significant number of sensor sales in the future. We also expect that most of our defense contractor partners will integrate our perception software into their solutions. |
• | maintain sensing superiority through advanced sensor development; |
• | provide actionable data through continual perception software refinement; and |
• | drive vehicle feature delivery through internal and external investment. |
• | Where is the road, how is it organized into lanes, and which is the proper lane? |
• | What driving rules apply to these lanes (e.g., lane change permission, speed, direction, traffic type)? |
• | How is the vehicle moving now (speed, direction)? |
• | What obstacles and other fellow travelers are in or near the roadway? |
• | Where are these external objects (which lane, sidewalk, etc.), and how are they moving? |
• | Automatic sensor discovery to expedite system startup time; |
• | Extrinsic calibration to automate multi-lidar geometrical alignment; |
• | Proprietary middleware to streamline advanced user interaction with both our hardware and software; |
• | Horizon tracking to automate region-of-interest |
• | Normal vector point attributes to associate common surfaces like drivable space quickly and accurately assess object headings without multiple frames; and |
• | Velocity vector point attribute to provide both radial and crossing velocities, point-by-point |
• | Semantic Segmentation |
• | Instance detection and Tracking |
• | State Estimation |
• | Highway Autonomy: |
• | Proactive Safety: out-of-the-loop |
• | How we perform against and complement entrenched, non-lidar sensing technologies currently in-use; and |
• | How we perform against potential lidar competitors. |
• | Range |
• | Resolution |
• | Field-of-view |
• | Fidelity |
• | Frame rate. |
Design Area |
Common Lidar Architectures |
Luminar Lidar Architecture | ||
Wavelength |
905nm • Range limited by eye-safety • Resolution limited by eye-safety |
1550nm • Low cost with single pixel InGaAs • Allows for long range, high resolution • Allows for deeper weather penetration | ||
Ranging |
FMCW • Range/Resolution limited by continuous wave measurement • Costly due to high transceiver count |
Single-pulse time of flight • Low complexity, low part-count • High rate measurements with high confidence | ||
Single Photon Detection • Range/Resolution limited by continuous wave measurement • Costly due to large, complex detector array |
Design Area |
Common Lidar Architectures |
Luminar Lidar Architecture | ||
Scanning |
Flash • eye-safety • |
Low-mass, encoded mirror scanning• • | ||
Spinning 1D Array • • • | ||||
MEMS • • non-micro scanner• | ||||
Optical Phased Array • • • |
Name |
Age |
Position | ||||
Executive Officers |
||||||
Austin Russell |
25 | President and Chief Executive Officer | ||||
Thomas J. Fennimore |
44 | Chief Financial Officer | ||||
M. Scott Faris |
55 | Chief Business Officer | ||||
Jason Eichenholz |
48 | Chief Technology Officer | ||||
Non-Employee Directors |
||||||
Matthew J. Simoncini |
59 | Director | ||||
Scott A. McGregor |
64 | Director | ||||
Benjamin J. Kortlang |
45 | Director |
• | Personnel-related expenses, including salaries, benefits, and stock-based compensation expense, for personnel in Luminar’s research and engineering functions; |
• | Expenses related to materials, software licenses, supplies and third-party services; |
• | Prototype expenses; |
• | An allocated portion of facility and IT costs and depreciation; and |
• | Other Component Sales services provided to Luminar are accounted for as R&D by Luminar. |
Year Ended December 31, |
Change |
Change |
||||||||||||||
2019 |
2018 |
$ |
% |
|||||||||||||
Net Sales: |
12,602 | 11,692 | 910 | 8 | % | |||||||||||
Cost of sales |
16,655 | 10,939 | 5,716 | 52 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit (loss) |
(4,053 | ) | 753 | (4,806 | ) | nm | ||||||||||
Selling and marketing expenses |
4,730 | 3,025 | 1,705 | 56 | % | |||||||||||
General and administrative expenses |
16,861 | 21,872 | (5,011 | ) | -23 | % | ||||||||||
Research and development expenses |
36,971 | 40,085 | (3,114 | ) | -8 | % | ||||||||||
Operating income (loss) |
(62,615 | ) | (64,229 | ) | 1,614 | 3 | % | |||||||||
Interest income |
509 | 12 | 497 | nm | ||||||||||||
Interest expense |
(2,239 | ) | (2,654 | ) | 415 | -16 | % | |||||||||
Change in fair value of SAFE notes |
(24,215 | ) | (12,345 | ) | (11,870 | ) | 96 | % | ||||||||
Change in fair values of warrant liabilities |
(256 | ) | (143 | ) | (113 | ) | nm | |||||||||
Loss on extinguishment of debt |
(6,124 | ) | — | (6,124 | ) | nm | ||||||||||
Other income |
262 | — | 262 | nm | ||||||||||||
Other expense |
(40 | ) | (191 | ) | 151 | -79 | % | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes |
(94,718 | ) | (79,550 | ) | (15,168 | ) | -19 | % | ||||||||
Income taxes |
— | — | — | nm | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
(94,718 | ) | (79,550 | ) | (15,168 | ) | -19 | % | ||||||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
Change |
Change |
||||||||||||||
2019 |
2018 |
$ |
% |
|||||||||||||
Net Sales: |
||||||||||||||||
Autonomy Solutions |
9,666 | 7,236 | 2,430 | 34 | % | |||||||||||
Other Component Sales |
2,936 | 4,456 | (1,520 | ) | -34 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total |
12,602 | 11,692 | 910 |
Year Ended December 31, |
Change |
Change |
||||||||||||||
2019 |
2018 |
$ |
% |
|||||||||||||
Segment operating profit (loss) |
||||||||||||||||
Autonomy Solutions |
(62,874 | ) | (63,845 | ) | (971 | ) | 1 | % | ||||||||
Other Component Sales |
259 | (384 | ) | 643 | 167 | % |
For the six months ended June 30, |
Change |
Change |
||||||||||||||
2020 |
2019 |
$ |
% |
|||||||||||||
Net Sales |
7,296 | 3,719 | 3,577 | 96 | % | |||||||||||
Cost of sales |
11,285 | 6,805 | 4,480 | 66 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross loss |
(3,989 | ) | (3,086 | ) | (903 | ) | 29 | % | ||||||||
Selling and marketing expenses |
3,075 | 2,121 | 954 | 45 | % | |||||||||||
General and administrative expenses |
9,505 | 8,059 | 1,446 | 18 | % | |||||||||||
Research and development expenses |
18,116 | 18,450 | (334 | ) | -2 | % | ||||||||||
Operating loss |
(34,685 | ) | (31,716 | ) | (2,969 | ) | 9 | % | ||||||||
Interest income |
121 | 37 | 84 | nm | ||||||||||||
Interest expense |
(1,021 | ) | (1,235 | ) | 214 | -17 | % | |||||||||
Change in fair value of SAFE notes |
(24,215 | ) | 24,215 | nm | ||||||||||||
Change in fair values of warrant liabilities |
(4,574 | ) | (72 | ) | (4,502 | ) | nm | |||||||||
Loss on extinguishment of debt |
(866 | ) | (6,124 | ) | 5,258 | -86 | % | |||||||||
Other income |
10 | 233 | (223 | ) | nm | |||||||||||
Other expense |
(1 | ) | (3 | ) | 2 | nm | ||||||||||
Loss before income taxes |
(41,016 | ) | (63,095 | ) | 22,079 | -35 | % | |||||||||
Income taxes |
— | — | — | nm | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
(41,016 | ) | (63,095 | ) | 22,079 | -35 | % | |||||||||
|
|
|
|
|
|
|
|
Six Months Ended June 30 |
Change |
Change |
||||||||||||||
2020 |
2019 |
$ |
% |
|||||||||||||
Net sales: |
||||||||||||||||
Autonomy Solutions |
6,106 | 2,015 | 4,091 | 203 | % | |||||||||||
Other Component Sales |
1,190 | 1,704 | (514 | ) | -30 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
7,296 | 3,719 | 3,577 |
Six Months Ended June 30, |
Change |
Change |
||||||||||||||
2020 |
2019 |
$ |
% |
|||||||||||||
Segment profit (loss) |
||||||||||||||||
Autonomy Solutions |
(34,873 | ) | (31,979 | ) | (2,894 | ) | 9 | % | ||||||||
Other Component Sales |
188 | 263 | (75 | ) | -29 | % |
Year ended December 31, |
Six months ended June 30, |
|||||||||||||||
2019 |
2018 |
2020 |
2019 |
|||||||||||||
Net cash provided by (used in): |
||||||||||||||||
Operating activities |
$ | (60,201 | ) | $ | (67,089 | ) | $ | (33,978 | ) | $ | (26,693 | ) | ||||
Investing activities |
$ | (7,778 | ) | $ | (4,388 | ) | $ | (423 | ) | $ | (774 | ) | ||||
Financing activities |
$ | 85,457 | $ | 67,919 | $ | 27,964 | $ | 80,366 |
• | Expected Term—Luminar uses the simplified method when calculating the expected term due to insufficient historical exercise data. |
• | Expected Volatility—As Luminar’s stock is not currently publicly traded, the volatility is based on a benchmark of comparable companies within the automotive and energy storage industries. |
• | Expected Dividend Yield—The dividend rate used is zero as Luminar has never paid any cash dividends on its common stock and does not anticipate doing so in the foreseeable future. |
• | Risk-Free Interest Rate—The interest rates used are based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award. |
Name |
Age |
Position | ||
Executive Officers |
||||
Austin Russell |
25 |
Chairperson, Director (Class III), President and Chief Executive Officer | ||
Thomas J. Fennimore |
44 | Chief Financial Officer | ||
M. Scott Faris |
55 | Chief Business Officer | ||
Jason Eichenholz |
48 | Chief Technology Officer | ||
Non-Employee Directors |
||||
Alec E. Gores |
67 | Director (Class II) | ||
Matthew J. Simoncini |
59 | Director (Class II) | ||
Scott A. McGregor |
64 | Director (Class I) | ||
Benjamin J. Kortlang |
45 | Director (Class I) |
• | Class I, which Luminar anticipates will consist of Scott McGregor and Benjamin Kortlang, whose terms will expire at the Post-Combination Company’s first annual meeting of stockholders to be held after consummation of the Business Combination; |
• | Class II, which Luminar anticipates will consist of Alec E. Gores and Matthew J. Simoncini, whose terms will expire at the Post-Combination Company’s second annual meeting of stockholders to be held after consummation of the Business Combination; and |
• | Class III, which Luminar anticipates will consist of Austin Russell, whose term will expire at the Post-Combination Company’s third annual meeting of stockholders to be held after consummation of the Business Combination. |
• | selecting a qualified firm to serve as the independent registered public accounting firm to audit the Post-Combination Company’s financial statements; |
• | helping to ensure the independence and overseeing the performance of the independent registered public accounting firm; |
• | reviewing and discussing the results of the audit with the independent registered public accounting firm and reviewing, with management and that firm, the Post-Combination Company’s interim and year-end operating results; |
• | reviewing the Post-Combination Company’s financial statements and critical accounting policies and estimates; |
• | reviewing the adequacy and effectiveness of the Post-Combination Company’s internal controls; |
• | developing procedures for employees to submit concerns anonymously about questionable accounting, internal accounting controls, or audit matters; |
• | overseeing the Post-Combination Company’s policies on risk assessment and risk management; |
• | overseeing compliance with the Post-Combination Company’s code of business conduct and ethics; |
• | reviewing related party transactions; and |
• | approving or, as permitted, pre-approving all audit and all permissible non-audit services (other than de minimis non-audit services) to be performed by the independent registered public accounting firm. |
• | reviewing, approving and determining, or making recommendations to the board of the Post-Combination Company regarding, the compensation of the Post-Combination Company’s executive officers, including the Chief Executive Officer; |
• | making recommendations regarding non-employee director compensation to the Post-Combination Company’s full board of directors; |
• | administering the Post-Combination Company’s equity compensation plans and agreements with the Post-Combination Company executive officers; |
• | reviewing, approving and administering incentive compensation and equity compensation plans; and |
• | reviewing and approving the Post-Combination Company’s overall compensation philosophy. |
• | identifying, evaluating and selecting, or making recommendations to the board of the Post-Combination Company regarding nominees for election to the board of directors and its committees; |
• | considering and making recommendations to the board of the Post-Combination Company regarding the composition of the board of directors and its committees; |
• | developing and making recommendations to the board of the Post-Combination Company regarding corporate governance guidelines and matters; |
• | overseeing the Post-Combination Company’s corporate governance practices; |
• | overseeing the evaluation and the performance of the board of the Post-Combination Company and individual directors; and |
• | contributing to succession planning. |
• | for any transaction from which the director derives an improper personal benefit; |
• | for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | for any unlawful payment of dividends or redemption of shares; or |
• | for any breach of a director’s duty of loyalty to the corporation or its stockholders. |
• | Austin Russell, President and Chief Executive Officer; |
• | Scott Faris, Chief Business Officer; and |
• | Jason Eichenholz, Chief Technology Officer. |
Name and Principal Position |
Fiscal Year |
Salary ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||
Austin Russell President and Chief Executive Officer |
2019 | 175,000 | — | 175,000 | ||||||||||||
Scott Faris Chief Business Officer |
2019 | 300,000 | — | 300,000 | ||||||||||||
Jason Eichenholz Chief Technology Officer |
2019 | 200,000 | — | 200,000 |
Stock awards | ||||||||||
Name |
Number of shares or units of stock that have not vested (#) |
Market value of shares or units of stock that have not vested ($) | ||||||||
Austin Russell |
— | — | ||||||||
Scott Faris |
11,250 | (1) |
255,713 | (2 ) | ||||||
Jason Eichenholz |
— | — |
(1) | Represents Luminar Restricted Stock issued April 24, 2017, which was subject to release from Luminar’s repurchase right per the following schedule: 1/4 of the grant on September 1, 2017, and 1/48 of the total grant on each monthly anniversary thereafter until September 1, 2020, at which time the entire award became vested. |
(2) | Determined with reference to $22.73, the value of a share of Luminar Class A Stock on December 31, 2019. |
• | 715,000,000 shares of Class A Stock, $0.0001 par value per share; |
• | 121,000,000 shares of Class B Stock, $0.0001 par value per share; |
• | 0 shares of Class F Stock, $0.0001 par value per share; and |
• | 10,000,000 shares of undesignated Preferred Stock, $0.0001 par value per share. |
• | if we were to seek to amend the Second Amended and Restated Certificate of Incorporation to increase or decrease the par value of a class of the capital stock, then that class would be required to vote separately to approve the proposed amendment; and |
• | if we were to seek to amend the Second Amended and Restated Certificate of Incorporation in a manner that alters or changes the powers, preferences, or special rights of a class of capital stock in a manner that affected its holders adversely, then that class would be required to vote separately to approve the proposed amendment. |
• | in whole and not in part; |
• | at a price of $0.01 per Public Warrant; |
• | upon not less than 30 days’ prior written notice of redemption (the “ 30-day redemption period |
• | if, and only if, the reported last sale price of the Class A Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at a price equal to a number of shares of Class A Stock to be determined by reference to the table below, based on the redemption date and the “fair market value” of our Class A Stock except as otherwise described below; |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | if, and only if, the last reported sale price of our Class A Stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. |
Redemption Date |
Fair Market Value of Class A Stock |
|||||||||||||||||||||||||||||||||||
(period to expiration of warrants) |
$10.00 |
$11.00 |
$12.00 |
$13.00 |
$14.00 |
$15.00 |
$16.00 |
$17.00 |
$18.00 |
|||||||||||||||||||||||||||
57 months |
0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.365 | |||||||||||||||||||||||||||
54 months |
0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.365 | |||||||||||||||||||||||||||
51 months |
0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.365 | |||||||||||||||||||||||||||
48 months |
0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.365 | |||||||||||||||||||||||||||
45 months |
0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.365 | |||||||||||||||||||||||||||
42 months |
0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.364 | |||||||||||||||||||||||||||
39 months |
0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.364 | |||||||||||||||||||||||||||
36 months |
0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.364 | |||||||||||||||||||||||||||
33 months |
0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.364 | |||||||||||||||||||||||||||
30 months |
0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.364 | |||||||||||||||||||||||||||
27 months |
0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.364 | |||||||||||||||||||||||||||
24 months |
0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.364 | |||||||||||||||||||||||||||
21 months |
0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.364 | |||||||||||||||||||||||||||
18 months |
0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.363 | |||||||||||||||||||||||||||
15 months |
0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.363 | |||||||||||||||||||||||||||
12 months |
0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.363 | |||||||||||||||||||||||||||
9 months |
0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.362 | |||||||||||||||||||||||||||
6 months |
0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.362 | |||||||||||||||||||||||||||
3 months |
0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months |
— | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted |
• | the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding |
• | at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder. |
• | Dual Class Common Stock |
• | Board of Directors Vacancies |
• | Classified Board Management of the Post-Combination Company |
• | Directors Removed Only for Cause |
• | Supermajority Requirements for Amendments of The Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws two-thirds of the voting power of all of the then outstanding shares of voting stock will be required to amend certain provisions of the Second Amended and Restated Certificate of Incorporation, including provisions relating to the classified board, the size of the board, removal of directors, special meetings, actions by written consent, and designation of Preferred Stock. In addition, the affirmative vote of holders of 75% of the voting power of each of the then-outstanding Class A Stock and Class B Stock, voting separately by class, will be required to amend the provisions of the Second Amended and Restated Certificate of Incorporation relating to the terms of the Class B Stock. The affirmative vote of holders of at least two-thirds of the voting power of all of the then outstanding shares of voting stock will be required to amend or repeal the Amended and Restated Bylaws, although the Amended and Restated Bylaws may be amended by a simple majority vote of the board of directors of the Post-Combination Company. |
• | Stockholder Action; Special Meeting of Stockholders |
stockholders may not take action by written consent, but may only take action at annual or special meetings of stockholders. As a result, holders of capital stock would not be able to amend the Amended and Restated Bylaws or remove directors without holding a meeting of stockholders called in accordance with the Amended and Restated Bylaws. These provisions might delay the ability of stockholders to force consideration of a proposal or for stockholders to take any action, including the removal of directors. |
• | Notice Requirements for Stockholder Proposals and Director Nominations |
• | No Cumulative Voting |
• | Issuance of Undesignated Preferred Stock |
• | Choice of Forum |
Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, the Second Amended and Restated Certificate of Incorporation provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. |
• | 1% of the total number of shares of the Class A Stock then outstanding; or |
• | the average weekly reported trading volume of the Class A Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10-type information with the SEC reflecting its status as an entity that is not a shell company. |
• | any breach of the director’s duty of loyalty to the Post-Combination Company or to its stockholders; |
• | acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; |
• | unlawful payment of dividends or unlawful stock repurchases or redemptions; and |
• | any transaction from which the director derived an improper personal benefit. |
Company |
Post-Combination Company | |||
Authorized Capital | The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Company is authorized to issue is 221,000,000 shares, consisting of (a) 220,000,000 shares of Common Stock, comprised of (i) 200,000,000 shares of Class A Stock and (ii) 20,000,000 shares of Class F Stock, and (b) 1,000,000 shares of Preferred Stock. | The total number of shares of all classes of capital stock that the Post-Combination Company will have authority to issue is 846,000,000 shares, consisting of four classes: 715,000,000 shares of Class A Stock, $0.0001 par value per share, 121,000,000 shares of Class B Stock, $0.0001 par value per share, 0 shares of Class F Stock, $0.0001 par value per share, and 10,000,000 shares of Preferred Stock, $0.0001 par value per share. | ||
Upon the consummation of the Business Combination, we expect there will be approximately 216,949,000 million shares of the Class A Stock and approximately 104,715,000 million shares of the Class B Stock (in each |
Company |
Post-Combination Company | |||
case, assuming no redemptions) outstanding. Immediately following the consummation of the Business Combination, the Post-Combination Company is not expected to have any Preferred Stock outstanding. | ||||
Class B Common Stock |
None. | Shares of Class B Stock will carry voting rights in the form of 10 votes per share. Post-Combination Company stockholders will have no preemptive or other subscription rights and there will be no sinking fund or redemption provisions applicable to the Class B Stock. The Class B Stock will be convertible into shares of Class A Stock on a one-to-one | ||
Rights of Preferred Stock | Subject to certain requirements relating to an initial business combination set forth in the Current Company Certificate, the Board is expressly authorized to provide out of the unissued shares of the Preferred Stock for one or more series of Preferred Stock and to establish from time to time the number of shares to be included in each such series and to fix the voting rights, if any, designations, powers, preferences and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions thereof, as shall be stated in the resolution or resolutions adopted by the Board providing for the issuance of such series and included in a certificate | The Second Amended and Restated Certificate of Incorporation authorizes the Post-Combination Company’s board of directors, subject to any limitations prescribed by the law of the State of Delaware, by resolution or resolutions adopted from time to time, to provide for the issuance of shares of Preferred Stock in one or more series, and, by filing a certificate of designation pursuant to the applicable law of the State of Delaware, to establish from time to time the number of shares to be included in each such series, to fix the designation, vesting, powers (including voting powers), preferences and relative, participating, optional or other rights (and the qualifications, limitations or restrictions |
Company |
Post-Combination Company | |||
of designation filed pursuant to the DGCL. | thereof) of the shares of each such series and to increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares of such series then outstanding) the number of shares of any such series. | |||
Voting Rights |
Except as otherwise required by law or the Current Company Certificate, the holders of shares of Common Stock shall be entitled to one vote for each such share on each matter properly submitted to the stockholders on which the holders of the Common Stock are entitled to vote. | Except as otherwise expressly provided by the Second Amended and Restated Certificate of Incorporation or required by applicable law, each holder of Class A Stock shall have the right to one vote per share of Class A Stock held of record by such holder as of the applicable record date and each holder of Class B Stock shall have the right to 10 votes per share of Class B Stock held of record by such holder as of the applicable record date. | ||
Cumulative Voting |
Delaware law provides that a corporation may grant stockholders cumulative voting rights for the election of directors in its certificate of incorporation; however, the Current Company Certificate does not authorize cumulative voting. | Delaware law provides that a corporation may grant stockholders cumulative voting rights for the election of directors in its certificate of incorporation; however, the Second Amended and Restated Certificate of Incorporation does not authorize cumulative voting. | ||
Number of Directors |
The Current Company Certificate provides that the number of directors of the Company shall be fixed from time to time exclusively by resolution of the Board. Subject to the special rights of the holders of any series of Preferred Stock to elect directors, the Board shall be divided into three classes, as nearly equal in number as possible and designated Class I, Class II and Class III. The Board is authorized to assign members of the Board already in office to Class I, Class II or Class III. At each succeeding annual meeting of the stockholders of the Corporation, successors to the class of directors whose term expires at that annual meeting shall be elected for a three-year term or until the election and qualification of their respective | The Second Amended and Restated Certificate of Incorporation provides that, subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the total number of authorized directors whether or not there exist any vacancies or unfilled seats in previously authorized directorships (the “ Whole Board |
Company |
Post-Combination Company | |||
successors in office, subject to their earlier death, resignation or removal. | annual meeting at which such director’s term expires and until such director’s successor is elected and qualified or until such director’s earlier death, resignation, disqualification or removal from office. | |||
Election of Directors |
The Current Company Certificate requires that directors be elected by a plurality of the votes cast at an annual meeting of stockholders by holders of the Common Stock. | The Amended and Restated Bylaws require that directors be elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote thereon. | ||
Manner of Acting by Board | The Company’s bylaws provide that a majority of the Board shall constitute a quorum for the transaction of business at any meeting of the Board, and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board, except as may be otherwise specifically provided by applicable law, the Current Company Certificate or the Company’s bylaws. | The Amended and Restated Bylaws provide that the vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Post-Combination Company’s board of directors. | ||
Removal of Directors |
The Current Company Certificate provides that, subject to the special rights of the holders of any series of Preferred Stock to elect directors, any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class. | The Second Amended Certificate of Incorporation provides that, subject to the special rights of the holders of any series of Preferred Stock, a director may be removed from the Post-Combination Company’s board of directors (i) only for cause and (ii) only by the affirmative vote of the holders of at least two-thirds of the voting power of the then-outstanding shares of capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class. | ||
Vacancies on Board |
The Current Company Certificate provides that, subject to the special rights of the holders of any series of Preferred Stock to elect directors, if any, newly created directorships resulting from an increase in the number of directors and any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal or other cause may be filled | The Second Amended and Restated Certificate of Incorporation provides that, subject to the special rights of the holders of any series of Preferred Stock to elect directors, any vacancy occurring in the Post-Combination Company’s board of directors for any cause, and any newly created directorship resulting from any increase in the authorized number of directors, |
Company |
Post-Combination Company | |||
solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by stockholders). | shall, unless (a) the Post-Combination Company’s board of directors determines by resolution that any such vacancies or newly created directorships shall be filled by the Post-Combination Company’s stockholders or (b) as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even if less than a quorum, or by a sole remaining director, and not by the Post-Combination Company’s stockholders. | |||
Nomination of Director Candidates | The Company’s bylaws provide that, subject to the special rights of the holders of any series of Preferred Stock to elect directors, nominations of persons for election to the Board at any annual meeting of stockholders, or at any special meeting of stockholders called for the purpose of electing directors as set forth in the Company’s notice of such special meeting, may be made (i) by or at the direction of the Board or (ii) by any stockholder of the Company (a) who is a stockholder of record entitled to vote in the election of directors on the date of the giving of the notice and (b) who complies with the notice and other procedures set forth in the Company’s bylaws. To be timely, a stockholder’s notice to the Company must be received by the Company at the principal executive offices of the Company (1) in the case of an annual meeting, not later than the close of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary date of the immediately preceding annual meeting of stockholders; provided, however , that in the event that the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so received not earlier than the close of business on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th day before the meeting or (y) the close |
The Amended and Restated Bylaws provide that nominations of persons for election to the Post-Combination Company’s board of directors may be made at an annual meeting of stockholders only: (i) pursuant to the Post-Combination Company’s notice of such meeting (or any supplement thereto), (ii) by or at the direction of the Post-Combination Company’s board of directors or any committee thereof or (iii) by any stockholder of the Post-Combination Company who was a stockholder of record at the time of giving of the notice (the “ Record Stockholder |
Company |
Post-Combination Company | |||
of business on the 10th day following the day on which public announcement of the date of the annual meeting was first made by the Company; and (2) in the case of a special meeting of stockholders called for the purpose of electing directors, not later than the close of business on the 10th day following the day on which public announcement of the date of the special meeting is first made by the Company. | and (b) no later than the close of business on the later of the 90th day prior to such annual meeting or the close of business on the 10th day following the day on which public announcement of the date of such meeting is first made by the Post-Combination Company. | |||
Business Proposals by Stockholders | The Company’s bylaws provide that no business may be transacted at an annual meeting of stockholders, other than business that is either (i) specified in the Company’s notice of meeting (or any supplement thereto) given by or at the direction of the Board, (ii) otherwise properly brought before the annual meeting by or at the direction of the Board or (iii) otherwise properly brought before the annual meeting by any stockholder of the Company (a) who is a stockholder of record entitled to vote at such annual meeting on the date of the giving of the notice and on the record date for the determination of stockholders entitled to vote at such annual meeting and (b) whose notice is timely. To be timely, a stockholder’s notice to the Company with respect to such business must be received not later than the close of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement | The Amended and Restated Bylaws provide that business proposals to be considered by the stockholders may be made at an annual meeting of stockholders only: (i) pursuant to the Post-Combination Company’s notice of such meeting (or any supplement thereto), (ii) by or at the direction of the Post-Combination Company’s board of directors or any committee thereof or (iii) by any Record Stockholder, who is entitled to vote at such meeting and who complies with the notice and other procedures set forth in the Amended and Restated Bylaws. To be timely, a Record Stockholder’s notice must be delivered to the Secretary at the principal executive offices of the Post-Combination Company not later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the first anniversary of the preceding year’s annual meeting; provided, however, that in the event that no annual meeting was held during the preceding year or the date of the annual meeting is more than 30 days before, or more than 60 days after, such anniversary date, notice by the Record Stockholder to be timely must be so delivered (a) no earlier than the close of business on the 120th day prior to such annual meeting and (b) no later than the close of business on the later of the ninetieth 90th day prior to such annual meeting or the close of business on the tenth 10th day following the day on which public announcement of the date of |
Company |
Post-Combination Company | |||
of the date of the annual meeting is first made by the Company. | such meeting is first made by the Post-Combination Company. | |||
Special Meetings of the Board | The Company’s bylaws provide that special meetings of the Board (a) may be called by the Chairman of the Board or President and (b) shall be called by the chairman of the Board, president or secretary on the written request of at least a majority of directors then in office, or the sole director, as the case may be, and shall be held at such time, date and place (within or without the State of Delaware) as may be determined by the person calling the meeting or, if called upon the request of directors or the sole director, as specified in such written request. | The Amended and Restated Bylaws provide that special meetings of the Post-Combination Company’s board of directors may be called by the Chairperson of the Post-Combination Company’s board of directors, the Chief Executive Officer, the Lead Independent Director or at least two members of the Post-Combination Company’s board of directors then in office. | ||
Notice of Stockholder Meetings | The Company’s bylaws provide that written notice of each stockholders meeting stating the place, if any, date, and time of the meeting, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, shall be given in the permitted manners set forth in the Bylaws to each stockholder entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting, by the Company not less than 10 nor more than 60 days before the date of the meeting unless otherwise required by the DGCL. If said notice is for a stockholders meeting other than an annual meeting, it shall in addition state the purpose or purposes for which the meeting is called, and the business transacted at such meeting shall be limited to the matters so stated in the Company’s notice of meeting (or any supplement thereto). | The Amended and Restated Bylaws provide that notice of all meetings of the Post-Combination Company’s stockholders shall be given in writing or by electronic transmission in the manner provided by applicable law stating the date, time and place, if any, of the meeting, the means of remote communication, if any, by which the Post-Combination Company’s stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and the record date for determining the Post-Combination Company’s stockholders entitled to vote at the meeting. In the case of a special meeting, such notice shall also set forth the purpose or purposes for which the meeting is called. Unless otherwise required by applicable law or the Second Amended and Restated Certificate of Incorporation, notice of any meeting of the Post-Combination Company’s stockholders shall be given not less than 10, nor more than 60, days before the date of the meeting to each Post-Combination Company’s stockholder of record entitled to vote at such meeting. |
Company |
Post-Combination Company | |||
Special Meetings of Stockholders | The Company’s bylaws provide that, subject to the rights of the holders of any outstanding series of the Preferred Stock and to the requirement of applicable law, special meetings of stockholders, for any purpose or purposes, may be called only by the chairman of the Board, the chief executive officer, or the Board pursuant to a resolution adopted by a majority of the Board, and may not be called by any other person. | The Second Amended and Restated Certificate of Incorporation provides that special meetings of the Post-Combination Company’s stockholders may be called only by the Chairman of the Post-Combination Company’s board of directors, the Chief Executive Officer or the Post-Combination Company’s board of directors acting pursuant to a resolution adopted by a majority of the Whole Board, and may not be called by any other person or persons. | ||
Manner of Acting by Stockholders | The Company’s bylaws provide that at all meetings of stockholders all matters other than the election of directors presented to the stockholders at a meeting at which a quorum is present shall be determined by the vote of a majority of the votes cast by the stockholders present in person or represented by proxy at the meeting and entitled to vote thereon, unless the matter is one upon which, by applicable law, the Current Company Certificate, the Company’s bylaws or applicable stock exchange rules, a different vote is required, in which case such provision shall govern and control the decision of such matter. | The Amended and Restated Bylaws provide that every matter other than the election of directors shall be decided by the affirmative vote of the holders of a majority of the voting power of the shares of stock entitled to vote on such matter that are present in person or represented by proxy at the meeting and are voted for or against the matter (or if there are two or more classes or series of stock entitled to vote as separate classes, then in the case of each class or series, the holders of a majority of the voting power of the shares of stock of that class or series present in person or represented by proxy at the meeting voting for or against such matter), unless a different vote is required under applicable law, rule or regulation applicable to the Post-Combination Company or its securities, the rules or regulations of any stock exchange applicable to the Post-Combination Company, the Second Amended and Restated Certificate of Incorporation or the Amended and Restated Bylaws. | ||
Stockholder Action Without Meeting | The Current Company Certificate provides that, except as may be otherwise provided for or fixed relating to the rights of the holders of any outstanding series of Preferred Stock, subsequent to the consummation of the Company IPO, any action required or permitted to be taken by the stockholders of the Company must be effected by a duly called annual or | The Second Amended and Restated Certificate of Incorporation provides that, subject to the rights of any series of Preferred Stock then outstanding, any action required or permitted to be taken by the Post-Combination Company’s stockholders must be effected at a duly called annual or special meeting of the Post- Combination Company’s stockholders |
Company |
Post-Combination Company | |||
special meeting of such stockholders and may not be effected by written consent of the stockholders. | and may not be effected by a consent in writing by such stockholders. | |||
Quorum |
Board of Directors Stockholders |
Board of Directors. Stockholders. | ||
Anti-Takeover Provisions | The Current Company Certificate provides for a classified Board, as well as other features such as limiting the ability of stockholders to transact business outside of stockholder meetings. Additionally, section 203 of the DGCL generally prohibits any “business combination,” including mergers, sales and leases of assets, issuances of securities and similar transactions, by a corporation or any of its direct or indirect majority-owned subsidiaries with an “interested stockholder” who beneficially owns | The Second Amended and Restated Certificate of Incorporation provides for a classified Post-Combination Company board, as well as other features such as limiting the ability of stockholders to transact business outside of stockholder meetings. Additionally, Section 203 of the DGCL generally prohibits any “business combination,” including mergers, sales and leases of assets, issuances of securities and similar transactions, by a corporation or any of its direct or indirect majority-owned subsidiaries |
Company |
Post-Combination Company | |||
15% or more of a corporation’s voting stock, within three years after the person or entity becomes an interested stockholder, unless: (i) the transaction that will cause the person or entity to become an interested stockholder under Section 203 is approved by the Board; (ii) after the completion of the transaction in which the person or entity becomes an interested stockholder, the interested stockholder holds at least 85% of the voting stock of the Company outstanding at the time the transaction commenced but not including shares held by persons who are directors and also officers and shares held by specified employee benefit plans; or (iii) after the person or entity becomes an interested stockholder, the business combination is approved by the Board and the holders of at least two-thirds of the Company’s outstanding voting stock, excluding shares held by the interested stockholder. |
with an “interested stockholder” who beneficially owns 15% or more of a corporation’s voting stock, within three years after the person or entity becomes an interested stockholder, unless: (i) the transaction that will cause the person or entity to become an interested stockholder under Section 203 is approved by the Post-Combination Company board; (ii) after the completion of the transaction in which the person or entity becomes an interested stockholder, the interested stockholder holds at least 85% of the voting stock of the Post-Combination Company outstanding at the time the transaction commenced but not including shares held by persons who are directors and also officers and shares held by specified employee benefit plans; or (iii) after the person or entity becomes an interested stockholder, the business combination is approved by the Post-Combination Company board and the holders of at least two-thirds of the Post-Combination Company’s outstanding voting stock, excluding shares held by the interested stockholder. | |||
Exclusive Forum Provisions | None. | The Second Amended and Restated Certificate of Incorporation provides that, unless the Post-Combination Company consents in writing to the selection of an alternative forum, the Court of Chancery (or, if and only if the Chancery Court lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for: (i) any derivative action or proceeding brought on behalf of the Post-Combination Company, (ii) any action or proceeding asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee of the Post- Combination Company or any |
Company |
Post-Combination Company | |||
stockholder to the Post-Combination Company or the Post-Combination Company’s stockholders; (iii) any action or proceeding asserting a claim against the Post-Combination Company or any current or former director, officer or other employee of the Post-Combination Company or any stockholder in such stockholder’s capacity as such arising out of or pursuant to any provision of the DGCL, the Second Amended and Restated Certificate of Incorporation or the Amended and Restated Bylaws; (iv) any action or proceeding to interpret, apply, enforce or determine the validity of the Second Amended and Restated Certificate of Incorporation or the Amended and Restated Bylaws (including any right, obligation or remedy thereunder); (v) any action or proceeding as to which the DGCL confers jurisdiction to the Chancery Court; and (vi) any action asserting a claim against the Post-Combination Company or any director, officer or other employee of the Post-Combination Company or any stockholder, governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court’s having personal jurisdiction over the indispensable parties named as defendants. The exclusive forum provision shall not apply to suits brought to enforce a duty or liability created by the Securities Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Unless the Post-Combination Company consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. |
Company |
Post-Combination Company | |||
Indemnification of Directors and Officers | The Current Company Certificate provides that, to the fullest extent permitted by applicable law, the Company shall indemnify and hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was a director or officer of the Company or, while a director or officer of the Company, is or was serving at the request of the Company as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses. | The Amended and Restated Bylaws provide that each director and officer shall be indemnified and held harmless by the Post-Combination Company to the fullest extent permitted by the DGCL against all expenses, liability and loss reasonably incurred or suffered by such director or officer in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, legislative or any other type whatsoever, by reason of the fact that such person (or a person of whom such person is the legal representative) is or was a director or officer of the Post-Combination Company or, while serving as a director or officer of the Post-Combination Company, is or was serving at the request of the Post-Combination Company as a director, officer, employee, agent or trustee of another corporation, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans; provided that such director or officer acted in good faith and in a manner that the director or officer reasonably believed to be in or not opposed to the best interests of the Post-Combination Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the director’s or officer’s conduct was unlawful. | ||
Limitation on Liability of Directors | The Current Company Certificate provides that a director of the Company shall not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL as the same exists or may hereafter be amended unless they violated their duty of loyalty to the Corporation or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock | The Second Amended and Restated Certificate of Incorporation provides that, to the fullest extent permitted by law, no director of the Post-Combination Company shall be personally liable to the Post-Combination Company or its stockholders for monetary damages for breach of fiduciary duty as a director. |
Company |
Post-Combination Company | |||
purchases or unlawful redemptions, or derived improper personal benefit from their actions as directors. | ||||
Amendments to Charter |
The Current Company Certificate provides that the Company reserves the right at any time and from time to time to amend, alter, change or repeal any provision of the Current Company Certificate as authorized by the laws of the State of Delaware. Under the DGCL, an amendment to a corporation’s certificate of incorporation generally requires the approval of the board of directors and a majority of the combined voting power of the then-outstanding shares of voting stock, voting together as a single class. | Under the DGCL, an amendment to a corporation’s certificate of incorporation generally requires the approval of the board of directors and a majority of the combined voting power of the then-outstanding shares of voting stock, voting together as a single class. Notwithstanding the foregoing, the Second Amended and Restated Certificate of Incorporation requires the affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class, to amend or repeal or adopt any provision inconsistent with Sections 1.3 and 2 of Article IV, or Article V, Article VI, Article VII, Article VIII, Article IX, Article X, Article XI, or Section 1 of Article XII of the Second Amended and Restated Certificate of Incorporation (the “Specified Provisions provided that two-thirds of the Whole Board has approved such amendment or repeal of, or any provision inconsistent with, the Specified Provisions, then only the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend or repeal, or adopt any provision inconsistent with, the Specified Provisions.The Second Amended and Restated Certificate of Incorporation requires the affirmative vote of the holders of Class A Stock representing at least seventy-five percent of the voting power of the then-outstanding shares of |
Company |
Post-Combination Company | |||
Class A Stock, voting separately as a single class, and the affirmative vote of the holders of Class B Stock representing at least seventy-five percent of the voting power of the then-outstanding shares of Class B Stock, each voting separately as single classes, to amend or repeal, or to adopt any provision inconsistent with, Section 3 of Article IV or Section 2 of Article XII of the Second Amended and Restated Certificate of Incorporation. | ||||
Amendments to Bylaws |
The Company’s bylaws provide that the Board shall have the power to adopt, amend, alter or repeal the bylaws. The affirmative vote of a majority of the Board shall be required to adopt, amend, alter or repeal the bylaws. The Company’s bylaws also may be adopted, amended, altered or repealed by the stockholders; provided, however, that in addition to any vote of the holders of any class or series of capital stock of the Company required by applicable law or the Current Company Certificate, the affirmative vote of the holders of at least a majority of the voting (except as otherwise provided in relevant sections of the Company’s bylaws) power of all outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class, shall be required for the stockholders to adopt, amend, alter or repeal the Company’s bylaws. | The Second Amended and Restated Certificate of Incorporation provides that the Amended and Restated Bylaws may be adopted, amended or repealed by a majority of the Whole Board. The stockholders may also adopt, amend or repeal the Amended and Restated Bylaws by the affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class; provided that, if two-thirds of the Whole Board has approved such adoption, amendment or repeal of any provisions of the Amended and Restated Bylaws, then only the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class, shall be required to adopt, amend or repeal any provision of the Amended and Restated Bylaws. | ||
Liquidation |
The Current Company Certificate provides that, subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock and certain provisions of the Current Company Certificate, in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, after payment or | The Second Amended and Restated Certificate of Incorporation provides that, subject to any preferential or other rights of any holders of Preferred Stock then outstanding, upon the liquidation, dissolution or winding up of the Post-Combination Company, whether voluntary or involuntary, holders of Class A Stock and Class B Stock will |
Company |
Post-Combination Company | |||
provision for payment of the debts and other liabilities of the Company, the holders of shares of Common Stock shall be entitled to receive all the remaining assets of the Company available for distribution to its stockholders, ratably in proportion to the number of shares of Class A Stock (on an as-converted basis with respect to the Class F Stock) held by them. | be entitled to receive ratably all assets of the Post-Combination Company available for distribution to its stockholders unless disparate or different treatment of the shares of each such class with respect to distributions upon any such liquidation, dissolution or winding up is approved in advance by the affirmative vote of the holders of a majority of the voting power of all the then-outstanding shares of Class A Stock and the affirmative vote of the holders of a majority of the voting power of all the then-outstanding shares of Class B Stock, each voting separately as a class. | |||
Redemption Rights |
The Current Company Certificate provides that, prior to the consummation of the initial Business Combination, the Company shall provide all holders of Public Shares with the opportunity to have their Public Shares redeemed upon the consummation of an initial business combination pursuant to, and subject to certain limitations set forth in the Current Company Certificate for cash equal to the applicable redemption price per share; provided, however, that the Corporation shall not redeem or repurchase Public Shares to the extent that such redemption would result in the Company’s failure to have net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) in excess of $5 million or any greater net tangible asset or cash requirement which may be contained in the agreement relating to an initial business combination. |
None. |
• | Luminar has been or is to be a participant; |
• | the amount involved exceeded or exceeds $120,000; and |
• | any of Luminar’s directors, executive officers or holders of more than 5% of its capital stock prior to the Business Combination, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest. |
Name of Stockholder (1) |
SAFE Principal Amount ($) |
Shares of Series A-2 Preferred Stock |
Shares of Series A-7 Preferred Stock |
Shares of Series A-9 Preferred Stock |
||||||||||||
GVA Auto, LLC* |
20,000,000 | 1,322,780 | ||||||||||||||
Scott A. McGregor (2) |
1,000,000 | 25,658 |
* | Owners of more than 5% of Luminar capital stock. |
(1) | Additional details regarding these stockholders and their equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | Scott A. McGregor is a member of Luminar’s board of directors. |
Name of Stockholder (1) |
No. of Shares (Series A) |
Aggregate Purchase Price ($) |
||||||
G2VP I, LLC for itself and as nominee for G2VP Founders Fund I, LLC* (2) |
461,852 | 19,999,992.83 |
* | Owners of more than 5% of Luminar capital stock. |
(1) | Additional details regarding these stockholders and their equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | G2VP I, LLC is an affiliate of Benjamin J. Kortlang, a member of Luminar’s board of directors. |
Name of Stockholder (1) |
No. of Shares (Series A-2) |
Aggregate Purchase Price ($) |
||||||
GVA Auto, LLC* |
1,322,780 | 20,000,000 |
* | Owners of more than 5% of Luminar capital stock. |
(1) | Additional details regarding this stockholder and its equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
Name of Stockholder (1) |
No. of Shares (Series A-9) |
Aggregate Purchase Price ($) |
||||||
Scott A. McGregor (2) |
25,658 | 1,000,000 |
(1) | Additional details regarding this stockholder and his equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | Scott A. McGregor is a member of Luminar’s board of directors. |
Name of Stockholder (1) |
No. of Shares (Series X) |
Aggregate Purchase Price ($) |
||||||
G2VP I, LLC for itself and as nominee for G2VP Founders Fund I, LLC* (2) |
6,839 | $ | 928,640.46 |
* | Owners of more than 5% of Luminar capital stock. |
(1) | Additional details regarding these stockholders and their equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | G2VP I, LLC is an affiliate of Benjamin J. Kortlang, a member of Luminar’s board of directors. |
• | each person who is, or is expected to be, the beneficial owner of more than 5% of the outstanding shares of Common Stock; |
• | each of our named executive officers and directors; |
• | each person who will become an executive officer or director of the Post-Combination Company; and |
• | all current executive officers and directors of the Company as a group, and all executive officers and directors of the Post-Combination Company as a group. |
After the Business Combination |
||||||||||||||||||||||||||||||||||||
Before the Business Combination (1) |
Assuming No Redemption |
Assuming Maximum Redemption Shares of Class A Stock (13) |
||||||||||||||||||||||||||||||||||
Name and Address of Beneficial Owners |
Number of Shares |
% |
% of Total Voting Power |
Number of Shares |
% |
% of Total Voting Power** |
Number of Shares |
% |
% of Total Voting Power** |
|||||||||||||||||||||||||||
Directors and Named Executive Officers of the Company |
||||||||||||||||||||||||||||||||||||
Gores Metropoulos Sponsor, LLC (2)(3) |
9,925,000 | 19.9 | 19.9 | 9,925,000 | 3.1 | * | 9,925,000 | 3.5 | * | |||||||||||||||||||||||||||
Alec Gores (2)(3) |
9,925,000 | 19.9 | 19.9 | 11,928,290 | 3.7 | * | 11,928,290 | 4.2 | * | |||||||||||||||||||||||||||
Dean E. Metropoulos (2)(3) |
— | * | * | 99,993 | * | * | 99,993 | * | * | |||||||||||||||||||||||||||
Andrew McBride |
— | * | * | 4,127 | * | * | 4,127 | * | * | |||||||||||||||||||||||||||
Randall Bort (2) |
25,000 | * | * | 25,000 | * | * | 25,000 | * | * | |||||||||||||||||||||||||||
Joseph Gatto (2) |
25,000 | * | * | 25,000 | * | * | 25,000 | * | * | |||||||||||||||||||||||||||
Michael Cramer (2) |
25,000 | * | * | 25,000 | * | * | 25,000 | * | * | |||||||||||||||||||||||||||
All directors and executive officers as a group (6 individuals) |
10,000,000 | 20.0 | 20.0 | 2,182,410 | * | * | 2,182,410 | * | * | |||||||||||||||||||||||||||
Five Percent Holders (14) |
||||||||||||||||||||||||||||||||||||
Deutsche Bank AG (4) |
2,489,679 | 6.2 | 5.0 | 2,489,679 | * | * | 30,631 | * | * | |||||||||||||||||||||||||||
HGC Investment Management Inc. (5) |
2,081,434 | 5.2 | 4.2 | 2,081,434 | * | * | 25,608 | * | * | |||||||||||||||||||||||||||
Goldman & Co., L.P. (6) |
2,615,504 | 6.5 | 5.2 | 2,615,504 | * | * | 32,179 | * | * | |||||||||||||||||||||||||||
Millennium Management LLC (7) |
2,104,887 | 5.3 | 4.2 | 2,104,887 | * | * | 25,897 | * | * | |||||||||||||||||||||||||||
Element Capital Master Fund Limited (8) |
2,045,600 | 5.1 | 4.1 | 2,045,600 | * | * | 25,167 | * | * | |||||||||||||||||||||||||||
G2VP I, LLC (for itself and as nominee for G2VP Founders Fund I, LLC) (9) |
— | * | * | 15,886,418 | 4.9 | 1.3 | 15,886,418 | 5.6 | 1.3 | |||||||||||||||||||||||||||
GVA Auto, LLC (10) |
— | * | * | 17,961,608 | 5.6 | 1.4 | 17,961,608 | 6.4 | 1.5 | |||||||||||||||||||||||||||
The Phoenix Holdings, Ltd. (11) |
2,826,692 | 7.1 | 5.7 | 2,826,692 | * | * | 34,777 | * | * | |||||||||||||||||||||||||||
Directors and Named Executive Officers of the Post-Combination Company After Consummation of the Business Combination |
||||||||||||||||||||||||||||||||||||
Austin Russell (12) |
— | * | * | 104,715,233 | 32.6 | 82.8 | 104,715,233 | 37.1 | 85.5 | |||||||||||||||||||||||||||
Thomas J. Fennimore (12) |
— | * | * | — | * | * | — | * | * | |||||||||||||||||||||||||||
Alec E. Gores (2)(3) |
9,925,000 | 19.9 | 19.9 | 11,928,290 | 3.7 | * | 11,928,290 | 4.2 | * | |||||||||||||||||||||||||||
Jason Eichenholz (12) |
— | * | * | 8,568,609 | 2.7 | * | 8,568,609 | 3.0 | * | |||||||||||||||||||||||||||
M. Scott Faris (12) |
— | * | * | 814,720 | * | * | 814,720 | * | * | |||||||||||||||||||||||||||
Matthew J. Simoncini (12) |
— | * | * | — | * | * | — | * | * | |||||||||||||||||||||||||||
Scott A. McGregor (12) |
— | * | * | 914,171 | * | * | 914,171 | * | * | |||||||||||||||||||||||||||
Benjamin J. Kortlang (9) |
— | * | * | 15,886,418 | 4.9 | 1.3 | 15,886,418 | 5.6 | 1.3 | |||||||||||||||||||||||||||
All Directors and Executive Officers of the Post-Combination Company as a Group (8 individuals) |
9,925,000 | 19.9 | 19.9 | 142,827,441 | 44.4 | 85.9 | 142,827,441 | 50.6 | 88.6 |
* | Less than one percent. |
** | Percentage of total voting power represents voting power with respect to all shares of the Post-Combination Company’s Class A Stock and Class B Stock, as a single class. Following the closing of the Business Combination, each share of the Post-Combination Company’s Class B Stock will be entitled to ten votes per share and each share of the Post-Combination Company’s Class A Stock will be entitled to one vote per share. For more information about the voting rights of the Post-Combination Company’s Class A Stock and Class B Stock following the closing of the Business Combination, see the section entitled “ Description of Securities. |
(1) | Unless otherwise indicated, the business address of each of the entities, directors and executives listed directly below is 9800 Wilshire Blvd., Beverly Hills, California 90212. |
(2) | Represents Founder Shares that are automatically convertible into shares of Class A Stock at the time of the Business Combination on a one-for-one |
(3) | Represents shares held by our Sponsor, which is controlled indirectly by Mr. Metropoulos and Mr. Gores. They may be deemed to beneficially own 9,925,000 shares of Class F Stock and ultimately exercise voting and dispositive power of the securities held by our Sponsor. Voting and disposition decisions with respect to such securities are made by Mr. Metropoulos and Mr. Gores. They both disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. |
(4) | Based solely on a Schedule 13G, filed on February 14, 2020 by Deutsche Bank Securities Inc. on behalf of Deutsche Bank AG. The business address of Deutsche Bank AG is Taunusanlage 12, 60325 Frankfurt am Main, Federal Republic of Germany. |
(5) | Based solely on a Schedule 13G, filed on February 14, 2020 by HGC Investment Management Inc. on behalf of HGC Arbitrage Fund LP. The business address of HGC Investment Management Inc. is 366 Adelaide, Suite 601, Toronto, Ontario M5V 1R9, Canada. |
(6) | Based solely on a Schedule 13G filed on February 14, 2020. Jay G. Goldman is the Chief Executive Officer of Goldman & Co., L.P. and may be deemed responsible for voting and disposition decisions related to the securities reported therein. The business address of Goldman & Co., L.P. is 510 Madison Avenue, 26th Floor, New York, NY 10022. |
(7) | Based solely on a Schedule 13G filed on March 25, 2020. Represents 1,920,000 shares of Class A Stock beneficially owned by Integrated Core Strategies (US) LLC (“ Integrated Core Strategies Riverview |
(8) | Based solely on a Schedule 13G filed on October 13, 2020. Represents 2,045,600 shares of Class A Stock deemed to be beneficially owned by Element Capital Master Fund Limited, Element Capital Management LLC and Jeffrey Talpins, whom collectively have shared voting power over such Class A Stock. |
(9) | Represents shares of Class A Stock held by G2VP I, LLC for itself and as nominee for G2VP Founders Fund I, LLC (“G2VP”). Benjamin J. Kortlang, a member of Luminar’s board of directors, Brook Porter, Daniel Oros and David Mount are the Managing Members of G2VP I Associates, LLC, the Managing Member of G2VP, and therefore, may be deemed to hold voting and dispositive power over the shares held by G2VP. The address of G2VP is 2730 Sand Hill Road, Suite 210, Menlo Park, CA 94025. |
(10) | Represents shares of Class A Stock held by GVA Auto, LLC. The address of GVA Auto, LLC is 900 Broadway, San Francisco, CA 94133. |
(11) | Based solely on a Schedule 13G filed on September 30, 2020. Represents 2,826,692 shares of Class A Stock beneficially owned by The Phoenix Holdings Ltd. and various direct or indirect, majority or wholly-owned subsidiaries of The Phoenix Holdings Ltd. |
(12) | The principal business address is c/o Luminar Technologies, Inc., 2603 Discovery Drive, Suite 100, Orlando, FL 32826. |
(13) | Assumes each Public Stockholder participates pro-rata with respect to its Public Shares in the maximum redemption scenario where approximately 39,507,871 shares of Class A Stock may be redeemed and still enable us to have sufficient cash to satisfy the cash closing conditions in the Merger Agreement. |
(14) | Ownership percentages for five percent holders before the Business Combination is based upon 40,000,000 shares of Class A Stock outstanding as of September 30, 2020. |
Public Units (GMHIU) |
Public Shares (GMHI) |
Public Warrants (GMHIW) |
||||||||||||||||||||||
High |
Low |
High |
Low |
High |
Low |
|||||||||||||||||||
Fiscal Year 2020: |
||||||||||||||||||||||||
Quarter ended March 31, 2020 |
$ | 12.00 | $ | 9.69 | $ | 11.00 | $ | 9.45 | $ | 1.82 | $ | 0.65 | ||||||||||||
Quarter ended June 30, 2020 |
$ | 12.50 | $ | 10.18 | $ | 10.82 | $ | 9.87 | $ | 2.25 | $ | 1.00 | ||||||||||||
Fiscal Year 2019: |
||||||||||||||||||||||||
Quarter ended March 31, 2019 (1)(2) |
$ | 10.25 | $ | 10.12 | $ | 9.81 | $ | 9.75 | $ | 1.40 | $ | 1.30 | ||||||||||||
Quarter ended June 30, 2019 |
$ | 10.50 | $ | 10.19 | $ | 10.28 | $ | 9.79 | $ | 1.35 | $ | 1.15 | ||||||||||||
Quarter ended September 30, 2019 |
$ | 10.63 | $ | 10.47 | $ | 10.34 | $ | 10.02 | $ | 1.42 | $ | 1.28 | ||||||||||||
Quarter ended December 31, 2019 |
$ | 10.75 | $ | 10.58 | $ | 10.20 | $ | 10.05 | $ | 1.54 | $ | 1.25 |
(1) | Beginning on February 1, 2019 with respect to GMHIU. |
(2) | Beginning on March 25, 2019 with respect to GMHI and GMHIW. |
• | change the Post-Combination Company’s name to “Luminar Technologies, Inc.”; |
• | change the nature of the business or purpose of the Post-Combination Company to “any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware”; |
• | increase the Post-Combination Company’s total number of authorized shares of all classes of Common Stock from 220,000,000 shares to 836,000,000 shares, which would consist of (i) increasing the Post-Combination Company’s Class A Stock from 200,000,000 shares to 715,000,000 shares, (ii) authorizing the creation of the Post-Combination Company’s Class B Stock, which will consist of 121,000,000 authorized shares, and (iii) decreasing the Post-Combination Company’s Class F Stock from 20,000,000 shares to zero shares (after giving effect to the conversion of each outstanding share of Class F Stock immediately prior to the closing of the Business Combination into one share of Class A Stock); |
• | cause the conversion of our outstanding shares of Class F Stock into Class A Stock and make certain conforming changes; |
• | provide for a dual class common stock structure pursuant to which holders of Class B Stock will be entitled to 10 votes per share, thus having the ability to control the outcome of matters requiring stockholder approval (even if they own significantly less than a majority of the shares of outstanding Class A Stock), including the election of directors and significant corporate transactions (such as a merger or other sale of the Post-Combination Company or its assets); |
• | increase the required vote to remove a director of the Post-Combination Company’s board of directors from at least a majority of the voting power of the then-outstanding shares to at least two-thirds of the voting power of the then-outstanding shares of capital stock of the Post-Combination Company, voting together as a single class; |
• | add a provision in the Second Amended and Restated Certificate of Incorporation increasing the required vote to adopt, amend or repeal any provision of the Amended and Restated Bylaws from at least a majority of the voting power of the then-outstanding shares entitled to vote generally in the election of directors, voting together as a single class, to at least two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class; provided, that if two-thirds of the Whole Board has approved such adoption, amendment or repeal of any provisions of the Amended and Restated Bylaws, then only at least a majority of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class, would be required to adopt, amend or repeal any provision of the Amended and Restated Bylaws; |
• | add a provision in the Second Amended and Restated Certificate of Incorporation providing that special meetings of the Post-Combination Company’s stockholders may be called only by the Chairman of the Post-Combination Company’s board of directors, the Chief Executive Officer or the Post-Combination Company’s board of directors acting pursuant to a resolution adopted by a majority of the Whole Board, and may not be called by any other person or persons; |
• | provide that the Court of Chancery of the State of Delaware (the “ Court of Chancery |
• | require (i) the approval by affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company to make amendments to certain provisions of the Second Amended and Restated Certificate of Incorporation relating to authorized shares and preferred stock, Class B Stock, the board of directors, limitations on the liability of directors, bylaws, special meetings, exclusive forum, enforceability and amendments, and (ii) the approval by affirmative vote of (A) the holders of at least 75% of the Class A Stock of the Post-Combination Company voting separately as a single class and (B) the holders of at least 75% of the Class B Stock of the Post-Combination Company voting separately as a single class to amend or repeal or adopt any provision inconsistent with certain provisions of the Second Amended and Restated Certificate of Incorporation relating to the relative rights of Class A Stock and Class B Stock; and |
• | delete the prior provisions under Article IX (Business Combination Requirements; Existence) relating to our status as a blank check company |
• | Amending Article I |
• | Amending Article III |
• | Amending Section 1.1 Section 1.2 Article IV |
• | Amending Article IV Article V |
the outcome of matters requiring stockholder approval (even if they own significantly less than a majority of the shares of outstanding Class A Stock), including the election of directors and significant corporate transactions (such as a merger or other sale of the Post-Combination Company or its assets). The amendment is intended to align the Post-Combination Company’s capital structure with that of Luminar, was negotiated for by Luminar’s board of directors and Mr. Austin Russell in the negotiations with respect to the Business Combination, and enables Mr. Austin Russell, Founder, President and Chief Executive Officer of Luminar, to maintain his visionary leadership of Luminar and execute on the Post-Combination Company’s long-term strategy while helping alleviate short term market pressure on the Post-Combination Company. |
• | Amending Section 4 Article VI two-thirds of the voting power of the then-outstanding shares of capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class. The amendment is intended to protect all stockholders against the potential self-interested actions by one or a few large stockholders once the Class B Stock of the Post-Combination Company is no longer outstanding. In addition, our Board believes that following the time that the Class B Stock of the Post-Combination Company is no longer outstanding, a supermajority voting requirement encourages any person seeking control of the Post-Combination Company to negotiate with our Board to reach terms that are appropriate for all stockholders. |
• | Amending Article VIII two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class; provided, that if two-thirds of the Whole Board has approved such adoption, amendment or repeal of any provisions of the Amended and Restated Bylaws, then only the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company entitled to vote generally in the election of directors, voting together as a single class, would be required to adopt, amend or repeal any provision of the Amended and Restated Bylaws. The amendment is intended to protect all stockholders against the potential self-interested actions by one or a few large stockholders once the Class B Stock of the Post-Combination Company is no longer outstanding. In addition, our Board believes that following the time that the Class B Stock of the Post-Combination Company is no longer outstanding, a supermajority voting requirement encourages any person seeking control of the Post-Combination Company to negotiate with our Board to reach terms that are appropriate for all stockholders. |
• | Amending Article IX |
meetings in addition to the annual meeting unless the Chairman of the Post-Combination Company’s board of directors, the Chief Executive Officer or the Post-Combination Company’s board of directors acting pursuant to a resolution adopted by a majority of the Whole Board, determines such expense and management focus is warranted. |
• | Amending Article X case-by-case |
• | Amending Article XII two-thirds of the voting power of all of the then-outstanding shares of the capital stock of the Post-Combination Company to make amendments to certain provisions of the Second Amended and Restated Certificate of Incorporation relating to authorized shares and preferred stock, Class B Stock, the board of directors, limitations on the liability of directors, bylaws, special meetings, exclusive forum, enforceability and amendments, and (i) the holders of at least 75% of the Class A Stock of the Post-Combination Company voting separately as a single class and (ii) the holders of at least 75% of the Class B Stock of the Post-Combination Company voting separately as a single class to amend or repeal or adopt any provision inconsistent with certain provisions of the Second Amended and Restated Certificate of Incorporation relating to the relative rights of Class A Stock and Class B Stock. The amendment is intended to protect key provisions of the Second Amended and Restated Certificate of Incorporation from arbitrary amendment following the time that the Class B Stock of the Post-Combination Company is no longer outstanding to prevent a simple majority of stockholders from taking actions that may be harmful to other stockholders or making changes to provisions that are intended to protect all stockholders as negotiated by the parties with respect to the Business Combination. |
• | Deleting the prior Article IX to eliminate provisions specific to our status as a blank check company and to make conforming changes. This revision is desirable because it will serve no purpose following the Business Combination. |
• | a transfer of all or substantially all of our company’s assets; |
• | a merger, consolidation or other capital reorganization or business combination transaction of our company with or into another corporation, entity or person; |
• | the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of our then outstanding capital stock; or |
• | a change in the effective control of our company; |
Plan Category |
Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) |
Weighted average exercise price of outstanding options, warrants and rights (b) |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) |
|||||||||
Equity compensation plans approved by security holders |
1,239,374 | (1) |
$ | 22.73 | 110,972 | |||||||
Equity compensation plans not approved by security holders |
— | — | — | |||||||||
Total |
1,239,374 | $ | 22.73 | 110,972 |
(1) | Consists of stock options and restricted stock granted under the Luminar Stock Plan. |
• | Subject to capitalization adjustments and the share counting provisions described below, 36,588,278 shares of Class A Stock will initially be authorized for stock awards granted under the Omnibus Incentive Plan. |
• | Under the Omnibus Incentive Plan, no outside director may receive awards under the Omnibus Incentive Plan with a total grant date fair value that, when combined with cash compensation received for service as an outside director, exceeds $750,000 in a calendar year, increased to $1,000,000 in the calendar year of their initial service as an outside director. |
• | The Omnibus Incentive Plan provides that all stock awards granted thereunder will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as otherwise required by applicable law or imposed by the Board. |
Shares underlying outstanding Luminar Restricted Stock and Luminar Stock Options (#) |
Weighted avg. exercise price per share of Luminar Stock Options ($) |
Weighted avg. remaining term of Luminar Stock Options | ||
2,957,463 |
22.73 | 9.57 |
Metric |
2019 |
2018 |
2017 |
Average |
||||||||||||
Annual Dilution (1) |
6.61 | % | 4.37 | % | 6.44 | % | 5.81 | % | ||||||||
Annual Burn Rate (2) |
7.68 | % | 5.40 | % | 7.73 | % | 6.94 | % | ||||||||
Year-End Overhang(3) |
214.22 | % | 135.51 | % | 141.71 | % | 163.82 | % |
(1) | Calculated by dividing (i) the number of shares underlying awards granted to all recipients during the year, minus award cancellations and forfeitures during the year, by (ii) the number of shares outstanding at year-end. |
(2) | Calculated by dividing (i) the number of shares underlying awards granted during the year to all recipients by (ii) the number of shares outstanding at year-end. |
(3) | Calculated by dividing (a) the sum of (i) the number of shares underlying outstanding awards and (ii) shares available for future awards, by (b) the number of shares outstanding, in each case at year-end. |
• | No Discounted Stock Options or SARs |
• | No Reload Stock Options, Reload SARs or Tax Gross-ups gross-ups in any circumstance. |
• | Limit on Non-Employee Director Awards |
• | Awards Subject to Clawback |
• | a transfer of all or substantially all of our company’s assets; |
• | a merger, consolidation or other capital reorganization or business combination transaction of our company with or into another corporation, entity or person; |
• | the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of our then outstanding capital stock; or |
• | a change in the effective control of our company; |
Plan Category |
Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) |
Weighted average exercise price of outstanding options, warrants and rights (b) |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) |
|||||||||
Equity compensation plans approved by security holders |
1,224,704 | (1) |
$ | 22.73 | 125,642 | |||||||
Equity compensation plans not approved by security holders |
— | — | — | |||||||||
Total |
1,224,704 | $ | 22.73 | 125,642 |
(1) | Consists of Luminar Stock Options. |
• | a transfer of all or substantially all of our company’s assets; |
• | a merger, consolidation or other capital reorganization or business combination transaction of our company with or into another corporation, entity or person; |
• | the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of our then outstanding capital stock; or |
• | a change in the effective control of our company; |
• | If the stock is disposed of more than two years after the beginning of the offering and more than one year after the stock is transferred to the participant, then the lesser of (i) the excess of the fair market value of the stock at the time of such disposition over the purchase price, or (ii) the excess of the fair market value of the stock as of the beginning of the offering over the purchase price (determined as of the beginning of the offering) will be treated as ordinary income. Any further gain or any loss will be taxed as a long-term capital gain or loss. |
• | If the stock is sold or disposed of before the expiration of either of the holding periods described above, then the excess of the fair market value of the stock on the purchase date over the purchase price will be treated as ordinary income at the time of such disposition. The balance of any gain will be treated as capital gain. Even if the stock is later disposed of for less than its fair market value on the purchase date, the same amount of ordinary income is attributed to the participant, and a capital loss is recognized equal to the difference between the sales price and the fair market value of the stock on such purchase date. |
• | If the shares are registered in the name of the stockholder, the stockholder should contact us at our offices at Gores Metropoulos, Inc., 9800 Wilshire Blvd., Beverly Hills, California 90212 or by telephone at (310) 209-3010, to inform us of his or her request; or |
• | If a bank, broker or other nominee holds the shares, the stockholder should contact the bank, broker or other nominee directly. |
Page |
||||
Gores Metropoulos, Inc.—Unaudited Financial Statements |
||||
F-2 | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
Gores Metropoulos, Inc.—Audited Financial Statements |
||||
F-16 | ||||
F-17 | ||||
F-18 | ||||
F-19 | ||||
F-20 | ||||
F-21 | ||||
Luminar Technologies, Inc.—Unaudited Financial Statements |
||||
F-31 | ||||
F-32 | ||||
F-33 | ||||
F-36 | ||||
F-37 | ||||
Luminar Technologies, Inc.—Audited Financial Statements |
||||
F-61 | ||||
F-62 | ||||
F-63 | ||||
F-64 | ||||
F-66 | ||||
F-67 |
June 30, 2020 (unaudited) |
December 31, 2019 (audited) |
|||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Prepaid assets |
||||||||
Total current assets |
||||||||
Deferred income tax |
||||||||
Investments and cash held in Trust Account |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Accrued expenses, formation and offering costs |
$ | $ | ||||||
State franchise tax accrual |
||||||||
Current income tax and interest payable |
||||||||
Total current liabilities |
||||||||
Deferred underwriting compensation |
||||||||
Total liabilities |
$ | $ | ||||||
Commitments and Contingencies: |
||||||||
Class A subject to possible redemption, |
||||||||
Stockholders’ equity: |
||||||||
Preferred stock, $ |
||||||||
Common stock |
||||||||
Class A common stock, $ |
||||||||
Class F common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Three Months Ended June 30, 2020 |
Three Months Ended June 30, 2019 |
Six Months Ended June 30, 2020 |
Six Months Ended June 30, 2019 |
|||||||||||||
Revenues |
$ | — | $ | — | $ | — | $ | — | ||||||||
Professional fees and other expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
State franchise taxes, other than income tax |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other income—interest income |
||||||||||||||||
Net income before income taxes |
$ | ( |
) | $ | $ | $ | ||||||||||
Income tax provision and interest |
( |
) | ( |
) | ( |
) | ||||||||||
Net Income attributable to common shares |
$ | ( |
) | $ | $ | $ | ||||||||||
Net income/(loss) per ordinary share: |
||||||||||||||||
Class A ordinary shares—basic and diluted |
$ | ( |
) | $ | $ | $ | ||||||||||
Class F ordinary shares—basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Three Months Ended June 30, 2019 |
||||||||||||||||||||||||||||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Retained Earnings |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Beginning Balance at April 1, 2019 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Class A common stock subject to possible redemption; |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance at June 30, 2019 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Six Months Ended June 30, 2019 |
||||||||||||||||||||||||||||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Retained Earnings/ (Acc. Deficit) |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Beginning Balance at January 1, 2019 |
— | $ | — | $ | $ | $ | ( |
) | $ | |||||||||||||||||||
Forfeited Class F Common stock by Sponsor |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Proceeds from initial public offering of Units on February 5, 2019 at $10.00 per Unit |
— | — | — | |||||||||||||||||||||||||
Sale of 6,666,666 Private Placement Warrants to Sponsor on February 5, 2019 at $1.50 per Private Placement Warrant |
— | — | — | — | — | |||||||||||||||||||||||
Underwriters discounts |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Offering costs charged to additional paid-in capital |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Deferred underwriting compensation |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Class A common stock subject to possible redemption; 38,489,273 shares at a redemption price of $10.00 |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance at June 30, 2019 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Three Months Ended June 30, 2020 |
||||||||||||||||||||||||||||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Retained Earnings |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Beginning Balance at April 1, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Class A common stock subject to possible redemption; |
— | — | — | — | — | — | — | |||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance at June 30, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Six Months Ended June 30, 2020 |
||||||||||||||||||||||||||||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Retained Earnings |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Beginning Balance at January 1, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Class A common stock subject to possible redemption; 38,713,476 shares at a redemption price of $10.00 |
— | — | — | — | — | — | — | |||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance at June 30, 2020 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Six Months Ended June 30, 2020 |
Six Months Ended June 30, 2019 |
|||||||
Cash flows from operating activities: |
||||||||
Net Income |
$ | $ | ||||||
Changes in state franchise tax accrual |
( |
) | ||||||
Changes in prepaid assets and deferred costs |
( |
) | ||||||
Changes in deferred offering costs |
— | |||||||
Changes in accrued expenses, formation and offering costs |
( |
) | ||||||
Changes in current income tax and interest payable |
( |
) | ||||||
Changes in deferred income tax |
( |
) | ||||||
Net cash provided by/(used in) operating activities |
( |
) | ||||||
Cash flows from investing activities: |
||||||||
Cash deposited in Trust Account |
— | ( |
) | |||||
Interest reinvested in Trust Account |
( |
) | ||||||
Net cash provided by/(used in) investing activities |
( |
) | ||||||
Cash flows from financing activities: |
||||||||
Proceeds from sale of Units in initial public offering |
— | |||||||
Proceeds from sale of Private Placement Warrants to Sponsor |
— | |||||||
Repayment of notes and advances payable—related party |
— | ( |
) | |||||
Payment of underwriters’ discounts and commissions |
— | ( |
) | |||||
Payment of accrued offering costs |
— | ( |
) | |||||
Net cash provided by financing activities |
— | |||||||
Increase/(decrease) in cash |
( |
) | ||||||
Cash at beginning of period |
||||||||
Cash at end of period |
$ | $ | ||||||
Supplemental disclosure of cash and non-cash financing activities: |
||||||||
Deferred underwriting compensation |
$ | — | $ | |||||
Accrued expenses, formation, and offering costs |
— | |||||||
Cash paid for income and state franchise taxes |
For the Three Months Ended June 30, 2020 |
For the Three Months Ended June 30, 2019 |
For the Six Months Ended June 30, 2020 |
For the Six Months Ended June 30, 2019 |
|||||||||||||||||||||||||||||
Class A |
Class F |
Class A |
Class F |
Class A |
Class F |
Class A |
Class F |
|||||||||||||||||||||||||
Basic and diluted net income/(loss) per share: |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Allocation of net income/(loss) |
$ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Weighted-average shares outstanding |
||||||||||||||||||||||||||||||||
Basic and diluted net income/(loss) per share |
$ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) |
Description |
June 30, 2020 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Investments and cash held in Trust Account |
— | — | ||||||||||||||
Total |
$ | $ | $ | — | $ | — | ||||||||||
December 31, 2019 |
December 31, 2018 |
|||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Deferred offering costs |
— | |||||||
Prepaid assets |
— | |||||||
Total current assets |
||||||||
Deferred income tax |
— | |||||||
Investments and cash held in Trust Account |
— | |||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Accrued expenses, formation and offering costs |
$ | $ | ||||||
State franchise tax accrual |
||||||||
Notes and advances payable—related party |
— | |||||||
Income tax payable |
— | |||||||
Total current liabilities |
||||||||
Deferred underwriting compensation |
— | |||||||
Total liabilities |
$ | $ | ||||||
Commitments and Contingencies: |
||||||||
Class A subject to possible redemption, 38,713,476 and - |
— | |||||||
Stockholders’ equity: |
||||||||
Preferred stock, $ |
||||||||
Common stock |
||||||||
Class A common stock, $ - - 0 - |
— | |||||||
Class F common stock, $ |
||||||||
Additional paid-in-capital |
||||||||
Retained earnings/(accumulated deficit) |
( |
) | ||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Year ended December 31, 2019 |
For the Period from August 28, 2018 (inception) to December 31, 2018 |
|||||||
Professional fees and other expenses |
( |
) | ( |
) | ||||
State franchise taxes, other than income tax |
( |
) | ( |
) | ||||
Loss from operations |
( |
) | ( |
) | ||||
Other income—interest income |
— | |||||||
Net income/(loss) before income taxes |
$ | $ | ( |
) | ||||
Provision for income tax |
( |
) | — | |||||
Net income/(loss) attributable to common shares |
$ | $ | ( |
) | ||||
Net income/(loss) per ordinary share: |
||||||||
Class A ordinary shares—basic and diluted |
$ | $ | — | |||||
Class F ordinary shares—basic and diluted |
$ | ( |
) | $ | ( |
) | ||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at August 28, 2018 (inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Sale of Class F common stock to sponsor in October 2018 |
— | — | $ | $ | $ | — | $ | |||||||||||||||||||||
Net loss |
— | — | — | $ | — | $ | — | $ | ( |
) | $ | ( |
) | |||||||||||||||
Balance at December 31, 2018 |
— | $ | — | $ | $ | $ | ( |
) | $ | |||||||||||||||||||
For the Year ended December 31, 2019 |
||||||||||||||||||||||||||||
Class A Ordinary Shares |
Class F Ordinary Shares |
Additional Paid-In Capital |
Retained Earnings |
Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Forfeited Class F Common stock by Sponsor |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Proceeds from initial public offering of Units on February 5, 2019 at $ |
— | — | — | |||||||||||||||||||||||||
Sale of |
— | — | — | — | — | |||||||||||||||||||||||
Underwriters discounts |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||
Offering costs charged to additional paid-in capital |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Deferred underwriting compensation |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Class A common stock subject to possible redemption; |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance at December 31, 2019 |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Year Ended December 31, 2019 |
For the Period from August 28, 2018 (inception) to December 31, 2018 |
|||||||
Cash flows from operating activities: |
||||||||
Net income/(loss) |
$ | $ | ( |
) | ||||
Changes in state franchise tax accrual |
||||||||
Changes in prepaid assets |
( |
) | — | |||||
Changes in deferred offering costs |
( |
) | ||||||
Changes in current income tax |
||||||||
Changes in deferred income tax |
( |
) | — | |||||
Changes in accrued expenses, formation and offering costs |
( |
) | ||||||
Net cash provided by/(used in) operating activities |
( |
) | ||||||
Cash flows from investing activities: |
||||||||
Cash deposited in Trust Account |
( |
) | — | |||||
Interest reinvested in Trust Account |
( |
) | — | |||||
Net cash used in investing activities |
( |
) | — | |||||
Cash flows from financing activities: |
||||||||
Proceeds from notes and advances payable—related party |
— | |||||||
Proceeds from sale of Class F common stock to Sponsor |
— | |||||||
Proceeds from sale of Units in initial public offering |
— | |||||||
Proceeds from sale of Private Placement Warrants to Sponsor |
— | |||||||
Repayment of notes and advances payable—related party |
( |
) | — | |||||
Payment of underwriter’s discounts and commissions |
( |
) | — | |||||
Payment of accrued offering costs |
( |
) | — | |||||
Net cash provided by financing activities |
||||||||
Increase in cash |
||||||||
Cash at beginning of period |
— | |||||||
Cash at end of period |
$ | $ | ||||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Deferred underwriting compensation |
$ | $ | — | |||||
Cash paid for income and state franchise taxes |
$ | $ | — |
Year Ended December 31, 2019 |
For the Period from August 28, 2018 (inception) to December 31, 2018 |
|||||||||||||||
Class A |
Class F |
Class A |
Class F |
|||||||||||||
Basic and diluted net income/(loss) per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income/(loss) |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
||||||||||||||||
Basic and diluted net income/(loss) per share |
$ | $ | ( |
) | $ | $ | ( |
) |
Year Ended December 31, 2019 |
Year Ended December 31, 2018 |
|||||||
Income tax expense at the federal statutory rate |
$ | $ | ( |
) | ||||
State income taxes—net of federal income tax benefits |
( |
) | ( |
) | ||||
Change in valuation allowance |
||||||||
Total income tax expense (benefit) |
$ | $ | — | |||||
Year Ended December 31, 2019 |
Year Ended December 31, 2018 |
|||||||
Current income tax expense |
||||||||
Federal |
$ | $ | — | |||||
State |
— | — | ||||||
Total current income tax expense |
$ | $ | — | |||||
Deferred income tax expense |
||||||||
Federal |
$ | ( |
) | $ | — | |||
State |
— | — | ||||||
Total deferred income tax expense |
$ | ( |
) | $ | — | |||
Provision for income taxes |
$ | $ | — | |||||
Year Ended December 31, 2019 |
Year Ended December 31, 2018 |
|||||||
Deferred tax assets/(liabilities) |
||||||||
Tax attribute carryovers |
$ | $ | ||||||
Valuation allowance |
( |
) | ( |
) | ||||
Net deferred tax assets/(liabilities) |
$ | $ | ||||||
Description |
December 31, 2019 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Investments and cash held in Trust Account |
— | — | ||||||||||||||
Total |
$ | $ | $ | — | $ | — | ||||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 20,643 | $ | 27,080 | ||||
Restricted cash and cash equivalents |
225 | 225 | ||||||
Marketable securities |
6,374 | 6,659 | ||||||
Accounts receivable |
5,618 | 1,677 | ||||||
Inventories |
4,961 | 4,002 | ||||||
Other current assets |
2,873 | 1,824 | ||||||
|
|
|
|
|||||
Total current assets |
40,694 | 41,467 | ||||||
|
|
|
|
|||||
Property and equipment, net |
7,630 | 7,867 | ||||||
Goodwill |
701 | 701 | ||||||
Other long-term assets |
1,191 | 1,829 | ||||||
|
|
|
|
|||||
Total assets |
$ | 50,216 | $ | 51,864 | ||||
|
|
|
|
|||||
Liabilities, mezzanine equity and deficit |
||||||||
Accounts payable |
$ | 3,553 | $ | 3,456 | ||||
Accrued liabilities |
5,544 | 3,182 | ||||||
Current portion of long-term debt, net |
3,948 | 7,791 | ||||||
Other current liabilities |
593 | 344 | ||||||
|
|
|
|
|||||
Total current liabilities |
13,638 | 14,773 | ||||||
|
|
|
|
|||||
Long-term debt, net |
32,602 | 1,555 | ||||||
Warrant liabilities |
7,425 | 1,122 | ||||||
Other long-term liabilities |
1,113 | 1,401 | ||||||
|
|
|
|
|||||
Total liabilities |
54,778 | 18,851 | ||||||
|
|
|
|
|||||
Commitments and contingencies (Note 15) |
||||||||
Mezzanine equity |
||||||||
Series A preferred stock, $0.00001 par value; 7,537,269 shares authorized as of December 31, 2019 and June 30, 2020, 6,956,100 issued and outstanding as of December 31, 2019 and June 30, 2020. |
244,743 | 244,743 | ||||||
Deficit |
||||||||
Founders’ preferred stock, $0.00001 par value; 1,922,600 shares authorized as of December 31, 2019 and June 30, 2020, 1,922,600 shares issued and outstanding as of December 31, 2019 and June 30, 2020 |
— | — | ||||||
Common stock, $0.00001 par value; 20,800,000 shares authorized as of December 31, 2019 and June 30, 2020, 10,244,043 shares issued and 9,880,277 and 9,841,350 outstanding as of December 31, 2019 and June 30, 2020 |
— | — | ||||||
Additional paid-in capital |
13,906 | 10,474 | ||||||
Accumulated other comprehensive income (loss) |
8 | (1 | ) | |||||
Treasury stock, at cost, 363,766 and 402,693 shares at December 31, 2019 and June 30, 2020, respectively |
— | — | ||||||
Accumulated deficit |
(263,219 | ) | (222,203 | ) | ||||
|
|
|
|
|||||
Total deficit |
(249,305 | ) | (211,730 | ) | ||||
|
|
|
|
|||||
Total liabilities, mezzanine equity and deficit |
$ | 50,216 | $ | 51,864 | ||||
|
|
|
|
Six months ended June 30, |
||||||||
2020 |
2019 |
|||||||
Net sales |
$ | 7,296 | $ | 3,719 | ||||
Cost of sales |
11,285 | 6,805 | ||||||
|
|
|
|
|||||
Gross profit (loss) |
(3,989 | ) | (3,086 | ) | ||||
|
|
|
|
|||||
Selling and marketing expenses |
3,075 | 2,121 | ||||||
General and administrative expenses |
9,505 | 8,059 | ||||||
Research and development expenses |
18,116 | 18,450 | ||||||
|
|
|
|
|||||
Operating loss |
(34,685 | ) | (31,716 | ) | ||||
Interest income |
121 | 37 | ||||||
Interest expense |
(1,021 | ) | (1,235 | ) | ||||
Change in fair value of SAFE notes |
— | (24,215 | ) | |||||
Change in fair values of warrant liabilities |
(4,574 | ) | (72 | ) | ||||
Loss on extinguishment of debt |
(866 | ) | (6,124 | ) | ||||
Other income |
10 | 233 | ||||||
Other expense |
(1 | ) | (3 | ) | ||||
|
|
|
|
|||||
Loss before income taxes |
(41,016 | ) | (63,095 | ) | ||||
Income taxes |
— | — | ||||||
|
|
|
|
|||||
Net loss |
$ | (41,016 | ) | $ | (63,095 | ) | ||
|
|
|
|
|||||
Net loss attributable to common stockholders, basic and diluted |
$ | (4.34 | ) | $ | (8.43 | ) | ||
|
|
|
|
|||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
9,447,670 | 8,111,670 | ||||||
|
|
|
|
Six Months ended June 30, |
||||||||
2020 |
2019 |
|||||||
Net loss |
$ | (41,016 | ) | $ | (63,095 | ) | ||
Other comprehensive loss, net of tax: |
||||||||
Changes in unrealized gain on marketable securities |
9 | — | ||||||
|
|
|
|
|||||
Total other comprehensive loss, net of tax |
(41,007 | ) | (63,095 | ) | ||||
|
|
|
|
|||||
Comprehensive loss |
$ | (41,007 | ) | $ | (63,095 | ) | ||
|
|
|
|
Series A Convertible Preferred stock |
Founders Preferred Stock |
Common Stock |
Treasury stock |
Additional paid-in capital |
Accumulated other comprehensive (loss) |
Accumulated deficit |
Total deficit |
|||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Amount |
||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2018 |
— | $ | 1,922,600 | $ | — | 9,855,336 | $ | — | $ | — | $ | 2,818 | $ | — | $ | (127,485 | ) | $ | (124,667 | ) | ||||||||||||||||||||||||
Issuance of restricted common stock |
123,717 | — | 12 | 12 | ||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
1,170 | 1,170 | ||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock (1) |
— | |||||||||||||||||||||||||||||||||||||||||||
Conversion of SAFE into common stock |
264,990 | 4,925 | 4,925 | |||||||||||||||||||||||||||||||||||||||||
Net loss |
(63,095 | ) | (63,095 | ) | ||||||||||||||||||||||||||||||||||||||||
Conversion of SAFE into preferred stock for cash, net of issuance costs of $3,775 |
5,053,022 | 169,951 | ||||||||||||||||||||||||||||||||||||||||||
Conversion of debt into preferred stock |
317,404 | 7,719 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of Series A stock for cash, net of issuance costs of $1,001 |
1,340,847 | 57,062 | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Balance as of June 30, 2019 |
6,711,273 | $ | 234,732 | 1,922,600 | $ | — | 10,244,043 | $ | — | $ | — | $ | 8,925 | $ | — | $ | (190,580 | ) | $ | (181,655 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Amounts within common stock and treasury stock round to zero. |
Series A Convertible Preferred stock |
Founders Preferred Stock |
Common Stock |
Treasury stock |
Additional paid-in capital |
Accumulated other comprehensive (loss) |
Accumulated deficit |
Total deficit |
|||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Amount |
||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2019 |
6,956,100 | $ | 244,743 | 1,922,600 | $ | 10,244,043 | $ | — | $ | — | $ | 10,474 | $ | (1 | ) | $ | (222,203 | ) | $ | (211,730 | ) | |||||||||||||||||||||||
Repurchase of common stock (1) |
— | |||||||||||||||||||||||||||||||||||||||||||
Share-based compensation and conversion to common stock |
3,432 | 3,432 | ||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss, net of tax |
9 | 9 | ||||||||||||||||||||||||||||||||||||||||||
Net loss |
(41,016 | ) | (41,016 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Balance as of June 30, 2020 |
6,956,100 | $ | 244,743 | 1,922,600 | $ | 10,244,043 | $ | — | $ | — | $ | 13,906 | $ | 8 | $ | (263,219 | ) | $ | (249,305 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Amounts within common stock and treasury stock round to zero. |
Six months ended June 30, |
||||||||
2020 |
2019 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (41,016 | ) | $ | (63,095 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
1,241 | 1,136 | ||||||
Change in fair value of warrants and SAFE liabilities |
4,574 | 24,287 | ||||||
Impairment of inventories |
2,481 | — | ||||||
Loss on extinguishment of debt |
866 | 6,124 | ||||||
Share-based compensation |
3,413 | 1,170 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(3,940 | ) | 2,143 | |||||
Inventories |
(3,440 | ) | (2,524 | ) | ||||
Other current assets |
(1,049 | ) | 331 | |||||
Other long-term assets |
638 | 2 | ||||||
Accounts payable |
92 | 3,135 | ||||||
Accrued liabilities |
2,302 | 527 | ||||||
Other current liabilities |
229 | 126 | ||||||
Other long-term liabilities |
(369 | ) | (55 | ) | ||||
|
|
|
|
|||||
Net cash used in operating activities |
(33,978 | ) | (26,693 | ) | ||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Proceeds from sale of marketable securities |
285 | — | ||||||
Purchase of property and equipment |
(708 | ) | (774 | ) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
(423 | ) | (774 | ) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Settlement of SAFE notes |
— | (5,609 | ) | |||||
Principal payments on financing obligations |
(3,843 | ) | (4,719 | ) | ||||
Proceeds from the issuance of debt |
31,910 | — | ||||||
Proceeds from issuance of SAFE notes |
— | 37,379 | ||||||
Principal payments on capital leases |
(108 | ) | (26 | ) | ||||
Proceeds from issuance of Series A Convertible Preferred stock |
— | 58,064 | ||||||
Proceeds from issuance of restricted common stock |
9 | 61 | ||||||
Financing costs paid |
— | (4,776 | ) | |||||
Repurchase of Common Stock |
(4 | ) | (8 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
27,964 | 80,366 | ||||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents |
(6,437 | ) | 52,899 | |||||
Beginning cash and cash equivalents and restricted cash and cash equivalents |
27,305 | 9,827 | ||||||
|
|
|
|
|||||
Ending cash and cash equivalents and restricted cash and cash equivalents |
$ | 20,868 | $ | 62,726 | ||||
|
|
|
|
|||||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid for interest |
$ | 1,328 | $ | 803 | ||||
Supplemental disclosures of noncash investing and financing activities |
||||||||
Conversion of Bridge Note to Series A Convertible Preferred stock |
— | 7,719 | ||||||
Conversion of SAFE notes into common stock |
— | 4,925 | ||||||
Conversion of SAFE notes into Series A Convertible Preferred stock |
— | 173,726 | ||||||
Assets acquired on capital leases |
123 | 80 | ||||||
Purchases of property and equipment recorded in accounts payable and accrued liabilities |
65 | 144 |
Six months ended June 30, |
||||||||||||||||
2020 |
2019 |
|||||||||||||||
Revenue |
% of Revenue |
Revenue |
% of Revenue |
|||||||||||||
Revenue by primary geographical market: |
||||||||||||||||
North America |
$ | 1,725 | 24 | % | $ | 2,838 | 76 | % | ||||||||
Asia Pacific |
213 | 3 | % | 258 | 7 | % | ||||||||||
Europe, Middle East, and Asia |
5,358 | 73 | % | 623 | 17 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
7,296 | 100 | % | 3,719 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Revenue by timing of recognition: |
||||||||||||||||
Revenue recognized at a point in time |
790 | 11 | % | 2,015 | 54 | % | ||||||||||
Revenue recognized over time |
6,506 | 89 | % | 1,704 | 46 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
7,296 | 100 | % | 3,719 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Revenue by segment: |
||||||||||||||||
Autonomy Solutions |
6,106 | 84 | % | 2,015 | 54 | % | ||||||||||
Other Component Sales |
1,190 | 16 | % | 1,704 | 46 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 7,296 | 100 | % | $ | 3,719 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
As of |
||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
Contract liabilities, current |
$ | 372 | $ | 225 | ||||
|
|
|
|
|||||
Total contract liabilities |
$ | 372 | $ | 225 | ||||
|
|
|
|
As of June 30, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ | 225 | $ | — | ||||
Revenue recognized that was included in the contract liabilities beginning balance |
(225 | ) | — | |||||
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period |
372 | 131 | ||||||
|
|
|
|
|||||
Ending balance |
$ | 372 | $ | 131 | ||||
|
|
|
|
As of |
||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
Raw materials |
$ | 51 | $ | 1,998 | ||||
Work-in-process |
427 | 1,376 | ||||||
Finished goods |
4,483 | 628 | ||||||
|
|
|
|
|||||
Total inventory, net of allowance |
$ | 4,961 | $ | 4,002 | ||||
|
|
|
|
Autonomy Solutions |
Other Component Sales |
Total |
||||||||||
Balance as of December 31, 2019 |
$ | 687 | $ | 14 | $ | 701 | ||||||
Balance as of June 30, 2020 |
$ | 687 | $ | 14 | $ | 701 |
As of |
||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
2017 Notes Principal Outstanding |
$ | 5,304 | ||||||
Unamortized discount (2017 Notes) |
(56 | ) | ||||||
2018 Notes |
2,707 | |||||||
Unamortized discount (2018 Notes) |
(81 | ) | ||||||
2020 Notes |
$ | 30,000 | ||||||
Unamortized discount (2020 Notes) |
(1,459 | ) | ||||||
|
|
|
|
|||||
Net carrying amount |
28,541 | 7,874 | ||||||
Less: current portion |
439 | 6,459 | ||||||
|
|
|
|
|||||
Non-current portion |
$ | 28,102 | $ | 1,415 | ||||
|
|
|
|
As of |
||||
December 31, 2019 |
||||
Notes Principal outstanding |
$ | 1,290 | ||
Unamortized discount |
(9 | ) | ||
|
|
|||
Net carrying amount |
1,281 | |||
Less: current portion |
1,281 | |||
|
|
|||
Non-current portion |
$ | — | ||
|
|
As of |
||||
June 30, 2020 |
||||
Paycheck Protection Program Note |
$ | 7,841 | ||
|
|
|||
Net carrying amount |
7,841 | |||
|
|
|||
Less: current portion |
3,456 | |||
Non-current portion |
$ | 4,385 | ||
|
|
As of |
||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
Vehicle Loan |
$ | 38 | $ | 45 | ||||
Additional Equipment Loan |
130 | 146 | ||||||
|
|
|
|
|||||
Total |
168 | 191 | ||||||
Less: current portion |
53 | 51 | ||||||
|
|
|
|
|||||
Non-current portion |
$ | 115 | $ | 140 | ||||
|
|
|
|
As of |
||||||||
June 30, 2020 |
December 31, 2019 |
|||||||
2017 Warrant |
$ | 3,744 | $ | 1,035 | ||||
2018 Warrant |
462 | 87 | ||||||
2020 Warrants |
3,219 | — | ||||||
|
|
|
|
|||||
Total |
$ | 7,425 | $ | 1,122 | ||||
|
|
|
|
Shares Authorized |
Shares Issued and Outstanding |
Per Share Liquidation Preference |
||||||||||
Series A |
2,228,361 | 1,660,839 | $ | 43.30 | ||||||||
Series A-1 |
163,306 | 163,306 | $ | 15.31 | ||||||||
Series A-2 |
1,322,780 | 1,322,780 | $ | 15.12 | ||||||||
Series A-3 |
223,548 | 223,548 | $ | 17.89 | ||||||||
Series A-4 |
49,827 | 49,827 | $ | 20.07 | ||||||||
Series A-5 |
137,715 | 124,068 | $ | 20.15 | ||||||||
Series A-6 |
247,420 | 247,420 | $ | 30.31 | ||||||||
Series A-7 |
1,459,656 | 1,459,656 | $ | 34.64 | ||||||||
Series A-8 |
385,777 | 385,777 | $ | 36.81 | ||||||||
Series A-9 |
748,674 | 748,674 | $ | 38.97 | ||||||||
Series A-10 |
252,801 | 252,801 | $ | 41.14 | ||||||||
Series A-11 |
317,404 | 317,404 | $ | 5.27 |
Effective Conversion Price |
||||
Series A |
$ | 43.30 | ||
Series A-1 |
$ | 15.31 | ||
Series A-2 |
$ | 15.12 | ||
Series A-3 |
$ | 17.89 | ||
Series A-4 |
$ | 20.07 | ||
Series A-5 |
$ | 20.15 | ||
Series A-6 |
$ | 30.31 | ||
Series A-7 |
$ | 34.64 | ||
Series A-8 |
$ | 36.81 | ||
Series A-9 |
$ | 38.97 | ||
Series A-10 |
$ | 41.14 | ||
Series A-11 |
$ | 24.30 |
Commitment Date |
Series |
Type of Consideration received (cash or settlement of other instruments) |
Effective Conversion Price |
Fair value of the Common Stock |
Number of Shares Issuable upon Conversion |
BCF |
||||||||||||||
6/24/2019 |
A | Cash | $ | 43.30 | $ | 18.59 | 648,069 | — | ||||||||||||
6/24/2019 |
A | Settlement of SAFEs | 43.30 | 18.59 | 75,165 | — | ||||||||||||||
6/24/2019 |
A-1 |
Settlement of SAFEs | 15.31 | 18.59 | 163,306 | $ | 536,000 | |||||||||||||
6/24/2019 |
A-2 |
Settlement of SAFEs | 15.12 | 18.59 | 1,322,780 | 4,590,000 | ||||||||||||||
6/24/2019 |
A-3 |
Settlement of SAFEs | 17.89 | 18.59 | 223,548 | 156,000 | ||||||||||||||
6/24/2019 |
A-4 |
Settlement of SAFEs | 20.07 | 18.59 | 49,827 | — | ||||||||||||||
6/24/2019 |
A-5 |
Settlement of SAFEs | 20.15 | 18.59 | 124,068 | — | ||||||||||||||
6/24/2019 |
A-6 |
Settlement of SAFEs | 30.31 | 18.59 | 247,420 | — | ||||||||||||||
6/24/2019 |
A-7 |
Settlement of SAFEs | 34.64 | 18.59 | 1,459,656 | — | ||||||||||||||
6/24/2019 |
A-8 |
Settlement of SAFEs | 36.81 | 18.59 | 385,777 | — | ||||||||||||||
6/24/2019 |
A-9 |
Settlement of SAFEs | 38.97 | 18.59 | 748,674 | — | ||||||||||||||
6/24/2019 |
A-10 |
Settlement of SAFEs | 41.14 | 18.59 | 252,801 | — | ||||||||||||||
6/24/2019 |
A-11 |
Settlement of Note | 24.30 | 18.59 | 317,404 | — | ||||||||||||||
6/26/2019 |
A | Cash | 43.30 | 18.59 | 692,778 | — | ||||||||||||||
7/15/2019 |
A | Cash | 43.30 | 18.59 | 11,546 | — | ||||||||||||||
|
|
|||||||||||||||||||
Total |
$ |
5,282,000 |
||||||||||||||||||
|
|
Fair Value (in thousands) Measured as of June 30, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Commercial papers |
$ | — | $ | 3,198 | — | $ | 3,198 | |||||||||
Corporate debt securities |
— | 3,176 | — | 3,176 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
— | 6,374 | — | 6,374 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
— | — | — | — | |||||||||||||
2017 Warrants |
— | — | 3,744 | 3,744 | ||||||||||||
2018 Warrants |
— | — | 462 | 462 | ||||||||||||
2020 Warrants |
— | — | 3,219 | 3,219 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
$ | — | $ | — | $ | 7,425 | $ | 7,425 | ||||||||
|
|
|
|
|
|
|
|
Fair Value Measured (in thousands) as of December 31, 2019 Using: |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Commercial papers |
$ | — | $ | 3,212 | — | $ | 3,212 | |||||||||
Corporate debt |
— | 2,698 | — | 2,698 | ||||||||||||
Treasury bills |
749 | — | — | 749 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
749 | 5,910 | — | 6,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
— | — | — | — | |||||||||||||
2017 Warrants |
— | — | 1,035 | 1,035 | ||||||||||||
2018 Warrants |
— | — | 87 | 87 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
$ | — | $ | — | $ | 1,122 | $ | 1,122 | ||||||||
|
|
|
|
|
|
|
|
For the six months ended June 30, 2020 |
||||||||||||
2017 Warrants |
2018 Warrants |
2020 Warrants |
||||||||||
Balance-beginning of period |
$ | 1,035 | $ | 87 | $ | — | ||||||
Additions |
— | — | 1,729 | |||||||||
Exercise or conversion |
— | — | — | |||||||||
Measurement adjustments |
2,709 | 375 | 1,490 | |||||||||
|
|
|
|
|
|
|||||||
Balance-end of period |
$ | 3,744 | $ | 462 | $ | 3,219 | ||||||
|
|
|
|
|
|
For six months ended June 30, 2019 |
||||||||||||
SAFEs |
2017 Warrants |
2018 Warrants |
||||||||||
Balance-beginning of period |
$ | 122,588 | $ | 808 | $ | 58 | ||||||
Additions |
37,379 | — | — | |||||||||
Exercise or conversion |
(184,182 | ) | — | — | ||||||||
Measurement adjustments |
24,215 | 66 | 5 | |||||||||
|
|
|
|
|
|
|||||||
Balance-end of six month period |
$ | — | $ | 874 | $ | 63 | ||||||
|
|
|
|
|
|
Six Months Ended June 30 |
||||||||
2020 |
2019 |
|||||||
Numerator: |
||||||||
Net loss |
$ | (41,016 | ) | $ | (63,095 | ) | ||
Deemed dividend attributable to BCF |
(5,282 | ) | ||||||
|
|
|
|
|||||
Net loss attributable to common shareholders |
$ | (41,016 | ) | $ | (68,377 | ) | ||
|
|
|
|
|||||
Denominator: |
||||||||
Weighted average Common shares outstanding- Basic |
9,447,670 | 8,111,670 | ||||||
|
|
|
|
|||||
Dilutive effect of potential common shares |
— | — | ||||||
|
|
|
|
|||||
Weighted average Common shares outstanding- Diluted |
9,447,670 | 8,111,670 | ||||||
|
|
|
|
|||||
Net loss per shares attributable to Common shareholders- Basic and Diluted |
$ | (4.34 | ) | $ | (8.43 | ) | ||
|
|
|
|
Six Months Ended June 30 |
||||||||
2020 |
2019 |
|||||||
Warrants |
440,906 | 71,281 | ||||||
Stock options |
1,214,644 | — | ||||||
Restricted Stock |
200,295 | 639,039 | ||||||
Series A Convertible Preferred Stock |
6,956,100 | 6,711,273 | ||||||
Founders Preferred Stock |
1,922,600 | 1,922,600 | ||||||
|
|
|
|
|||||
Total |
10,734,545 | 9,344,193 | ||||||
|
|
|
|
6/30/2020 |
12/31/2019 |
|||||||
Expected term (years) (1) |
5.96 – 6.02 | 5.27 – 6.02 | ||||||
Common stock value |
$ | 22.80 – 76.93 | $ | 17.38 – 22.80 | ||||
Expected volatility (2) |
49.3% – 51.9% | 44.6% – 49.3% | ||||||
Risk-free interest rate (3) |
0.4% – 1.8% | 1.6% – 1.9% | ||||||
Dividend yield (4) |
0% | 0% |
(1) | The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. |
(2) | Volatility, or the standard deviation of annualized returns was estimated based on comparable companies’ report volatilities. |
(3) | Risk free rate was obtained from US treasury notes for the expected terms noted as of the valuation date. |
(4) | The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future. |
Number of Common Stock Options |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Life (Years) |
Aggregate Intrinsic Value (In Thousands) |
|||||||||||||
Outstanding as of December 31, 2019 |
365,938 | $ | 22.73 | 9.76 | $ | 22 | ||||||||||
Granted |
921,721 | 22.73 | 9.69 | |||||||||||||
Exercised |
— | — | — | |||||||||||||
Forfeited |
(73,015 | ) | 22.73 | 9.45 | ||||||||||||
Expired |
— | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding as of June 30, 2020 |
1,214,644 | 22.73 | 9.57 | 45,985 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and exercisable as of June 30, 2020 |
46,946 | 22.73 | 9.25 | 2,353 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and expected to vest as of June 30, 2020 |
1,214,644 | $ | 22.73 | 9.57 | $ | 45,985 | ||||||||||
|
|
|
|
|
|
|
|
Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
Outstanding as of December 31, 2019 |
458,257 | $ | 10.92 | |||||
Granted |
— | — | ||||||
Forfeited |
(111,844 | ) | 11.35 | |||||
Vested |
(146,836 | ) | 10.43 | |||||
|
|
|
|
|||||
Outstanding as of June 30, 2020 |
199,577 | $ | 13.25 | |||||
|
|
|
|
Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
Outstanding as of December 31, 2019 |
1,999 | $ | 17.61 | |||||
Granted |
— | — | ||||||
Forfeited |
— | — | ||||||
Vested |
(1,281 | ) | 17.61 | |||||
|
|
|
|
|||||
Outstanding as of June 30, 2020 |
718 | $ | 17.61 | |||||
|
|
|
|
Six Months Ended June 30, |
||||||||
2020 |
2019 |
|||||||
Cost of sales |
$ | 154 | $ | 48 | ||||
Research and development |
1,067 | 402 | ||||||
Sales and marketing |
184 | 66 | ||||||
General and administrative |
2,008 | 654 | ||||||
|
|
|
|
|||||
Total |
$ | 3,413 | $ | 1,170 | ||||
|
|
|
|
Capital Leases |
Operating Leases |
|||||||
2020 |
$ | 133 | $ | 3,047 | ||||
2021 |
254 | 6,264 | ||||||
2022 |
162 | 5,975 | ||||||
2023 |
5 | 3,992 | ||||||
2024 |
— | 746 | ||||||
Thereafter |
— | — | ||||||
|
|
|
|
|||||
Total minimum lease payments |
$ | 554 | $ | 20,024 | ||||
|
|
|
|
|||||
Less: amount representing interest |
54 | |||||||
|
|
|||||||
Long-term capital lease obligations as of June 30, 2020 |
$ | 500 | ||||||
|
|
Six Months ended June 30, 2020 |
||||||||||||||||||||
Autonomy Solutions |
Other Component Sales |
Total reportable segments |
Eliminations(1) |
Total Consolidated |
||||||||||||||||
Revenue: |
||||||||||||||||||||
Revenues from external customers |
$ | 6,106 | $ | 1,190 | $ | 7,296 | $ | — | $ | 7,296 | ||||||||||
Revenues from internal customer |
— | 1,731 | 1,731 | (1,731 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Revenue |
6,106 | 2,921 | 9,027 | (1,731 | ) | 7,296 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization |
1,160 | 81 | 1,241 | — | 1,241 | |||||||||||||||
Operating profit (loss) |
(34,873 | ) | 188 | (34,685 | ) | — | (34,685 | ) | ||||||||||||
Other significant items: |
||||||||||||||||||||
Segment assets |
50,231 | 2,672 | 52,903 | (2,687 | ) | 50,216 | ||||||||||||||
Inventory |
$ | 4,961 | $ | — | $ | 4,961 | $ | — | $ | 4,961 | ||||||||||
Six Months ended June 30, 2019 |
||||||||||||||||||||
Autonomy Solutions |
Other Component Sales |
Total reportable segments |
Eliminations (1) |
Total Consolidated |
||||||||||||||||
Revenue: |
||||||||||||||||||||
Revenues from external customers |
$ | 2,015 | $ | 1,704 | $ | 3,719 | $ | — | $ | 3,719 | ||||||||||
Revenues from internal customer |
— | 1,371 | 1,371 | (1,371 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Revenue |
2,015 | 3,075 | 5,090 | (1,371 | ) | 3,719 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization |
1,046 | 90 | 1,136 | — | 1,136 | |||||||||||||||
Operating profit (loss) |
(31,979 | ) | 263 | (31,716 | ) | — | (31,716 | ) | ||||||||||||
Other significant items: |
||||||||||||||||||||
Segment assets |
81,276 | 2,286 | 83,562 | (2,532 | ) | 81,030 | ||||||||||||||
Inventory |
$ | 5,450 | $ | — | $ | 5,450 | $ | — | $ | 5,450 |
1. | Represent the eliminations of all intercompany balances and transactions during the period presented. |
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 27,080 | $ | 9,602 | ||||
Restricted cash and cash equivalents |
225 | — | ||||||
Marketable securities |
6,659 | — | ||||||
Accounts receivable |
1,677 | 2,482 | ||||||
Inventories |
4,002 | 2,926 | ||||||
Other current assets |
1,824 | 2,003 | ||||||
|
|
|
|
|||||
Total current assets |
41,467 | 17,013 | ||||||
|
|
|
|
|||||
Restricted cash and cash equivalents |
— | 225 | ||||||
Property and equipment, net |
7,867 | 8,436 | ||||||
Goodwill |
701 | 701 | ||||||
Other long-term assets |
1,829 | 1,827 | ||||||
|
|
|
|
|||||
Total assets |
$ | 51,864 | $ | 28,202 | ||||
|
|
|
|
|||||
Liabilities, mezzanine equity and deficit |
||||||||
Accounts payable |
$ | 3,456 | $ | 3,826 | ||||
Accrued liabilities |
3,182 | 3,817 | ||||||
Current portion of long-term debt, net |
7,791 | 9,585 | ||||||
Bridge note payable |
— | 1,500 | ||||||
Other current liabilities |
344 | 82 | ||||||
|
|
|
|
|||||
Total current liabilities |
14,773 | 18,810 | ||||||
|
|
|
|
|||||
Long-term debt, net |
1,555 | 9,301 | ||||||
Simple Agreements for Future Equity (“SAFE”) liabilities |
— | 122,588 | ||||||
Warrant liabilities |
1,122 | 866 | ||||||
Other long-term liabilities |
1,401 | 1,304 | ||||||
|
|
|
|
|||||
Total liabilities |
18,851 | 152,869 | ||||||
|
|
|
|
|||||
Commitments and contingencies (Note 18) |
||||||||
Mezzanine equity |
||||||||
Series A preferred stock, $0.00001 par value; 0 and 7,537,269 shares authorized as of December 31, 2018 and December 31, 2019, respectively, 0 and 6,956,100 shares issued and outstanding as of December 31, 2018 and December 31, 2019 |
244,743 | — | ||||||
Deficit |
||||||||
Founders’ preferred stock, $0.00001 par value; 1,922,600 shares authorized as of December 31, 2018 and December 31, 2019, 1,922,600 shares issued and outstanding as of December 31, 2018 and December 31, 2019. |
— | — | ||||||
Common stock, $0.00001 par value; 13,000,000 and 20,800,000 shares authorized as of December 31, 2018 and December 31, 2019, respectively, 9,855,336 and 10,244,043 shares issued and 9,593,220 and 9,880,277 outstanding as of December 31, 2018 and December 31, 2019, respectively |
— | — | ||||||
Additional paid-in capital |
10,474 | 2,818 | ||||||
Accumulated other comprehensive income (loss) |
(1 | ) | — | |||||
Treasury stock, at cost, 262,116 and 363,766 shares at December 31, 2018 and 2019, respectively |
— | — | ||||||
Accumulated deficit |
(222,203 | ) | (127,485 | ) | ||||
|
|
|
|
|||||
Total deficit |
(211,730 | ) | (124,667 | ) | ||||
|
|
|
|
|||||
Total liabilities, mezzanine equity and deficit |
$ | 51,864 | $ | 28,202 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Net sales |
$ | 12,602 | $ | 11,692 | ||||
Cost of sales |
16,655 | 10,939 | ||||||
|
|
|
|
|||||
Gross profit (loss) |
(4,053 | ) | 753 | |||||
Selling and marketing expenses |
4,730 | 3,025 | ||||||
General and administrative expenses |
16,861 | 21,872 | ||||||
Research and development expenses |
36,971 | 40,085 | ||||||
|
|
|
|
|||||
Operating loss |
(62,615 | ) | (64,229 | ) | ||||
Interest income |
509 | 12 | ||||||
Interest expense |
(2,239 | ) | (2,654 | ) | ||||
Change in fair value of SAFE notes |
(24,215 | ) | (12,345 | ) | ||||
Change in fair values of warrant liabilities |
(256 | ) | (143 | ) | ||||
Loss on extinguishment of debt |
(6,124 | ) | — | |||||
Other income |
262 | — | ||||||
Other expense |
(40 | ) | (191 | ) | ||||
|
|
|
|
|||||
Loss before income taxes |
(94,718 | ) | (79,550 | ) | ||||
Income taxes |
— | — | ||||||
|
|
|
|
|||||
Net loss |
$ | (94,718 | ) | (79,550 | ) | |||
|
|
|
|
|||||
Net loss attributable per share to common stockholders: |
||||||||
Basic and diluted |
$ | (11.47 | ) | $ | (12.00 | ) | ||
|
|
|
|
|||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
8,718,104 | 6,631,873 | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Net loss |
$ | (94,718 | ) | $ | (79,550 | ) | ||
Other comprehensive loss, net of tax: |
||||||||
Changes in unrealized gain on marketable securities |
(1 | ) | — | |||||
|
|
|
|
|||||
Comprehensive loss |
$ | (94,717 | ) | $ | (79,550 | ) | ||
|
|
|
|
Series A Convertible Preferred Stock |
Founders Preferred Stock |
Common Stock |
Treasury stock |
Additional paid-in capital |
Accumulated other comprehensive loss |
Accumulated deficit |
Total deficit |
|||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Amount |
||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2017 |
— | $ | — | 1,922,600 | $ | — | 9,337,270 | $ | — | $ | — | $ | 735 | $ | — | $ | (47,935 | ) | $ | (47,200 | ) | |||||||||||||||||||||||
Issuance of restricted common stock |
518,066 | 21 | 21 | |||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
2,062 | 2,062 | ||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock (1) |
$ | — | ||||||||||||||||||||||||||||||||||||||||||
Net loss |
(79,550 | ) | (79,550 | ) | ||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2018 |
— | — | 1,922,600 | — | 9,855,336 | — | — | 2,818 | (127,485 | ) | (124,667 | ) | ||||||||||||||||||||||||||||||||
Conversion of SAFE into preferred stock for cash, net of issuance costs of $3,775 |
5,053,022 | 169,951 | ||||||||||||||||||||||||||||||||||||||||||
Conversion of debt into preferred stock |
317,404 | 7,719 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of Series A stock for cash, net of issuance costs of $1,592 |
1,585,674 | 67,073 | ||||||||||||||||||||||||||||||||||||||||||
Issuance of restricted common stock |
123,717 | 29 | 29 | |||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
2,702 | 2,702 | ||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock (1) |
$ | — | ||||||||||||||||||||||||||||||||||||||||||
Conversion of SAFE into common stock |
264,990 | 4,925 | 4,925 | |||||||||||||||||||||||||||||||||||||||||
Net loss |
(94,718 | ) | (94,718 | ) | ||||||||||||||||||||||||||||||||||||||||
Other comprehensive Income |
(1 | ) | (1 | ) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Balance as of December 31, 2019 |
6,956,100 | $ | 244,743 | 1,922,600 | $ | — | 10,244,043 | $ | — | $ | — | $ | 10,474 | $ | (1 | ) | $ | (222,203 | ) | $ | (211,730 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Amounts within common stock and treasury stock round to zero. |
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (94,718 | ) | $ | (79,550 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
2,316 | 1,494 | ||||||
Change in fair value of warrants and SAFE liabilities |
24,471 | 12,488 | ||||||
Impairment of inventories |
1,378 | 3,486 | ||||||
Loss on disposal of property and equipment |
37 | 188 | ||||||
Loss on extinguishment of debt |
6,124 | — | ||||||
Share-based compensation |
2,702 | 2,062 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
805 | (364 | ) | |||||
Inventories |
(2,454 | ) | (6,054 | ) | ||||
Other current assets |
179 | (874 | ) | |||||
Other long-term assets |
(2 | ) | (887 | ) | ||||
Accounts payable |
(431 | ) | 454 | |||||
Accrued liabilities |
(550 | ) | (820 | ) | ||||
Other current liabilities |
102 | 36 | ||||||
Other long-term liabilities |
(160 | ) | 1,252 | |||||
|
|
|
|
|||||
Net cash used in operating activities |
(60,201 | ) | (67,089 | ) | ||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Purchase of marketable securities |
(6,908 | ) | — | |||||
Proceeds from sale of marketable securities |
249 | |||||||
Purchase of property and equipment |
(1,487 | ) | (4,388 | ) | ||||
Disposal of property and equipment |
368 | — | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
(7,778 | ) | (4,388 | ) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Settlement of SAFE notes |
(5,609 | ) | — | |||||
Principal payments on financing obligations |
(9,540 | ) | (4,556 | ) | ||||
Proceeds from the issuance of debt |
— | 5,940 | ||||||
Principal payments on capital leases |
(118 | ) | (15 | ) | ||||
Proceeds from issuance of Series A Convertible Preferred stock |
68,666 | — | ||||||
Proceeds from issuance of SAFE notes |
37,377 | 66,468 | ||||||
Proceeds from issuance of restricted common stock |
61 | 84 | ||||||
Financing costs paid |
(5,367 | ) | — | |||||
Repurchase of common stock |
(13 | ) | (2 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
85,457 | 67,919 | ||||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents |
17,478 | (3,558 | ) | |||||
Beginning cash and cash equivalents, and restricted cash and cash equivalents |
9,827 | 13,385 | ||||||
|
|
|
|
|||||
Ending cash and cash equivalents, and restricted cash and cash equivalents |
$ | 27,305 | $ | 9,827 | ||||
|
|
|
|
|||||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid for interest |
$ | 2,018 | $ | 2,220 | ||||
Cash paid for income taxes |
— | 1 | ||||||
Supplemental disclosures of noncash investing and financing activities: |
||||||||
Conversion of Bridge Note to Series A Convertible Preferred stock |
7,719 | — | ||||||
Conversion of SAFE notes into Common Stock |
4,925 | — | ||||||
Conversion of SAFE notes into Series A Convertible Preferred stock |
173,726 | — | ||||||
Assets acquired on capital leases |
397 | 79 | ||||||
Purchases of property and equipment recorded in accounts payable and accrued liabilities |
150 | 249 |
Estimated useful lives |
||||
Computer hardware and software |
3 years | |||
Demonstration units and fleet |
2-5 years |
|||
Machinery and equipment |
7 years | |||
Furnitures and fixtures |
7 years | |||
Vehicles |
5 years | |||
Leasehold improvements |
Lesser of lease term or 10 years |
• | Identifying the contract, or contracts, with the customer; |
• | Identifying the performance obligations in the contract; |
• | Determining the transaction price; |
• | Allocating the transaction price to performance obligations in the contract; and |
• | Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised good or services. |
Year Ended December 31, |
||||||||||||||||
2019 |
2018 |
|||||||||||||||
Revenue |
% of Revenue |
Revenue |
% of Revenue |
|||||||||||||
Revenue by primary geographical market: |
||||||||||||||||
North America |
$ | 10,453 | 83 | % | $ | 9,408 | 80 | % | ||||||||
Asia Pacific |
469 | 4 | % | 140 | 1 | % | ||||||||||
Europe, Middle East, and Asia |
1,680 | 13 | % | 2,144 | 19 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
12,602 | 100 | % | 11,692 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Revenue by timing of recognition: |
||||||||||||||||
Recognized at a point in time |
9,666 | 77 | % | 7,236 | 62 | % | ||||||||||
Recognized over time |
2,936 | 23 | % | 4,456 | 38 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
12,602 | 100 | % | 11,692 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Revenue by segment: |
||||||||||||||||
Autonomy Solutions |
9,666 | 77 | % | 7,236 | 62 | % | ||||||||||
Other component sales |
2,936 | 23 | % | 4,456 | 38 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
12,602 | 100 | % | 11,692 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
As of December 31, |
||||
2019 |
||||
Contract liabilities, current |
$ | 225 | ||
Contract liabilities, long-term |
— | |||
|
|
|||
Total |
$ | 225 | ||
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Beginning balance |
$ | $ | 1,250 | |||||
Impact of ASC 606 adoption |
— | — | ||||||
Revenue recognized that was included in the contract liabilities beginning balance |
(1,250 | ) | ||||||
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period |
225 | — | ||||||
Customer deposits reclassified to refund liabilities |
— | — | ||||||
|
|
|
|
|||||
Ending balance |
$ | 225 | $ | — | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Raw materials |
$ | 1,998 | $ | 1,800 | ||||
Work-in-process |
1,376 | 905 | ||||||
Finished goods |
628 | 221 | ||||||
|
|
|
|
|||||
Total inventory |
$ | 4,002 | $ | 2,926 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Computer hardware and software |
$ | 2,904 | $ | 1,522 | ||||
Demonstration fleet and demonstration units |
1,603 | 939 | ||||||
Machinery and equipment |
4,830 | 4,953 | ||||||
Furnitures and fixtures |
325 | 317 | ||||||
Vehicles |
902 | 872 | ||||||
Leasehold improvements |
821 | 788 | ||||||
Capital lease assets |
579 | 119 | ||||||
Construction in progress |
465 | 1,166 | ||||||
|
|
|
|
|||||
Total property and equipment |
12,429 | 10,676 | ||||||
Less: accumulated depreciation and amortization |
4,562 | 2,240 | ||||||
|
|
|
|
|||||
Total property and equipment, net |
$ | 7,867 | $ | 8,436 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Prepaid expenses |
$ | 817 | $ | 1,092 | ||||
Advance payments to vendors |
666 | — | ||||||
Prepaid rent and other |
12 | 210 | ||||||
Other receivables |
329 | 701 | ||||||
|
|
|
|
|||||
Total other current assets |
$ | 1,824 | $ | 2,003 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Security deposits |
$ | 1,793 | $ | 1,756 | ||||
Other long-term assets |
36 | 71 | ||||||
|
|
|
|
|||||
Total other assets |
$ | 1,829 | $ | 1,827 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Accrued expenses |
$ | 2,049 | $ | 2,853 | ||||
Warranty liabilities |
267 | 145 | ||||||
Contract liabilities |
225 | — | ||||||
Payroll payable |
473 | 818 | ||||||
Accrued bonuses |
350 | — | ||||||
Short-term lease liabilities and other |
162 | 83 | ||||||
|
|
|
|
|||||
Total accrued and other current liabilities |
$ | 3,526 | $ | 3,899 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Deferred rent |
1,106 | 1,193 | ||||||
Long-term lease liabilities |
295 | 111 | ||||||
|
|
|
|
|||||
Total accrued and other long-term liabilities |
$ | 1,401 | $ | 1,304 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Principal amount, inclusive of accrued interest and changes in fair value, if any |
— | $ | 122,588 | |||||
Losses reported from changes in fair value in the statement of operations |
$ | (24,215 | ) | $ | (12,345 | ) |
As of December 31, |
||||||||
2019 |
2018 |
|||||||
2017 Notes Principal Outstanding |
$ | 5,304 | $ | 11,648 | ||||
Unamortized discount (2017 Notes) |
(56 | ) | (307 | ) | ||||
2018 Notes |
2,707 | 3,000 | ||||||
Unamortized discount (2018 Notes) |
(81 | ) | (151 | ) | ||||
|
|
|
|
|||||
Net carrying amount |
7,874 | 14,190 | ||||||
Less: current portion |
6,459 | 6,320 | ||||||
|
|
|
|
|||||
Non-current portion |
$ | 1,415 | $ | 7,870 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Notes Principal Outstanding |
$ | 1,290 | $ | 4,023 | ||||
Unamortized discount |
(9 | ) | (66 | ) | ||||
|
|
|
|
|||||
Net carrying amount |
1,281 | 3,957 | ||||||
Less: current portion |
1,281 | 2,716 | ||||||
|
|
|
|
|||||
Non-current portion |
$ | — | $ | 1,241 | ||||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Revolving credit facility |
$ | — | $ | 500 | ||||
Vehicle loan |
45 | 60 | ||||||
Additional Equipment Loan |
146 | 179 | ||||||
|
|
|
|
|||||
Total |
191 | 739 | ||||||
Less: current portion |
51 | 549 | ||||||
|
|
|
|
|||||
Non-current portion |
$ | 140 | $ | 190 | ||||
|
|
|
|
As of December 31, 2019 |
||||
2020 |
$ | 7,912 | ||
2021 |
1,489 | |||
2022 |
54 | |||
2023 |
37 | |||
2024 |
— | |||
|
|
|||
Total |
9,492 | |||
Less unamortized debt cost |
146 | |||
|
|
|||
Long-term debt |
$ | 9,346 | ||
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
2017 Warrant |
$ | 1,035 | $ | 808 | ||||
2018 Warrant |
87 | 58 | ||||||
|
|
|
|
|||||
Total |
$ | 1,122 | $ | 866 | ||||
|
|
|
|
Shares Authorized |
Shares Issued and Outstanding |
Per Share Liquidation Preference |
||||||||||
Series A |
2,228,361 | 1,660,839 | $ | 43.30 | ||||||||
Series A-1 |
163,306 | 163,306 | 15.31 | |||||||||
Series A-2 |
1,322,780 | 1,322,780 | 15.12 | |||||||||
Series A-3 |
223,548 | 223,548 | 17.89 | |||||||||
Series A-4 |
49,827 | 49,827 | 20.07 | |||||||||
Series A-5 |
137,715 | 124,068 | 20.15 | |||||||||
Series A-6 |
247,420 | 247,420 | 30.31 | |||||||||
Series A-7 |
1,459,656 | 1,459,656 | 34.64 | |||||||||
Series A-8 |
385,777 | 385,777 | 36.81 | |||||||||
Series A-9 |
748,674 | 748,674 | 38.97 | |||||||||
Series A-10 |
252,801 | 252,801 | 41.14 | |||||||||
Series A-11 |
317,404 | 317,404 | $ | 5.27 | ||||||||
|
|
|
|
|||||||||
7,537,269 | 6,956,100 | |||||||||||
|
|
|
|
Effective conversion price |
||||
Series A |
$ | 43.30 | ||
Series A-1 |
15.31 | |||
Series A-2 |
15.12 | |||
Series A-3 |
17.89 | |||
Series A-4 |
20.07 | |||
Series A-5 |
20.15 | |||
Series A-6 |
30.31 | |||
Series A-7 |
34.64 | |||
Series A-8 |
36.81 | |||
Series A-9 |
38.97 | |||
Series A-10 |
41.14 | |||
Series A-11 |
24.30 |
Commitment Date |
Series |
Type of Consideration received (cash or settlement of other instruments) |
Effective Conversion Price |
Fair value of the Common Stock |
Number of Shares Issuable upon Conversion |
BCF |
||||||||||||||||||
6/24/2019 |
A | Cash | $ | 43.30 | $ | 18.59 | 648,069 | $ | — | |||||||||||||||
A | Settlement of SAFEs | 43.30 | 18.59 | 75,165 | — | |||||||||||||||||||
A-1 |
Settlement of SAFEs | 15.31 | 18.59 | 163,306 | 536,000 | |||||||||||||||||||
A-2 |
Settlement of SAFEs | 15.12 | 18.59 | 1,322,780 | 4,590,000 | |||||||||||||||||||
A-3 |
Settlement of SAFEs | 17.89 | 18.59 | 223,548 | 156,000 | |||||||||||||||||||
A-4 |
Settlement of SAFEs | 20.07 | 18.59 | 49,827 | — | |||||||||||||||||||
A-5 |
Settlement of SAFEs | 20.15 | 18.59 | 124,068 | — | |||||||||||||||||||
A-6 |
Settlement of SAFEs | 30.31 | 18.59 | 247,420 | — | |||||||||||||||||||
A-7 |
Settlement of SAFEs | 34.64 | 18.59 | 1,459,656 | — | |||||||||||||||||||
A-8 |
Settlement of SAFEs | 36.81 | 18.59 | 385,777 | — | |||||||||||||||||||
A-9 |
Settlement of SAFEs | 38.97 | 18.59 | 748,674 | — | |||||||||||||||||||
A-10 |
Settlement of SAFEs | 41.14 | 18.59 | 252,801 | — | |||||||||||||||||||
A-11 |
Settlement of Note | 24.30 | 18.59 | 317,404 | — | |||||||||||||||||||
6/26/2019 |
A | Cash | 43.30 | 18.59 | 692,778 | — | ||||||||||||||||||
7/15/2019 |
A | Cash | 43.30 | 18.59 | 11,546 | — | ||||||||||||||||||
7/22/2019 |
A | Cash | 43.30 | 18.59 | 233,281 | — | ||||||||||||||||||
|
|
|||||||||||||||||||||||
$ | 5,282,000 | |||||||||||||||||||||||
|
|
Fair Value (in thousands) Measured as of December 31, 2019 Using: |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Commercial papers |
$ | — | $ | 3,212 | $ | — | $ | 3,212 | ||||||||
Corporate debt |
— | 2,698 | — | 2,698 | ||||||||||||
Treasury bills |
749 | — | — | 749 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
749 | 5,910 | — | 6,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
SAFEs |
— | — | — | — | ||||||||||||
2017 Warrants |
— | — | 1,035 | 1,035 | ||||||||||||
2018 Warrants |
— | — | 87 | 87 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
$ | — | $ | — | $ | 1,122 | $ | 1,122 | ||||||||
|
|
|
|
|
|
|
|
Fair Value (in thousands) Measured as of December 31, 2018 Using: |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Liabilities: |
||||||||||||||||
SAFEs |
$ | — | $ | — | $ | 122,588 | $ | 122,588 | ||||||||
2017 Warrants |
— | — | 808 | 808 | ||||||||||||
2018 Warrants |
— | — | 58 | 58 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total fair value |
$ | — | $ | — | $ | 123,454 | $ | 123,454 | ||||||||
|
|
|
|
|
|
|
|
For the year ended December 31, 2019 |
||||||||||||
SAFEs |
2017 Warrants |
2018 Warrants |
||||||||||
Balance-beginning of year |
$ | 122,588 | $ | 808 | $ | 58 | ||||||
Additions |
37,379 | — | ||||||||||
Exercise or conversion |
(184,182 | ) | ||||||||||
Measurement adjustments |
24,215 | 227 | 29 | |||||||||
|
|
|
|
|
|
|||||||
Balance-end of year |
$ | — | $ | 1,035 | $ | 87 | ||||||
|
|
|
|
|
|
For the year ended December 31, 2018 |
||||||||||||
SAFEs |
2017 Warrants |
2018 Warrants |
||||||||||
Balance-beginning of year |
$ | 43,775 | $ | 723 | $ | |||||||
Additions |
66,467 | — | ||||||||||
Exercise or conversion |
||||||||||||
Measurement adjustments |
12,345 | 85 | 58 | |||||||||
|
|
|
|
|
|
|||||||
Balance-end of year |
$ | 122,588 | $ | 808 | $ | 58 | ||||||
|
|
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Numerator: |
||||||||
Net loss |
$ | (94,718 | ) | $ | (79,550 | ) | ||
Deemed dividend attributable to BCF accretion |
(5,282 | ) | — | |||||
|
|
|
|
|||||
Net loss attributable to common shareholders |
(100,000 | ) | (79,550 | ) | ||||
|
|
|
|
|||||
Denominator: |
||||||||
Weighted average Common shares outstanding- Basic |
8,718,104 | 6,631,873 | ||||||
Dilutive effect of potential common shares |
— | — | ||||||
|
|
|
|
|||||
Weighted average Common shares outstanding- Diluted |
8,718,104 | 6,631,873 | ||||||
|
|
|
|
|||||
Net loss per shares attributable to Common shareholders- Basic and Diluted |
$ | (11.47 | ) | $ | (12.00 | ) | ||
|
|
|
|
As of December 31, |
||||||||
2019 |
2018 |
|||||||
Warrants |
71,281 | 71,281 | ||||||
Stock Options |
365,938 | — | ||||||
Restricted Stock |
460,257 | 1,693,491 | ||||||
Series A Convertible Preferred Stock |
6,956,100 | — | ||||||
Founders Preferred Stock |
1,922,600 | 1,922,600 | ||||||
SAFE |
— | 4,488,738 | ||||||
|
|
|
|
|||||
Total |
9,776,176 | 8,176,110 | ||||||
|
|
|
|
2019 |
||||
Expected term (years) (1) |
5.27 – 6.02 | |||
Current stock value |
$ | 17.38 – 22.80 | ||
Expected volatility (2) |
44.6% – 49.3% | |||
Risk-free interest rate (3) |
1.6% – 1.9% | |||
Dividend yield (4) |
0% |
(1) | The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. |
(2) | Volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. |
(3) | Risk free rate was obtained from US treasury notes for the expected terms noted as of the valuation date. |
(4) | The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future. |
Number of Common Stock Options |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Life (Years) |
Aggregate Intrinsic Value (In Thousands) |
|||||||||||||
Outstanding as of January 1, 2019 |
— | $ | — | — | $ | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Granted |
366,988 | 22.73 | 9.76 | |||||||||||||
Exercised |
— | — | — | |||||||||||||
Forfeited |
(1,050 | ) | 22.73 | 9.61 | ||||||||||||
Expired |
— | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding as of December 31, 2019 |
365,938 | 22.73 | 9.76 | 22 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and exercisable as of December 31, 2019 |
26,035 | 22.73 | 9.75 | 2 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and expected to vest as of December 31, 2019 |
365,938 | $ | 22.73 | 9.76 | $ | 22 | ||||||||||
|
|
|
|
|
|
|
|
Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
Outstanding as of December 31, 2017 |
3,534,436 | $ | 0.36 | |||||
Granted |
509,379 | 12.39 | ||||||
Forfeited |
(89,047 | ) | 2.50 | |||||
Vested |
(2,278,495 | ) | 0.78 | |||||
|
|
|
|
|||||
Outstanding as of December 31, 2018 |
1,676,273 | 3.01 | ||||||
Granted |
150,800 | 17.54 | ||||||
Forfeited |
(97,150 | ) | 7.19 | |||||
Vested |
(1,271,666 | ) | 1.97 | |||||
|
|
|
|
|||||
Outstanding as of December 31, 2019 |
458,257 | $ | 10.92 | |||||
|
|
|
|
Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
Outstanding as of December 31, 2017 |
37,989 | $ | 0.05 | |||||
Granted |
2,800 | 13.75 | ||||||
Forfeited |
(625 | ) | 0.05 | |||||
Vested |
(22,946 | ) | 0.64 | |||||
|
|
|
|
|||||
Outstanding as of December 31, 2018 |
17,218 | 1.46 | ||||||
Granted |
— | — | ||||||
Forfeited |
— | — | ||||||
Vested |
(15,219 | ) | 17.61 | |||||
|
|
|
|
|||||
Outstanding as of December 31, 2019 |
1,999 | $ | 17.61 | |||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Cost of sales |
$ | 92 | $ | 66 | ||||
Research and development |
914 | 564 | ||||||
Sales and marketing |
163 | 83 | ||||||
General and administrative |
1,533 | 1,349 | ||||||
|
|
|
|
|||||
Total |
$ | 2,702 | $ | 2,062 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Domestic |
$ | 94,718 | $ | 79,550 | ||||
Foreign |
— | — | ||||||
|
|
|
|
|||||
Loss before income taxes |
$ | 94,718 | $ | 79,550 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
U.S. federal provision at statutory rate |
21.0 | % | 21.0 | % | ||||
State income taxes, net of federal benefit |
2.9 | 3.7 | ||||||
Tax credits |
1.9 | 2.2 | ||||||
Permanent items |
(7.4 | ) | (3.9 | ) | ||||
Uncertain tax benefits |
(0.9 | ) | (1.1 | ) | ||||
Change in valuation allowance |
(17.5 | ) | (21.9 | ) | ||||
|
|
|
|
|||||
Effective tax rate |
0.0 | % | 0.0 | % | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Deferred tax assets: |
||||||||
Net operating loss carry forward |
$ | 43,971 | $ | 27,644 | ||||
Tax credits |
2,397 | 1,473 | ||||||
Accruals and reserves |
1,671 | 2,063 | ||||||
Stock-based compensation |
23 | — | ||||||
Other |
2 | 1 | ||||||
|
|
|
|
|||||
Total deferred tax assets |
48,064 | 31,181 | ||||||
Valuation allowance |
(46,998 | ) | (29,771 | ) | ||||
|
|
|
|
|||||
Total deferred tax asset |
1,066 | 1,410 | ||||||
Deferred tax liabilities: |
||||||||
Depreciation and amortization |
1,066 | 1,410 | ||||||
|
|
|
|
|||||
Total deferred tax liabilities |
1,066 | 1,410 | ||||||
|
|
|
|
|||||
Net deferred tax assets (liabilities) |
$ | — | $ | — | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2018 |
|||||||
Unrecognized tax benefits as of the beginning of the year |
$ | 1,473 | $ | 549 | ||||
Increases related to prior year tax provisions |
||||||||
Decrease related to prior year tax provisions |
||||||||
Increase related to current year tax provisions |
924 | 924 | ||||||
Statue lapse |
||||||||
|
|
|
|
|||||
Unrecognized tax benefits as of the end of the year |
$ | 2,397 | $ | 1,473 | ||||
|
|
|
|
Capital Leases |
Operating Leases |
|||||||
2020 |
$ | 216 | $ | 5,965 | ||||
2021 |
204 | 6,264 | ||||||
2022 |
113 | 5,975 | ||||||
2023 |
4 | 3,992 | ||||||
2024 |
— | 746 | ||||||
Thereafter |
— | — | ||||||
|
|
|
|
|||||
Total minimum lease payments |
537 | $ | 22,942 | |||||
Less: amount representing interest |
83 | |||||||
|
|
|
|
|||||
Long-term capital lease obligations as of December 31, 2019 |
$ | 454 | ||||||
|
|
Year ended December 31, 2019 |
||||||||||||||||||||
Autonomy Solutions |
Other Component Sales |
Total reportable segments |
Eliminations (1) |
Total Consolidated |
||||||||||||||||
Revenue: |
||||||||||||||||||||
Revenues from external customers |
$ | 9,666 | $ | 2,936 | $ | 12,602 | $ | — | $ | 12,602 | ||||||||||
Revenues from internal customer |
— | 2,949 | 2,949 | (2,949 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Revenue |
9,666 | 5,885 | 15,551 | (2,949 | ) | 12,602 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization |
2,135 | 181 | 2,316 | — | 2,316 | |||||||||||||||
Operating loss |
(62,874 | ) | 259 | (62,615 | ) | — | (62,615 | ) | ||||||||||||
Other significant items: |
||||||||||||||||||||
Segment assets |
52,171 | 2,218 | 54,389 | (2,525 | ) | 51,864 | ||||||||||||||
Inventory |
$ | 4,002 | $ | — | $ | 4,002 | $ | — | $ | 4,002 |
Year ended December 31, 2018 |
||||||||||||||||||||
Autonomy Solutions |
Other Component Sales |
Total reportable segments |
Eliminations (1) | Total Consolidated |
||||||||||||||||
Revenue: |
||||||||||||||||||||
Revenues from external customers |
$ | 7,236 | $ | 4,456 | $ | 11,692 | $ | — | $ | 11,692 | ||||||||||
Revenues from internal customer |
— | 3,387 | 3,387 | (3,387 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Revenue |
7,236 | 7,843 | 15,079 | (3,387 | ) | 11,692 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization |
1,335 | 159 | 1,494 | — | 1,494 | |||||||||||||||
Operating loss |
(63,845 | ) | (384 | ) | (64,229 | ) | — | (64,229 | ) | |||||||||||
Other significant items: |
||||||||||||||||||||
Segment assets |
26,569 | 4,244 | 30,813 | (2,611 | ) | 28,202 | ||||||||||||||
Inventory |
$ | 2,926 | $ | — | $ | 2,926 | $ | — | $ | 2,926 |
1. | Represent the eliminations of all intercompany balances and transactions during the period presented. |
(i) | If to Parent, First Merger Sub or Second Merger Sub, to: |
(ii) | If to the Company to: |
GORES METROPOULOS, INC. | ||
By: | /s/ Alec Gores | |
Name: Alec Gores | ||
Title: Chief Executive Officer | ||
DAWN MERGER SUB, INC. | ||
By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Chief Financial Officer and Secretary | ||
DAWN MERGER SUB II, LLC | ||
By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Manager |
LUMINAR TECHNOLOGIES, INC. | ||
By: | /s/ Austin Russell | |
Name: Austin Russell | ||
Title: Founder & CEO, Luminar Technologies |
[●] |
[Title] |
Page |
||||||
C-1 | ||||||
1.1 |
Annual Meetings | C-1 | ||||
1.2 |
Special Meetings | C-1 | ||||
1.3 |
Notice of Meetings | C-1 | ||||
1.4 |
Adjournments | C-1 | ||||
1.5 |
Quorum | C-2 | ||||
1.6 |
Organization | C-2 | ||||
1.7 |
Voting; Proxies | C-2 | ||||
1.8 |
Fixing Date for Determination of Stockholders of Record | C-3 | ||||
1.9 |
List of Stockholders Entitled to Vote | C-3 | ||||
1.10 |
Inspectors of Elections | C-3 | ||||
1.11 |
Notice of Stockholder Business; Nominations | C-4 | ||||
C-10 | ||||||
2.1 |
Number; Qualifications | C-10 | ||||
2.2 |
Election; Resignation; Removal; Vacancies | C-10 | ||||
2.3 |
Regular Meetings | C-10 | ||||
2.4 |
Special Meetings | C-10 | ||||
2.5 |
Remote Meetings Permitted | C-10 | ||||
2.6 |
Quorum; Vote Required for Action | C-11 | ||||
2.7 |
Organization | C-11 | ||||
2.8 |
Unanimous Action by Directors in Lieu of a Meeting | C-11 | ||||
2.9 |
Powers | C-11 | ||||
2.10 |
Compensation of Directors | C-11 | ||||
C-11 | ||||||
3.1 |
Committees | C-11 | ||||
3.2 |
Committee Rules | C-12 | ||||
C-12 | ||||||
4.1 |
Generally | C-12 | ||||
4.2 |
Chief Executive Officer | C-12 | ||||
4.3 |
Chairperson of the Board | C-13 | ||||
4.4 |
Lead Independent Director | C-13 | ||||
4.5 |
President | C-13 | ||||
4.6 |
Chief Financial Officer | C-13 |
Page |
||||||
4.7 |
Treasurer | C-13 | ||||
4.8 |
Vice President | C-14 | ||||
4.9 |
Secretary | C-14 | ||||
4.10 |
Delegation of Authority | C-14 | ||||
4.11 |
Removal | C-14 | ||||
C-14 | ||||||
5.1 |
Certificates; Uncertificated Shares | C-14 | ||||
5.2 |
C-15 | |||||
5.3 |
Other Regulations | C-15 | ||||
C-15 | ||||||
6.1 |
Indemnification of Officers and Directors | C-15 | ||||
6.2 |
Advance of Expenses | C-15 | ||||
6.3 |
Non-Exclusivity of Rights | C-16 | ||||
6.4 |
Indemnification Contracts | C-16 | ||||
6.5 |
Right of Indemnitee to Bring Suit | C-16 | ||||
6.6 |
Nature of Rights | C-16 | ||||
6.7 |
Insurance | C-17 | ||||
C-17 | ||||||
7.1 |
Notice | C-17 | ||||
7.2 |
Waiver of Notice | C-18 | ||||
C-18 | ||||||
8.1 |
Interested Directors | C-18 | ||||
8.2 |
Quorum | C-18 | ||||
C-18 | ||||||
9.1 |
Fiscal Year | C-18 | ||||
9.2 |
Seal | C-18 | ||||
9.3 |
Form of Records | C-19 | ||||
9.4 |
Reliance Upon Books and Records | C-19 | ||||
9.5 |
Certificate of Incorporation Governs | C-19 | ||||
9.6 |
Severability | C-19 | ||||
9.7 |
Time Periods | C-19 | ||||
C-19 |
Dated: [●], 2020 |
[●] |
Secretary |
Redemption Date (period to expiration of warrants) |
Fair Market Value of Class A Common Stock |
|||||||||||||||||||||||||||||||||||
$10.00 |
$11.00 |
$12.00 |
$13.00 |
$14.00 |
$15.00 |
$16.00 |
$17.00 |
$18.00 |
||||||||||||||||||||||||||||
57 months |
0.257 | 0.277 | 0.294 | 0.31 | 0.324 | 0.337 | 0.348 | 0.358 | 0.365 | |||||||||||||||||||||||||||
54 months |
0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.365 | |||||||||||||||||||||||||||
51 months |
0.246 | 0.268 | 0.287 | 0.304 | 0.32 | 0.333 | 0.346 | 0.357 | 0.365 | |||||||||||||||||||||||||||
48 months |
0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.365 | |||||||||||||||||||||||||||
45 months |
0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.33 | 0.343 | 0.356 | 0.365 | |||||||||||||||||||||||||||
42 months |
0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.364 | |||||||||||||||||||||||||||
39 months |
0.221 | 0.246 | 0.269 | 0.29 | 0.309 | 0.325 | 0.34 | 0.354 | 0.364 | |||||||||||||||||||||||||||
36 months |
0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.364 | |||||||||||||||||||||||||||
33 months |
0.205 | 0.232 | 0.257 | 0.28 | 0.301 | 0.32 | 0.337 | 0.352 | 0.364 | |||||||||||||||||||||||||||
30 months |
0.196 | 0.224 | 0.25 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.364 | |||||||||||||||||||||||||||
27 months |
0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.35 | 0.364 | |||||||||||||||||||||||||||
24 months |
0.173 | 0.204 | 0.233 | 0.26 | 0.285 | 0.308 | 0.329 | 0.348 | 0.364 | |||||||||||||||||||||||||||
21 months |
0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.364 | |||||||||||||||||||||||||||
18 months |
0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.363 | |||||||||||||||||||||||||||
15 months |
0.13 | 0.164 | 0.197 | 0.23 | 0.262 | 0.291 | 0.317 | 0.342 | 0.363 | |||||||||||||||||||||||||||
12 months |
0.111 | 0.146 | 0.181 | 0.216 | 0.25 | 0.282 | 0.312 | 0.339 | 0.363 | |||||||||||||||||||||||||||
9 months |
0.09 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.362 | |||||||||||||||||||||||||||
6 months |
0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.362 | |||||||||||||||||||||||||||
3 months |
0.034 | 0.065 | 0.104 | 0.15 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months |
— | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
GORES METROPOULOS, INC. | ||
By: | /s/ Alec Gores | |
Name: | Alec Gores | |
Title: | Chief Executive Officer | |
CONTINENTAL STOCK TRANSFER & | ||
TRUST COMPANY, as Warrant Agent | ||
By: | /s/ Francis Wolf | |
Name: | Francis E. Wolf, Jr. | |
Title: | Vice President |
GORES METROPOULOS, INC. |
||
By: |
||
Name: |
||
Title: |
||
CONTINENTAL STOCK TRANSFER | ||
& TRUST COMPANY, as Warrant Agent | ||
By: |
||
Name: |
||
Title: |
Date: , 20 | ||||||
(Signature) | ||||||
(Address) | ||||||
(Tax Identification Number) |
GORES METROPOULOS, INC. | ||
By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Chief Financial Officer | ||
DAWN MERGER SUB, INC. | ||
By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Chief Financial Officer and Secretary | ||
DAWN MERGER SUB II, LLC | ||
By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Manager |
AUSTIN RUSSELL | ||
By: | /s/ Austin Russell |
Stockholder Name |
Physical Address for Notice |
Email Address for Notice |
Class/Series of Company Stock |
Number of Shares |
||||||
Austin Russell | Luminar Technologies, Inc., 1891 Page Mill Road, Palo Alto CA 94304 | Austin.russell@luminartech.com | Class A Common Stock | 6,029,138 | ||||||
Austin Russell | Luminar Technologies, Inc., 1891 Page Mill Road, Palo Alto CA 94304 | Austin.russell@luminartech.com | Company Founders Preferred Stock | 1,682,600 |
1. |
Merger Agreement and Mergers |
2. |
Waiver of Appraisal Rights |
3. |
Exchange Agreement |
4. |
Certain Stockholder Agreements |
5. |
General |
Actual Date of Signature: |
[●] | |||
|
||||
(Signature) |
a) | all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the Class A Common Stock is then listed; |
b) | fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities); |
c) | fees and disbursements of underwriters customarily paid by issuers or sellers of securities, but excluding underwriting discounts and commissions and transfer taxes, if any; |
d) | printing, messenger, telephone, delivery and road show or other marketing expenses; |
e) | reasonable fees and disbursements of counsel for the Company; |
f) | reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration; and |
g) | reasonable fees and expenses of one (1) legal counsel selected by either (i) the majority-in-interest Section 2.3 if the Registration was initiated by the Company for its own account or that of a Company stockholder other than pursuant to the rights under this Agreement, in each case to be registered for offer and sale in the applicable Registration. |
COMPANY: | ||
Luminar Technologies, Inc., a Delaware corporation | ||
By: | ||
Name: | ||
Title: | ||
GORES HOLDERS: | ||
GORES METROPOULOS SPONSOR LLC, a Delaware limited liability company | ||
By: GM Sponsor, LLC, its managing member | ||
By: AEG Holdings, LLC, its managing member | ||
By: | ||
Name: Alec Gores | ||
Title: Chairman | ||
By: | ||
Name: Randall Bort | ||
By: | ||
Name: Michael Cramer | ||
By: | ||
Name: Joseph Gatto | ||
LUMINAR HOLDERS: | ||
Austin Russell | ||
G2VP I, LLC | ||
FOR ITSELF AND AS NOMINEE FOR G2VP FOUNDERS FUND I, LLC | ||
By: G2VP I Associates, LLC Its: Managing Member | ||
By: | ||
Name: Ben Kortlang | ||
Title: Managing Member | ||
GVA AUTO, LLC | ||
By: | ||
Name: Pavel Cherkashin | ||
Title: CEO |
GORES METROPOULOS, INC. | ||
By: | /s/ Andrew McBride | |
Name: | Andrew McBride | |
Title: | Chief Financial Officer | |
AUSTIN RUSSELL | ||
/s/ Austin Russell | ||
Austin Russell | ||
Address: | 1891 Page Mill Road | |
Palo Alto, CA 94304 | ||
Email: | austin.russell@luminartech.com |
Very truly yours, |
MOELIS & COMPANY LLC |
Exhibit No. |
Description | |
2.1** | Agreement and Plan of Merger, dated as of August 24, 2020, by and among Gores Metropoulos, Inc., First Merger Sub, Second Merger Sub and Luminar Technologies, Inc. (included as Annex A to the proxy statement/consent solicitation statement/prospectus) | |
3.1** | Proposed Second Amended and Restated Certificate of Incorporation of Gores Metropoulos, Inc. (included as Annex B to the proxy statement/consent solicitation statement/prospectus) | |
3.2** | Form of Luminar Technologies, Inc. Restated Bylaws (included as Annex C to the proxy statement/consent solicitation statement/prospectus) | |
5.1* | Opinion of Weil, Gotshal & Manges LLP regarding validity of the securities being registered | |
8.1* | Opinion of Orrick, Herrington & Sutcliff LLP regarding certain U.S. tax matters | |
10.1** | Warrant Agreement, by and between Gores Metropoulos, Inc. and Continental Stock Transfer & Trust Company, as warrant agent, dated as of January 31, 2019 (included as Annex D to the proxy statement/consent solicitation statement/prospectus and the form of which was previously included as Exhibit 4.4 to the Company’s registration statement on Form S-1, filed December 11, 2018) | |
10.2* | Amended and Restated Support Agreement, dated October 13, 2020, by and among Gores Metropoulos, Inc., First Merger Sub, Second Merger Sub, and Austin Russell (included as Annex E to the proxy statement/consent solicitation statement/prospectus) | |
10.3** | Form of Registration Rights Agreement, to be entered into at the closing of the Business Combination, by and among Luminar Technologies, Inc. (f/k/a Gores Metropoulos, Inc.), the Initial Stockholders, Austin Russell, GVA and G2VP (included as Annex F to the proxy statement/consent solicitation statement/prospectus) | |
10.4** | Voting Agreement, by and among Gores Metropoulos, Inc. and Austin Russell (included as Annex G to the proxy statement/consent solicitation statement/prospectus) | |
10.5* | Management Longer Term Equity Incentive Plan (included as Annex I to the proxy statement/consent solicitation statement/prospectus) | |
10.6* | 2020 Equity Incentive Plan (included as Annex J to the proxy statement/consent solicitation statement/prospectus) | |
10.7* | 2020 Employee Stock Purchase Plan (included as Annex K to the proxy statement/consent solicitation statement/prospectus) | |
10.8*† | Framework Purchase Agreement, dated March 23, 2020, by and between Volvo Car Corporation and Luminar Technologies, Inc. | |
10.9*§ | ||
10.10* | Form of Stock Option Award Agreement under the Luminar Technologies, Inc. 2020 Equity Incentive Plan. | |
10.11* | Form of Restricted Stock Unit Award Agreement under the Luminar Technologies, Inc. 2020 Equity Incentive Plan. | |
23.1* | Consent of KPMG LLP, independent registered accounting firm for Gores Metropoulos, Inc. | |
23.2* | Consent of Deloitte & Touche LLP, independent registered accounting firm for Luminar Technologies, Inc. | |
23.3* | Consent of Moelis & Company LLC, financial advisor for Gores Metropoulos, Inc. | |
24.1** | Power of Attorney |
Exhibit No. |
Description | |
99.1* | Form of Proxy Card for Special Meeting | |
99.2* | Consent of Austin Russell to be named as a director | |
99.3* | Consent of Matthew J. Simoncini to be named as a director | |
99.4* | Consent of Alec E. Gores to be named as a director | |
99.5* | Consent of Scott A. McGregor to be named as a director | |
99.6* | Consent of Benjamin J. Kortlang to be named as a director | |
101.ins* | XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.sch* | Inline XBRL Taxonomy Schema Document | |
101.cal* | Inline XBRL Taxonomy Calculation Linkbase Document | |
101.def* | Inline XBRL Taxonomy Definition Linkbase Document | |
101.lab* | Inline XBRL Taxonomy Label Linkbase Document | |
101.pre* | Inline XBRL Taxonomy Presentation Linkbase Document | |
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* | Filed herewith |
** | Previously filed |
† | Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Regulation S-K, Item (601)(b)(10). |
§ | Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. |
Gores Metropoulos, Inc. | ||
By: | /s/ Dean Metropoulos | |
Name: | Dean Metropoulos | |
Title: | Chairman of the Board of Directors |
Signature |
Title |
Date | ||
/s/ Dean Metropoulos Dean Metropoulos |
Chairman and Director | October 19, 2020 | ||
* Alec Gores |
CEO and Director (Principal Executive Officer) |
October 19, 2020 | ||
/s/ Andrew McBride Andrew McBride |
CFO and Secretary (Principal Financial and Accounting Officer) |
October 19, 2020 | ||
* Randall Bort |
Director | October 19, 2020 | ||
* Michael Cramer |
Director | October 19, 2020 | ||
* Joseph Gatto |
Director | October 19, 2020 |
*By: | /s/ Andrew McBride | |
Name: Andrew McBride | ||
Title: Attorney-in-Fact |